
<html lang="en"     class="pb-page"  data-request-id="8d4deb80-514c-40e4-84b8-e9671b5cecf8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01964"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management" /></meta><meta name="dc.Creator" content="Youyi  Peng" /></meta><meta name="dc.Creator" content="Qiang  Zhang" /></meta><meta name="dc.Creator" content="William J.  Welsh" /></meta><meta name="dc.Description" content="The sigma 1 receptor (S1R) is a molecular chaperone protein located in the endoplasmic reticulum and plasma membranes and has been shown to play important roles in various pathological disorders in..." /></meta><meta name="Description" content="The sigma 1 receptor (S1R) is a molecular chaperone protein located in the endoplasmic reticulum and plasma membranes and has been shown to play important roles in various pathological disorders in..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 29, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01964" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01964" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01964" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01964" /></link>
        
    
    

<title>Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01964" /></meta><meta property="og:title" content="Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0011.jpeg" /></meta><meta property="og:description" content="The sigma 1 receptor (S1R) is a molecular chaperone protein located in the endoplasmic reticulum and plasma membranes and has been shown to play important roles in various pathological disorders including pain and, as recently discovered, COVID-19. Employing structure- and QSAR-based drug design strategies, we rationally designed, synthesized, and biologically evaluated a series of novel triazole-based S1R antagonists. Compound 10 exhibited potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slow clearance in liver microsomes, and excellent blood–brain barrier permeability in rats. Further in vivo studies in rats showed that 10 exhibited negligible acute toxicity in the rotarod test and statistically significant analgesic effects in the formalin test for acute inflammatory pain and paclitaxel-induced neuropathic pain models during cancer chemotherapy. These encouraging results promote further development of our triazole-based S1R antagonists as novel treatments for pain of different etiologies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01964"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01964">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01964&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01964&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01964&amp;href=/doi/10.1021/acs.jmedchem.0c01964" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 890-904</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01924" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02084" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Youyi Peng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Youyi Peng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biomedical Informatics Shared Resource, Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a8d8cdc6cfd1c7e8cbc1c6c286dadddccfcddadb86cdccdd"><span class="__cf_email__" data-cfemail="5424313a332d3b14373d3a3e7a262120333126277a313021">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Youyi++Peng">Youyi Peng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4797-995X" title="Orcid link">http://orcid.org/0000-0003-4797-995X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiang Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiang Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, 661 Hoes Lane West, Piscataway, New Jersey 08854, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Zhang">Qiang Zhang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">William J. Welsh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William J. Welsh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biomedical Informatics Shared Resource, Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, United States</div><div class="loa-info-affiliations-info">Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, 661 Hoes Lane West, Piscataway, New Jersey 08854, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4037252c3328372a0032372a2d336e323534272532336e252435"><span class="__cf_email__" data-cfemail="c2b5a7aeb1aab5a882b0b5a8afb1ecb0b7b6a5a7b0b1eca7a6b7">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+J.++Welsh">William J. Welsh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5618-2072" title="Orcid link">http://orcid.org/0000-0002-5618-2072</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01964&amp;href=/doi/10.1021%2Facs.jmedchem.0c01964" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 890–904</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 29, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 November 2020</li><li><span class="item_label"><b>Published</b> online</span>29 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01964</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D890%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYouyi%2BPeng%252C%2BQiang%2BZhang%252C%2BWilliam%2BJ.%2BWelsh%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01964%26title%3DNovel%2BSigma%2B1%2BReceptor%2BAntagonists%2Bas%2BPotential%2BTherapeutics%2Bfor%2BPain%2BManagement%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D904%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01964"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1022</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01964" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Youyi&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;J. Welsh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;890-904&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01964&quot;},&quot;abstract&quot;:&quot;The sigma 1 receptor (S1R) is a molecular chaperone protein located in the endoplasmic reticulum and plasma membranes and has been shown to play important roles in various pathological disorders including pain and, as recently discovered, COVID-19. Employing structure- and QSAR-based drug design strategies, we rationally designed, synthesized, and biologically evaluated a series of novel triazole-based S1R antagonists. Compound 10 exhibited potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slow clearance in liver microsomes, and excellent blood–brain barrier permeability in rats. Further in vivo studies in rats showed that 10 exhibited negligible acute toxicity in the rotarod test and statistically significant analgesic effects in the formalin test for acute inflammatory pain and paclitaxel-induced neuropathic pain models during cancer chemotherapy. These encouraging results promote further development of our triazole-based S1R anta&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01964&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01964" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01964&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01964" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01964&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01964" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01964&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01964&amp;href=/doi/10.1021/acs.jmedchem.0c01964" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01964" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01964" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01964%26sid%3Dliteratum%253Aachs%26pmid%3D33372782%26genre%3Darticle%26aulast%3DPeng%26date%3D2021%26atitle%3DNovel%2BSigma%2B1%2BReceptor%2BAntagonists%2Bas%2BPotential%2BTherapeutics%2Bfor%2BPain%2BManagement%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D890%26epage%3D904%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The sigma 1 receptor (S1R) is a molecular chaperone protein located in the endoplasmic reticulum and plasma membranes and has been shown to play important roles in various pathological disorders including pain and, as recently discovered, COVID-19. Employing structure- and QSAR-based drug design strategies, we rationally designed, synthesized, and biologically evaluated a series of novel triazole-based S1R antagonists. Compound <b>10</b> exhibited potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable <i>in vitro</i> metabolic stability, slow clearance in liver microsomes, and excellent blood–brain barrier permeability in rats. Further <i>in vivo</i> studies in rats showed that <b>10</b> exhibited negligible acute toxicity in the rotarod test and statistically significant analgesic effects in the formalin test for acute inflammatory pain and paclitaxel-induced neuropathic pain models during cancer chemotherapy. These encouraging results promote further development of our triazole-based S1R antagonists as novel treatments for pain of different etiologies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The sigma receptor was initially identified as an opioid receptor in 1970s and later recognized as a distinct family composed of two subtypes: sigma 1 receptor (S1R) and sigma 2 receptor (S2R).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The S1R encodes a protein of 223 amino acids in diverse species and has a molecular weight of 25.3 kDa,<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> while S2R was recently identified as the protein TREM97 with 176 amino acids.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The S1R is enriched in mitochondrion-associated endoplasmic reticulum (ER) membranes (MAMs)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and is highly expressed in both the central and peripheral nervous systems.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><div class="NLM_p">Recent research on the S1R has implicated its role in various pathological disorders, including pain, depression, Alzheimer’s disease, and Parkinson’s disease.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> The S1R has been shown to act as a ligand-regulated chaperone protein and to modulate a wide spectrum of target proteins by intracellular calcium signaling.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> For example, it upregulates the NMDA receptor activity through the interaction with the NR1 subunit<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> and modulates opioid receptors and voltage-gated calcium channels, all of which play important roles in the modulation of pain.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a></div><div class="NLM_p">S1R knockout (KO) mice and S1R antagonists have been shown to attenuate chemical-induced (<i>e.g.</i>, formalin and capsaicin) and chemotherapy-induced neuropathic pain<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> and to potentiate opioid (<i>e.g.</i> morphine and oxycodone) analgesia but not its side effects (<i>e.g.</i>, dependence, tolerance, and constipation).<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Emerging evidence also suggests that S1R antagonists may inhibit tumor growth in mouse prostate cancer xenograft models<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and induce autophagic degradation of programmed death ligand 1 (PD-L1).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> More recently, S1R antagonists have been found to exhibit antiviral activities against the coronavirus SARS-Cov-2 potentially <i>via</i> the interaction with the viral membrane proteins Nsp6 and Orf9c.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> S1RA (MR309/E-52862, <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), a potent and selective small-molecule S1R antagonist, is the only one in its kind that has advanced to phase II clinical trials. It has been shown to exhibit promising results as a treatment for chemotherapy-induced peripheral neuropathy and to potentiate opioid analgesia without inducing adverse effects such as tolerance.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, the clinical development of S1RA has been on hold without clear reasons. We speculate that the halt was in part due to S1RA’s poor oral bioavailability and/or consequent lack of sufficient efficacy, as the volunteers participating in the study were treated with very high oral doses (400 mg daily), considering its potent binding affinity for the S1R receptor (<i>K</i><sub>i</sub> = 17 nM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The development of S1R antagonists with improved oral bioavailability, metabolic stability, and efficacy would represent an invaluable step forward for the management of pain without addiction and other adverse effects associated with opioid drugs.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structure of the S1R antagonist S1RA. (B) Trimeric overall architecture of the human S1R in complex with PD144418 in the X-ray crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>) viewed perpendicular to the ER membrane.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Three protomers are rendered as ribbons, and PD144418 in the A chain is rendered as a green space-filling model. (C) Structures of our novel S1R ligands with substituents R<sub>1</sub>, R<sub class="stack">1</sub><sup class="stack">′</sup>, R<sub>2</sub>, and R<sub>3</sub>: Compound <b>2</b> is (3-(5-(4-(<i>tert</i>-butyl)phenyl)-3-((dimethylamino)methyl)-1<i>H</i>-1,2,4-triazol-1-yl)phenol), with Me = methyl and Bu = butyl. (D) Superposition of our S1R ligand <b>10</b> (magenta ball-and-stick model, docked binding pose) with PD144418 (green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>), haloperidol (golden, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ">6DJZ</a>), and NE-100 (dark gray, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0">6DK0</a>) in the ligand-binding site of the human S1R crystal structure. Compound <b>10</b> was docked inside the ligand-binding pocket of the S1R crystal structure 5HK1 using GOLD.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The salt bridge between Glu172 and the ligands is depicted as a blue dashed line. Residues engaged in extensive hydrophobic contacts with ligands are shown as solid gray lines and labeled accordingly. The topology of the ligand-binding pocket is depicted as a light-pink surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, the X-ray crystallographic structures of the human S1R in complex with several known agonists and antagonists were solved at high resolutions (2.5–3.1 Å). These crystal structures depicted a homotrimeric overall architecture with a single trans-membrane domain in each protomer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref33">(31,33)</a> The ligand-binding pocket of agonists and antagonists in the S1R structures was identified and revealed the detailed ligand–receptor interactions at the molecular level (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). The availability of crystal structures of ligand-bound S1R not only helps us to understand the molecular basis for ligand recognition by the receptor but also facilitates the structure-based design of novel S1R ligands. Very recently, a structure-based virtual screening platform using these S1R crystal structures was established to successfully identify potent and selective ligands for the S1R.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">During an earlier drug discovery campaign on trisubstituted 1,2,4-triazoles as potent and selective delta opioid receptor ligands, we found that compound <b>2</b> (3-(5-(4-(<i>tert</i>-butyl)phenyl)-3-((dimethylamino)methyl)-1<i>H</i>-1,2,4-triazol-1-yl)phenol) possessed moderate affinity for the off-target sigma receptor (IC<sub>50</sub> = 560 nM) compared with high affinity for the targeted delta opioid receptor (IC<sub>50</sub> = 5.8 nM).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> More recently, we have compiled an extensive library of diverse S1R antagonists and developed a statistically robust and highly predictive pharmacophore-based 3D-QSAR model (<i>R</i><sup>2</sup> = 0.92, <i>Q</i><sup>2</sup> = 0.62, <i>R</i><sub>pred</sub><sup>2</sup> = 0.81).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These 3D-QSAR models, together with the availability of the ligand-bound S1R crystal structures and the promising results for S1RA in preclinical and clinical studies, motivated us to structurally optimize this series of trisubstituted 1,2,4-triazoles (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) as high-affinity and selective S1R ligands for diverse therapeutic indications. In the present study, we report the rational design, chemical synthesis, and biological evaluation of structurally novel triazole-based S1R antagonists. The lead compound <b>10</b> exhibited potent binding affinity and high selectivity for the S1R, acceptable <i>in vitro</i> metabolic stability and clearance in liver microsomes, excellent blood–brain barrier (BBB) permeability, and <i>in vivo</i> safety and analgesic activity in rodent models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Rational Design</h3><div class="NLM_p">Starting with the high-resolution X-ray crystal structures of the human S1R in complex with several known agonists and antagonists, we proceeded to the structure-based design of novel S1R ligands. The ligand-binding pocket in the S1R structure is deeply buried and is mostly hydrophobic. The essential ligand–receptor interactions at the molecular level have been identified based on these crystal structures (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). The anionic side chain of Glu172 forms a salt bridge with the ligand’s cationic amine, while Asp126 in its protonated state forms a hydrogen bond with Glu172 to stabilize the interaction network. Tyr103 interacts with ligands through π–π stacking and forms a hydrogen bond with Glu172 to stabilize its orientation. A number of hydrophobic residues (Trp89, Met93, Leu95, Leu105, Phe107, Phe133, Phe146, and Trp164) engage in extensive nonpolar interactions with hydrophobic or aromatic moieties of the bound ligands.</div><div class="NLM_p">Molecular docking of compound <b>2</b> to the ligand-binding pocket of antagonist-bound S1R crystal structures (pdb ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0">6DK0</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ">6DJZ</a>)<a onclick="showRef(event, 'ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref33">(31,33)</a> indicated that the protonated basic amine atom is positioned well to form a salt bridge with the anionic side chain of Glu172. The substituents on the amine (R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) occupy a hydrophobic subpocket surrounded by Trp89, Phe133, and Phe146. Increasing the size of R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> (dimethyl in <b>2</b>) promotes more extensive contacts with the receptor in the binding pocket. The <i>tert</i>-butylphenyl group (R<sub>2</sub> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) is well accommodated within a hydrophobic pocket lined by several hydrophobic residues (Met93, Leu95, Leu105, and Tyr103). However, the phenol group on compound <b>2</b> (R<sub>3</sub> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) is too large and clashes with the side chain of Phe107, which is consistent with its low binding affinity for the S1R. Introduction of small and hydrophobic substituents at R<sub>3</sub> (<i>e.g.</i>, methyl, ethyl, isopropyl, and cyclopropyl, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) helps to engage in optimal interactions with the side chain of Phe107.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>In vivo</i> safety and efficacy studies of compound <b>10</b> in SD rats. (A) Rotarod test (<i>N</i> = 6). (B) Formalin tests (<i>N</i> = 6). (C) Mechanical allodynia in rat models of paclitaxel (Taxol)-induced neuropathic pain (<i>N</i> = 8). (D) Cold hyperalgesia in rat models of paclitaxel (Taxol)-induced neuropathic pain (<i>N</i> = 8). Pre-trt: pretreatment; Post-trt: post-treatment. In contrast, the “gold standard” drug gabapentin was used as the positive control in these studies. *<i>p</i>-value < 0.05 in ANOVA <i>vs</i> the vehicle. Data are expressed as mean ± S.E.M. (error bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Exploration of the Basic Amine Groups<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0006.gif" alt="" id="GRAPHIC-d7e543-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0007.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">See the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Assays were conducted using guinea pig whole brain homogenates. Radioligands: S1R, [<sup>3</sup>H]-(+)-pentazocine; S2R, [<sup>3</sup>H]DTG. The <i>K</i><sub>i</sub> values represent the mean ± S.E.M. of at least two independent experiments, each in duplicate.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration of the Substitutions at the Phenyl Group<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0008.gif" alt="" id="GRAPHIC-d7e572-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0009.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">See the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Assays were conducted using human Jurkat cell homogenates. Radioligands: S1R, [<sup>3</sup>H]-(+)-pentazocine; S2R, [<sup>3</sup>H]DTG.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">S1R binding percentage at 100 nM.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">One independent experimental measurement.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">S2R binding percentage at 1000 nM. The <i>K</i><sub>i</sub> values represent the mean ± S.E.M. of at least two independent experiments, each in duplicate. Compound <b>10</b> was assayed four times in human S1R radiolabeled binding assay.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Exploration of the <i>N</i>-Substitutions on the Triazole Ring<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0010.gif" alt="" id="GRAPHIC-d7e622-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>K</i><sub>i</sub> ± S.E.M. (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center" char="±">S1R</th><th class="colsep0 rowsep0" align="center">S2R</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">haloperidol</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.41</td><td class="colsep0 rowsep0" align="center">83 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">24 ± 4.8</td><td class="colsep0 rowsep0" align="center">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center">methyl</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 1.7</td><td class="colsep0 rowsep0" align="center">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>33</b></td><td class="colsep0 rowsep0" align="center">ethyl</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 0.95</td><td class="colsep0 rowsep0" align="center">1710<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>34</b></td><td class="colsep0 rowsep0" align="center">isopropyl</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.43</td><td class="colsep0 rowsep0" align="center">1460<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>35</b></td><td class="colsep0 rowsep0" align="center">cyclopropyl</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 3.8</td><td class="colsep0 rowsep0" align="center">750<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">See the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Assays were conducted using human Jurkat cell homogenates. Radioligands: S1R, [<sup>3</sup>H]-(+)-pentazocine; S2R, [<sup>3</sup>H]DTG.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">One independent experimental measurement. The <i>K</i><sub>i</sub> values represent the mean ± S.E.M. of at least two independent experiments, each in duplicate.</p></div></div></div><div class="NLM_p last">Recently, we compiled a large library of diverse S1R antagonists for the development of a statistically robust and highly predictive 3D-QSAR model.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The structural motifs and their bioisosteres (<i>e.g.</i>, <i>tert</i>-butyl <i>vs</i> trifluoromethylcyclopropyl) aligned at the positions of R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and R<sub>2</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) on potent S1R antagonists in the diverse library were modeled onto our 1,2,4-triazole scaffold to design new ligands, all of which conformed to Lipinski’s Rule of 5.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> All compounds were then docked inside the ligand-binding site in the antagonist-bound S1R crystal structure (pdb ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>) to evaluate their binding scores, followed by screening with the 3D-QSAR model to predict the S1R binding affinity (<i>K</i><sub>i</sub>). Compounds with top (high) docking scores and potent (low nM) predicted <i>K</i><sub>i</sub> values were selected for synthesis. This procedure also considered the structural diversity of the selected compounds based on our experience in drug discovery. All of the designed compounds passed the PAINS (pan assay interference compounds substructures) screening protocol.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Future X-ray crystallography studies of the S1R complexed with our lead compound are necessary to confirm the binding poses and to facilitate further optimization of the subject S1R antagonists.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">Two synthetic routes were developed to prepare all compounds. For compounds <b>3</b>–<b>11</b> and <b>33</b>–<b>35</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), 4-<i>tert</i>-butyl benzoic acid (<b>I-a</b>) was selected as the initial starting material. Different monosubstituted hydrazines were coupled with <b>I-a</b> using pentafluorophenol (Pfp-OH) and <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI) as activating reagents, and the products, hydrazides <b>I-b</b>, were isolated from its isomers without any difficulty by column chromatography. The triazole rings were subsequently cyclized by reacting <b>I-b</b> with ethyl-2-amino-thioxoacetate to give <b>I-c</b>. The ethyl ester in <b>I-c</b> was further replaced by amines, which produced key intermediates <b>I-d</b>. Final products were prepared by reducing the amide groups in <b>I-d</b> with di-<i>iso</i>-butylalumnium hydride (DIBAL-H). Most free amines of compounds <b>3</b>–<b>11</b> and <b>33</b>–<b>35</b> were eventually converted to HCl salts during HPLC purification processes to give products with superior stability.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>3–11</b> and <b>33–35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sub>3</sub>NHNH<sub>2</sub>, Pfp-OH, EDCI, DIEA, DCM, 25 °C; (b) ethyl-2-amino-thioxoacetate, CH<sub>3</sub>COOH, toluene, 90 °C; (c) R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup>NH, AlMe<sub>3</sub>, DCE, 0–50 °C; and (d) DIBAL-H, THF, 0 °C.</p></p></figure><div class="NLM_p">For the preparation of compounds <b>12–32</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), 1-methyl-1<i>H</i>-1,2,4-triazole-3-carboxylate (<b>II-a</b>) was used as the starting material. The 5-position of this 1<i>H</i>-1,2,4-triazole was brominated with <i>N</i>-bromosuccinimide (NBS) in moderate yields. The methyl ester group in <b>II-b</b> was converted to amide <b>II-d</b> by hydrolysis with lithium hydroxide (LiOH) and followed up by an amide coupling reaction with pyrrolidine. <b>II-d</b> was subsequently coupled with different commercially available boronic acids or internally synthesized dioxaborolanes, <i>via</i> Suzuki coupling reaction to give key intermediates <b>II-f</b>. The amide groups in <b>II-f</b> were reduced to amines with DIBAL-H to give products as free bases, which were finally converted to the corresponding HCl salts.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>12–32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, NBS, THF, 0–25 °C; (b) LiOH, THF, H<sub>2</sub>O, 0–20 °C; (c) pyrrolidine, HATU, DMF, 0–20 °C; (d) (HO)<sub>2</sub>B (CH)<sub>6</sub>R<sub>2</sub> or (Me<sub>2</sub>CHO)<sub>2</sub>B(CH)<sub>6</sub>R<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, Pd(dppf)Cl<sub>2</sub>, 1,4-dioxane, H<sub>2</sub>O, 20–80 °C; and (e) DIBAL-H, THF, 0 °C.</p></p></figure><div class="NLM_p last">Compound <b>27</b> was prepared directly from compound <b>25</b>. The α position of the benzothiaphene motif in <b>25</b> was deprotonated with <i>n</i>-butyllithium (BuLi), and the resulting anion was subsequently chlorinated with NCS under mild conditions to yield compound <b>27</b> in a single step.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure–Activity Relationships</h3><div class="NLM_p"><i>In vitro</i> binding affinities of all compounds for the S1R and S2R were determined by radiolabeled binding assays according to previously reported methods.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Compounds <b>3</b>–<b>11</b> were tested in guinea pig (g.p.) whole brain homogenates, while the other compounds were tested in human Jurkat cells using [<sup>3</sup>H]-(+)-pentazocine and [<sup>3</sup>H]DTG as the radioligands for S1R and S2R, respectively. Nonspecific binding for S1R was measured in the presence of 10 μM unlabeled (+)-pentazocine (g.p.) or haloperidol (human). Because a selective S2R radioligand is not available, the nonselective radioligand [<sup>3</sup>H]DTG was used in the presence of an excess of (+)-pentazocine to mask the S1R. The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">We first explored the structure–activity relationships (SARs) of the substituents (R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup>) on the basic amine group (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), guided by a combination of structure-based and QSAR-based rational design techniques. All compounds were docked inside the ligand-binding site of S1R X-ray structures using GOLD<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the top binding pose exemplified by <b>10</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D. As the crystal structures and predicted binding poses reveal, the basic nitrogen atom is an essential feature to confer potent binding to the S1R, while the R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> moiety sits in a hydrophobic subpocket within the ligand-binding site. Therefore, we retained the basic nitrogen atom and introduced different hydrophobic substituents to optimize ligand–receptor interactions. As the results show (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), increasing the basicity of the nitrogen atom favors the binding affinity for S1R by >10 fold, as seen in piperidine-substituted <b>3</b> (<i>K</i><sub>i</sub> = 3.7 nM) <i>versus</i> morpholine-substituted <b>4</b> (<i>K</i><sub>i</sub> = 56 nM). Increasing the length of the substituent is tolerated for S1R binding affinity but enhances S2R binding affinity, as demonstrated by compounds <b>7</b> (S1R <i>K</i><sub>i</sub> = 10 nM, S2R <i>K</i><sub>i</sub> = 14 nM) <i>versus</i><b>8</b> (S1R <i>K</i><sub>i</sub> = 5.5 nM, S2R <i>K</i><sub>i</sub> = 39 nM) <i>versus</i><b>6</b> (S1R <i>K</i><sub>i</sub> = 14 nM, S2R <i>K</i><sub>i</sub> > 1000 nM). Introduction of a second basic nitrogen atom slightly reduces the S1R binding affinity (<b>9</b><i>vs</i><b>8</b>). Small pyrrolidine (<b>10</b>) and branched methylcyclopropanamine (<b>11</b>) exhibit potent binding affinities for the S1R with <i>K</i><sub>i</sub> = 2.3 nM and <i>K</i><sub>i</sub> = 0.61 nM and high selectivity over S2R with <i>K</i><sub>i</sub> ratios of >200 and >500, respectively.</div><div class="NLM_p">In metabolic stability studies using both human and rat liver microsomes, <b>10</b> exhibited a longer half-life and correspondingly lower clearance than <b>11</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The presence of acyclic substituents at NR<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> of <b>11</b> would render it more labile to metabolism in liver microsomes than <b>10</b> with the more stable cyclic pyrrolidine (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Consequently, pyrrolidine at NR<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> of <b>11</b> was retained for the further exploration of SARs on other substitution sites (R<sub>2</sub> and R<sub>3</sub>). Based on insights gained from our structure-based (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D) and QSAR-based virtual screening of potential S1R ligands, we introduced several hydrophobic groups at R<sub>2</sub> to optimize ligand–receptor binding (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These compounds were evaluated in radiolabeled binding assays using human Jurkat cells. We first compared how our compounds performed in the g.p. and human receptor binding assays. Four compounds (haloperidol, <b>1</b>, <b>7</b>, and <b>10</b>) were assayed in both assays, and their binding affinities (<i>K</i><sub>i</sub>) for both sigma receptors were found to correlate well between g.p. and human assays. Positive controls haloperidol and S1RA (<b>1</b>) exhibited binding affinities <i>(K</i><sub>i</sub>) within the literature values.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Consequently, we felt confident that the SARs for substitutions at NR<sub>1</sub>R<sub>1</sub> observed in the g.p. binding assays (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) should be consistent with those of the human binding assays.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In vitro</i> Metabolic Stability in Rat and Human Liver Microsomes<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">rat liver microsomes</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">human liver microsomes</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> (μL/min/mg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center" char=".">3.6</td><td class="colsep0 rowsep0" align="center" char=".">189.9</td><td class="colsep0 rowsep0" align="center" char=".">64.6</td><td class="colsep0 rowsep0" align="center" char=".">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6</b></td><td class="colsep0 rowsep0" align="center" char=".">23.3</td><td class="colsep0 rowsep0" align="center" char=".">29.8</td><td class="colsep0 rowsep0" align="center" char=".">37.3</td><td class="colsep0 rowsep0" align="center" char=".">18.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center" char=".">9.6</td><td class="colsep0 rowsep0" align="center" char=".">72.0</td><td class="colsep0 rowsep0" align="center" char=".">119.5</td><td class="colsep0 rowsep0" align="center" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="center" char=".">3.5</td><td class="colsep0 rowsep0" align="center" char=".">196.0</td><td class="colsep0 rowsep0" align="center" char=".">61.3</td><td class="colsep0 rowsep0" align="center" char=".">11.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>12</b></td><td class="colsep0 rowsep0" align="center" char=".">3.3</td><td class="colsep0 rowsep0" align="center" char=".">207.2</td><td class="colsep0 rowsep0" align="center" char=".">172.2</td><td class="colsep0 rowsep0" align="center" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="center" char=".">5.1</td><td class="colsep0 rowsep0" align="center" char=".">135.0</td><td class="colsep0 rowsep0" align="center" char=".">84.7</td><td class="colsep0 rowsep0" align="center" char=".">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>15</b></td><td class="colsep0 rowsep0" align="center" char=".">2.6</td><td class="colsep0 rowsep0" align="center" char=".">262.9</td><td class="colsep0 rowsep0" align="center" char=".">74.9</td><td class="colsep0 rowsep0" align="center" char=".">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>19</b></td><td class="colsep0 rowsep0" align="center" char=".">4.8</td><td class="colsep0 rowsep0" align="center" char=".">144.1</td><td class="colsep0 rowsep0" align="center" char=".">87.6</td><td class="colsep0 rowsep0" align="center" char=".">7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">midazolam</td><td class="colsep0 rowsep0" align="center" char=".">2.4</td><td class="colsep0 rowsep0" align="center" char=".">292.7</td><td class="colsep0 rowsep0" align="center" char=".">2.6</td><td class="colsep0 rowsep0" align="center" char=".">262.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">diclofenac</td><td class="colsep0 rowsep0" align="center" char=".">3.5</td><td class="colsep0 rowsep0" align="center" char=".">196.2</td><td class="colsep0 rowsep0" align="center" char=".">3.7</td><td class="colsep0 rowsep0" align="center" char=".">188.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">See the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Each test compound was incubated at 10 μM with 0.1 mg/mL rat or human liver microsomes for 1 h.</p></div></div></div><div class="NLM_p">As <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> shows, more bulky hydrophobic substituents enhanced S1R binding affinity, as seen by the descending order of receptor binding affinities (<i>K</i><sub>i</sub>): <b>10</b> (<i>tert</i>-butyl, 7.5 nM) ≈ <b>12</b> (trifluoromethylcyclopropyl, 9.9 nM) > <b>16</b> (isopropyl, 96 nM) > <b>23</b> (cyclopropyl, 30% binding at 100 nM) > <b>22</b> (methyl, 3% binding at 100 nM). Substitutions at the 4-position of the phenyl ring were more favorable for S1R binding than those at the 3-position: <b>10</b> (7.5 nM) <i>versus</i><b>18</b> (29.4 nM), <b>12</b> (9.9 nM) <i>versus</i><b>19</b> (32 nM), <b>28</b> (90 nM) <i>versus</i><b>29</b> (40% binding at 100 nM), and <b>30</b> (39% binding) <i>versus</i><b>31</b> (21% binding). In general, elongation of the substituents reduced the S1R binding affinity but enhanced the S2R binding affinity, for example, <b>13</b> (S1R <i>K</i><sub>i</sub> = 22 nM, S2R <i>K</i><sub>i</sub> > 1000 nM) <i>versus</i><b>26</b> (43% S1R binding at 100 nM, 79% S2R binding at 1000 nM) and <b>28</b> (S1R <i>K</i><sub>i</sub> = 90 nM, 60% S2R binding) <i>versus</i><b>30</b> (29% S1R binding, 65% S2R binding). Taken together, the size and hydrophobicity of the substituent at R<sub>2</sub> are critical features in modulating the potency (binding affinity) and selectivity for the S1R over the S2R.</div><div class="NLM_p last">Subsequent SAR studies were focused on assessing the <i>N</i>-substitutions (R<sub>3</sub>) on the triazole ring by replacing methyl with three small, hydrophobic groups (ethyl, isopropyl, and cyclopropyl), keeping pyrrolidine at NR<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup> and 4-<i>tert</i>-butyl at R<sub>2</sub>. Increasing the size of R<sub>3</sub> from methyl to isopropyl improved the S1R binding affinity by threefold but yields minimal effects on S2R (<i>e.g.</i>, <b>10</b><i>vs</i><b>34</b>). However, introduction of a cyclopropyl (<b>35</b>, <i>K</i><sub>i</sub> = 14 nM) slightly reduced the S1R binding affinity in relation to methyl (<b>10</b>, <i>K</i><sub>i</sub> = 7.5 nM). As molecular docking shows that it is located near the side chain of Phe107 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D), R<sub>3</sub> is sterically restricted. Although isopropyl is slightly larger than cyclopropyl in terms of van der Waals volume (87 Å<sup>3</sup><i>vs</i> 73 Å<sup>3</sup>, calculated with MOE), its rotational flexibility affords induced fit inside the ligand-binding pocket of S1R. Based on our molecular modeling, the rigidity of cyclopropyl raises its potential for steric clashes with the side chain of Phe107. Consequently, the isopropyl group at R<sub>3</sub> appears as the optimal choice for conferring potent binding affinity for S1R and high selectivity for the S1R over the S2R. However, more analogues need to be synthesized and evaluated in the binding assays to confirm this SAR.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vitro</i> Metabolic Studies</h3><div class="NLM_p">Knowledge of the metabolic clearance of an absorbed drug is critical for gauging its stability, half-life, and dosing. <i>In vitro</i> metabolic stability studies were performed using rat and human liver microsomes for a subset of selected compounds to assess the effects of different substituents on liver metabolism in terms of half-life (<i>T</i><sub>1/2</sub>) and intrinsic clearance (CL<sub>int</sub>), which are inversely proportional to each other (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p last">Following incubation at 10 μM with the liver microsomes for 1 h, reaction samples were analyzed by LC–MS/MS at different time points (5 min, 15 min, 30 min, and 1 h). In human liver microsomal studies, all compounds except <b>6</b> showed equivalent or superior stability (higher <i>T</i><sub>1/2</sub>) and lower clearance (lower CL<sub>int</sub>) than the clinical candidate <b>1</b>. Compounds <b>10</b> and <b>12</b> exhibited about 2–3-fold improvement in the metabolic half-time (<i>T</i><sub>1/2</sub>) over <b>1</b> with <i>T</i><sub>1/2</sub> = 119.5 min (Cl<sub>int</sub> = 5.8 μL/min/mg) and <i>T</i><sub>1/2</sub> = 172.2 min (Cl<sub>int</sub> = 4.0 μL/min/mg), respectively. However, in rat liver microsomal studies, different patterns in the metabolism were observed. The majority of compounds appeared to be cleared at a similar rate as <b>1</b> except for <b>6</b> and <b>10</b>, which showed much longer half-lives (or lower intrinsic clearances) with <i>T</i><sub>1/2</sub> = 23.3 min (Cl<sub>int</sub> = 29.8 μL/min/mg) and <i>T</i><sub>1/2</sub> = 9.6 min (Cl<sub>int</sub> = 72.0 μL/min/mg), respectively. Considering the S1R binding affinity and selectivity, <i>in vitro</i> metabolic stability in liver microsomal studies, and ease of synthesis, compound <b>10</b> (S1R <i>K</i><sub>i</sub>: human 7.5 nM, g.p. 2.3 nM; S2R <i>K</i><sub>i</sub>: human >1000 nM, g.p. 474 nM; <i>T</i><sub>1/2</sub>: human 119.5 min, rat 9.6 min; Cl<sub>int</sub>: human 5.8 μL/min/mg, rat 72.0 μL/min/mg) was selected as the lead compound for further studies.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Functional Assay</h3><div class="NLM_p">We then proceeded to determine the S1R functionality of our novel ligands. Previous studies have shown that phenytoin, a low-potent allosteric modulator for the S1R, differentially modulates affinities of S1R ligands depending on their agonist <i>versus</i> antagonist functionality.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Phenytoin potentiates the receptor binding affinity of S1R agonists (ratios of <i>K</i><sub>i</sub> without phenytoin/with phenytoin > 1); however, it produces no effects or slightly reduced receptor binding affinity for S1R antagonists (ratios of <i>K</i><sub>i</sub> without phenytoin/with phenytoin ≤ 1). The functionality of compound <b>10</b> on S1R was determined by the radiolabeled binding assay using g.p. whole brain in the presence of phenytoin (250 μM), together with known S1R agonist dextromethorphan and antagonist haloperidol (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Both <b>10</b> and haloperidol exhibited a very small shift to lower receptor binding affinity with ratios of <i>K</i><sub>i</sub> without phenytoin/with phenytoin as 0.8 and 0.9, respectively. However, dextromethorphan showed a ratio of 6.3 in the presence of 250 μM phenytoin. These observations indicated that compound <b>10</b> acts as an antagonist for the S1R.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Ratio of <i>K</i><sub>i</sub> Values with or without Phenytoin in the S1R Radiolabeled Binding Assays</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM) + phenytoin</th><th class="colsep0 rowsep0" align="center" char=".">ratio <i>K</i><sub>i</sub> without/with phenytoin</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center" char=".">2.8</td><td class="colsep0 rowsep0" align="center" char=".">3.4</td><td class="colsep0 rowsep0" align="center" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">haloperidol</td><td class="colsep0 rowsep0" align="center" char=".">1.3</td><td class="colsep0 rowsep0" align="center" char=".">1.4</td><td class="colsep0 rowsep0" align="center" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">dextromethorphan</td><td class="colsep0 rowsep0" align="center" char=".">63</td><td class="colsep0 rowsep0" align="center" char=".">10</td><td class="colsep0 rowsep0" align="center" char=".">6.3</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Selectivity Screening</h3><div class="NLM_p last">To further assess its selectivity and cross-reactivity, compound <b>10</b> was tested against a diverse panel of 87 known human targets and antitargets (SafetyScreen87) at 1 μM, including GPCRs, ion channels, transporters, nuclear receptors, and enzymes. Some of the targets have been well established as contributors to clinical adverse drug reactions and should be avoided for any drugs to bind if possible.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The results, summarized in Table S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_001.pdf" class="ext-link">Supporting Information</a>, show that no targets exhibited ≥50% binding to <b>10</b> in the binding or enzymatic assay, indicating that <b>10</b> is relatively “clean” with respect to appreciable binding to other widely known human targets and antitargets. As expected, <b>10</b> showed negligible binding to the three opioid receptors δ, κ, and μ under the tested conditions because of the lack of an essential pharmacophore feature phenol. Notably, <b>10</b> exhibited minimal (8.4%) binding to human hERG, a target responsible for the QT-interval prolongation and whose binding should be avoided.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Vivo</i> Pharmacokinetic Studies</h3><div class="NLM_p">Pain modulation by S1R is primarily mediated through the central nervous system. Consequently, the drug is required to transport across the blood–brain barrier (BBB) in sufficient quantities to elicit the intended pharmacological effect. In order to assess the BBB permeability of the subject S1R ligands, compound <b>10</b> was selected for <i>in vivo</i> pharmacokinetic studies in rats at 10 mg/kg <i>via</i> i.p. administration. Brain and blood samples were collected at specific time points after drug administration (<i>N</i> = 3 per time point). The concentrations of compound <b>10</b> in the brain and plasma samples were determined by a LC–MS/MS method. The plasma <i>t</i><sub>1/2</sub> of compound <b>10</b> was found to be 0.56 h (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The ratios of brain to plasma (B/P) drug concentrations at different time points spanned from 12 to 15, which indicates good BBB permeability for compound <b>10</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties of Compound <b>10</b> Dosed at 10 mg/kg (i.p.) in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">plasma PK parameter</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="center">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="center">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="center">932</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">AUC<sub>0-4</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="center">633</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">AUC<sub>0-inf</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="center">635</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">MRT<sub>Inf</sub> (h)</td><td class="colsep0 rowsep0" align="center">0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">ratio (brain/plasma)</td><td class="colsep0 rowsep0" align="center">12–15</td></tr></tbody></table></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Rotarod Test</h3><div class="NLM_p last">The rotarod test is frequently used in early stages of drug development to screen out drugs that might later cause impairments in human motor coordination. To investigate the possibility that <b>10</b> could interfere with motor coordination, the motor performance was assessed in the rotarod test after a single treatment (i.p.) at two different doses (20 mg/kg and 40 mg/kg) in Sprague Dawley (SD) rats (<i>N</i> = 6). Gabapentin, a first-line medication for the treatment of neuropathic pain, was used as the positive control in this test at its equivalent therapeutic dose, 100 mg/kg (i.p.). Compound <b>10</b> did not induce any statistically significant effects on motor impairment in rats after the administration at both doses (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). At <i>t</i> = 60 min, the motor performance was slightly reduced (without statistical significance) by <b>10</b> but quickly resumed to normal at <i>t</i> = 90 min. In contrast, gabapentin exhibited significant (<i>p</i> < 0.05) effects in reducing rats’ motor coordination on the rotating rod at t = 60 min, 90 min, and 120 min compared to the vehicle group. These data indicate that <b>10</b> is safe in this rotarod test at both doses.<named-content content-type="anchor" rid="fig2" type="simple"></named-content></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Formalin Test</h3><div class="NLM_p last">The antinociceptive efficacy of compound <b>10</b> was first assessed using the rat formalin test, a widely used model in which 2% formalin solution is injected to the hind paw of the rats and biphasic pain responses are characterized by analyzing the behavior of licking the affected hind paw.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> The acute phase (0–10 min) mostly represents nociceptive pain, while the late phase (after 10 min) reflects the inflammatory responses. In this study, after rats were administered (i.p.) with compound <b>10</b> at two doses (20 mg/kg and 40 mg/kg), the time spent licking the hind paw after the injection of formalin was recorded (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Compared with the vehicle group, compound <b>10</b> significantly attenuated paw-licking behaviors in both phases at 40 mg/kg and only in the late phase at 20 mg/kg. In contrast, gabapentin at 100 mg/kg (i.p.) produced reduction in the paw-licking behaviors only in the late phase.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Paclitaxel-Induced Neuropathic Pain Model</h3><div class="NLM_p">Chemotherapy-induced peripheral neuropathy is one of the most serious complications associated with anticancer drugs, and its symptoms include allodynia and hyperalgesia. Paclitaxel, a commonly used anticancer chemotherapy, can cause dose-limiting painful peripheral neuropathy when given intraperitoneally (i.p.) and has been widely used preclinically to evaluate the analgesic effects of various drugs in neuropathic pain.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In the present study, paclitaxel (Taxol) at a total cumulative dose of 8 mg/kg was injected (i.p.) to rats to induce neuropathic pain. Mechanical allodynia and cold hyperalgesia were measured to assess the behavioral changes caused by i.p. administration of compound <b>10</b> (20 mg/kg), the vehicle (sterile water), and gabapentin (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">Compared with the basal values on day 0 (prepaclitaxel), the mechanical allodynia thresholds were greatly reduced by paclitaxel challenge (pretreatment), suggesting successful development of neuropathic pain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). At both 0.5 h and 1.5 h after i.p. administration, compound <b>10</b> appeared to alleviate mechanical allodynia by increasing the pain threshold by 180–190% compared with the vehicle. Although the alleviation of pain was tangible, it did not achieve statistical significance with <i>p</i> = 0.6 and <i>p</i> = 0.1 (ANOVA). On the other hand, gabapentin (100 mg/kg) significantly attenuated the mechanical pain at both time points in this neuropathic pain model.</div><div class="NLM_p last">Likewise, the pretreatment values of cold hyperalgesia thresholds were measured as the paw withdrawal latencies in seconds were markedly reduced after the paclitaxel challenge when compared with the basal values on day 0 (prepaclitaxel). After treatment, <b>10</b> significantly attenuated cold hyperalgesia by increasing the withdrawal latencies by 120–130% at 1 h and 2 h postdosing compared with the vehicle control (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). Interestingly, <b>10</b> seemingly elevated the cold hyperalgesia thresholds when compared with the basal values before the paclitaxel challenge on day 0 (prepaclitaxel). However, the differences are not statistically significant at either time point with <i>p</i> = 0.61 (<i>t</i> = 1 h) and <i>p</i> = 0.08 (<i>t</i> = 2 h). On the other hand, gabapentin failed to achieve statistical significance in alleviating cold hyperalgesia in this study at both time points. It is a common observation in the same pain study of compounds with different mechanisms of action that gabapentin does show significant efficacy in attenuating mechanical allodynia but not cold hyperalgesia (Eurofins Pharmacology Discovery Services Taiwan, private communication, November 4, 2020). This may result from the heterogeneous nature of neuropathic pain and also from the suboptimal treatment plan for this study. Previously, gabapentin has been reported to elicit delayed onset of analgesic efficacy in some neuropathic pain studies after a single dose.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> The study may require extended durations to observe the significant attenuation of cold hyperalgesia in this paclitaxel-induced neuropathic pain model. Future studies with optimized treatment regimens are necessary to further assess the analgesic efficacy of compound <b>10</b> for neuropathic pain of different etiologies.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Employing structure- and QSAR-based design strategies, we rationally designed, chemically synthesized, and biologically evaluated a series of novel triazole-based S1R antagonists. Compound <b>10</b> exhibited potent binding affinity (S1R <i>K</i><sub>i</sub>: human 7.5 nM, g.p. 2.3 nM) and high selectivity for S1R over S2R and other 87 human targets, acceptable <i>in vitro</i> metabolic stability and intrinsic clearance in liver microsomes (<i>T</i><sub>1/2</sub>: human 119.5 min, rat 9.6 min; Cl<sub>int</sub>: human 5.8 μL/min/mg, rat 72.0 μL/min/mg), and excellent BBB permeability in rats (B/P = 12–15). Compound <b>10</b> demonstrated negligible acute toxicity in the rat rotarod test at doses up to 40 mg/kg and statistically significant analgesic effects in the rat formalin test for acute inflammatory pain and paclitaxel-induced neuropathic pain model during cancer chemotherapy. Compared with the clinical candidate <b>1</b> (S1RA), our lead compound <b>10</b> exhibited more potent S1R binding affinity and superior <i>in vitro</i> metabolic stability. The encouraging results from these proof-of-concept studies promote further development of our triazole-based S1R antagonists as novel treatments for pain of different etiologies. More studies are currently underway to assess <b>10</b> in streptozotocin-induced diabetic and nerve injury neuropathic pain models using the clinical candidate <b>1</b> as the positive control and to further optimize S1R binding affinity and drug properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Molecular Modeling</h3><div class="NLM_p">All computational molecular modeling and docking studies were performed on an Intel Xeon CPU E5-2643 3.4 GHz processor with a memory of 64 GB RAM using Molecular Operating Environment (MOE 2018.08, Chemical Computing Group, Montreal, QC, Canada), or GOLD (version 5.7.3) from the Cambridge Crystallographic Data Centre (CCDC, Cambridge, UK).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The binding site was defined as the atoms within 10 Å radius around the centroids of the cocrystalized ligands. GoldScore was selected as the scoring and ranking function for all docking. Binding poses were exported to MOE for analyses.</div><div class="NLM_p last">Ligands were constructed with the Builder module in MOE, and the structures were geometry optimized by energy minimization with the MMFF94X force field and partial atomic charges. All X-ray crystallographic structures (pdb ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0">6DK0</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ">6DJZ</a>) were downloaded from the PDB (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>) and processed in MOE using the Structure Preparation and Protonate 3D modules with default settings. All water molecules in the crystal structures were removed prior to the calculations. Default settings were used unless specifically stated.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p">All starting materials, reagents, and solvents were purchased from commercial suppliers and used without any further purification. All reactions involving air- or moisture-sensitive reagents were performed under an argon and dry atmosphere. The progress of reactions was monitored by TLC on SiO<sub>2</sub>, which was coated with a fluorescence indicator. Spots were visualized by fluorescence quenching under a UV lamp. All products, unless otherwise specified, were purified by column chromatography and/or preparative reverse-phase HPLC. Column chromatography separation was performed using the Agela purification system. SiO<sub>2</sub> for column chromatography was amorphous, with a particle size of 40–60 μm and a pore size of 60 Å. Separation was performed with a Gilson preparative HPLC system, which was equipped with a 333/334 pump, a UV/VIS-156 detector, and a GX-281 fraction collector. The following methods were used for general compound purification: a Phenomenex Luna C18 150 × 30 mm column with a particle size of 5 μm was used; mobile phase A, 0.04% HCl or 0.1% TFA in water; mobile phase B, acetonitrile; the gradient was 5%–40% B in A; HPLC run time was16 min at room temperature; flow rate was 60 mL/min; detection wavelength was 220 nm; and the gradient was optimized based on the compound polarity. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker spectrometer with a frequency of 400 MHz and 101 MHz, respectively. Chemical shifts are reported in delta (δ) units, parts per million (ppm) downfield from tetramethylsilane (TMS). Coupling constants (<i>J</i><sub>s</sub>) are reported in hertz (Hz). Splitting patterns are designated as follows: s, singlet; br, broad singlet; d, doublet; t, triplet; q, quartet; and m, multiplet. Purity of final products (>98%) was determined by analytical HPLC at 40 °C on a Shimadzu 20AB system: a Kintex C18 2.1 × 50 mm or a Luna C18 2.0 × 50 mm column with a particle size of 5 μm was used; detection at 220 nm, 215 nm or 254 nm on a SPD-M20A variable wavelength detector; flow rate = 0.5 mL/min; mobile phase A, 0.037% TFA (v/v) in water; mobile B, 0.018% TFA (v/v) in acetonitrile; gradient, 90/10–20/80 A/B in 4.5 min. The gradient was optimized based on the compound polarity. Mass spectra were recorded on a LCMS2010EV mass spectrometer from Shimazu with electron spray ionization (ESI) as the ionization method. High-resolution mass spectral (HRMS) data were determined using an LCT Premier XE mass spectrometer from Waters. All reaction yields were not optimized.</div><div class="NLM_p last">Representative synthetic procedures of 1<i>H</i>-1,2,4-triazole derivatives for compounds are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a><i>via</i><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>10</b>)</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Step a: 4-(<i>tert</i>-Butyl)-<i>N</i>-methyl Benzohydrazide (<b>I-b</b>; R<sub>3</sub> = Me)</h4><div class="NLM_p last">4-(<i>tert</i>-butyl) benzoic acids (<b>I-a</b>) (5.0 g, 28.1 mmol, 1.0 equiv) and Pfp-OH (5.7 g, 1.1 equiv) were mixed in 100 mL of dichloromethane (DCM) at 25 °C and EDCI (5.9 g, 1.1 equiv), followed by stirring for 4 h under a N<sub>2</sub> atmosphere. To another reaction flask containing DCM (100 mL), methylhydrazine-oxalic acid salt (11.5 g, 3.0 equiv) and 13.9 mL <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA, 3.0 equiv) were added at 25 °C. The activated <b>I-a</b> solution was added dropwise to the methylhydrazine solution at 25 °C while stirring. The resulting mixture was stirred for additional 1 h. TLC was used to confirm the completion of reactions. H<sub>2</sub>O (150 mL) was then added to quench the reaction and the mixture was extracted with DCM (80 mL × 3). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, and solvents were removed to leave the crude product as an oil, which was then loaded on a silica gel column and eluted with petroleum ether/ethyl acetate (100:1–1:1) to give compound <b>I-b</b> (4.5 g, 21.8 mmol, 83.8% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): δ 7.52–7.34 (m, 4H), 4.44 (br s, 2H), 3.51 (s, 3H), 1.34 (s, 9H).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step b: Ethyl 5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazole-3-carboxylate (<b>I-c</b>; R<sub>3</sub> = Me)</h4><div class="NLM_p last">Compound <b>I-b</b> (7.9 g, 41.3 mmol, 1.0 equiv) was dissolved in toluene (90 mL), followed by the addition of ethyl 2-amino-2-thioxo-acetate (11.0 g, 82.6 mmol, 2.0 equiv) and acetic acid (9.0 mL). The mixture was stirred at 90 °C, and TLC indicated the completion of reaction after 12 h. The reaction mixture was poured into saturated NaHCO<sub>3</sub> (100 mL) and extracted with ethyl acetate (50 mL × 3). Combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, and solvents were removed to leave the crude product as a yellow oil, which was then loaded on a silica gel column and eluted with petroleum ether/ethyl acetate (100:1–1:1) to give compound <b>I-c</b> (8.1 g, 72.3% yield) as a yellow solid. <sup>1</sup>H NMR: (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.70–7.55 (m, 4H), 4.34 (qd, <i>J</i> = 7.1, 11.2 Hz, 2H), 3.49 (s, 3H), 1.35–1.28 (m, 12H).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step c: (5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl) (pyrrolidin-1-yl)methanone (<b>I-d</b>; R<sub>1</sub>,R<sub class="stack">1</sub><sup class="stack">′</sup> = cyclopentyl, R<sub>3</sub> = Me)</h4><div class="NLM_p last">To a solution of pyrrolidine (260 mg, 3.65 mmol, 1.1 equiv) in 20 mL of 1,2-dichloroethane (DCE), Al(CH<sub>3</sub>)<sub>3</sub> (2.00 M, 4.9 mL, 3.0 equiv) was added dropwise at 0 °C. The resulting mixture was allowed to warm up to room temperature (25 °C) and was stirred for 0.5 h and then cooled to 0 °C. Compound <b>I-c</b> (950 mg, 3.32 mmol, 1.0 equiv) was added to the aforementioned mixture, which was further stirred at 50 °C for 12 h. The reaction was then cooled to 0 °C and HCl (1.0 M, 100 mL) was added to quench the reaction. DCM (30 mL × 3) was added to extract the organic layers, which were combined and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were removed, and the residue was loaded on the silica gel column and eluted with petroleum ether/ethyl acetate (100:1–0:1) to give compound <b>I-d</b> (0.50 g, 47.9% yield) as a yellow oil. <sup>1</sup>HNMR: (400 MHz, CDCl<sub>3</sub>): δ 7.65 (d, <i>J</i> = 8.4 Hz, 2H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 4.04 (s, 3H), 3.94 (t, <i>J</i> = 6.4 Hz, 2H), 3.71 (t, <i>J</i> = 6.4 Hz, 2H), 1.90–1.97 (m, 4H), 1.36 (s, 9H).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step d: 5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>10</b>)</h4><div class="NLM_p last">To a solution of the compound <b>I-d</b> (8.7 g, 28.0 mmol, 1.0 equiv) in THF (80 mL), DIBAL-H (1 M, 70 mL, 2.5 equiv) was added dropwise at 0 °C. The reaction was stirred at 0 °C for 5 h. HCl (3 M, 75 mL) was added dropwise slowly to maintain temperature at <5 °C. Ethyl acetate (50 mL × 3) was then added to extract neutral impurities. The basicity of the aqueous solution was adjusted to pH = 14 with NaOH (2 N), and the mixture was extracted with ethyl acetate (50 mL × 2). The organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. All solvents were subsequently removed. HCl (4 N in ethyl acetate, 100 mL) was then added to the residue and the resulting solution was stirred at 25 °C for 3 h, which yielded white solid precipitates. The solid was filtered and washed with ethyl acetate (30 mL) to yield the crude compound <b>10</b> (6.0 g), which was dissolved in 50 mL of H<sub>2</sub>O, followed by the addition of NaOH (2 N) to adjust the basicity to pH = 14. Ethyl acetate (100 mL) was then added to the aqueous mixture. The organic layer was separated and washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. All solvents were then removed under reduced pressure, and the crude product was purified by reversed-phase chromatography under acidic conditions. The fractions containing the product were combined and lyophilized to give compound <b>10</b> (4.8 g, 51.3% yield, purity 98.3% as an off-white solid). The total yield was 14.9%. <sup>1</sup>H NMR: (400 MHz, CDCl<sub>3</sub>): δ 12.88–13.13 (br s, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 2H), 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 4.33 (s, 2H), 4.01 (s, 3H), 3.15–3.82 (m, 4H), 1.75–2.51 (m, 4H), 1.36 (s, 9H). <sup>13</sup>C (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 155.41, 154.56, 153.52, 128.82, 126.16, 124.73, 53.47, 49.66, 37.75, 35.09, 31.38, 23.25. HRMS (ESI) <i>m</i>/<i>z</i>: for C<sub>18</sub>H<sub>26</sub>N<sub>4</sub> calcd [M + H]<sup>+</sup>, 299.2157; found, 299.2162.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-((5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)piperidine (<b>3</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Off-white solid; yield 14.5%; purity 98.2%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 7.53 (d, <i>J</i> = 7.7 Hz, 2H), 3.98 (s, 3H), 3.63 (s, 3.73 (m, 2H), 2.62 (b, 4H), 1.67 (b, 4H), 1.37 (b, 2H), 1.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 313.2; found, 313.3.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-((5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)morpholine (<b>4</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Off-white solid; yield 14.4%; purity 99.1%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 7.53 (d, <i>J</i> = 7.7 Hz, 2H), 3.98 (s, 3H), 3.63 (s, 3.73 (m, 2H), 2.62 (b, 4H), 1.67 (b, 4H), 1.37 (b, 2H), 1.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 315.2; found, 315.3.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-((5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)-4-methylpiperazine (<b>5</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Lightly yellow solid; yield 12.7%; purity 99.5%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.62 (d, <i>J</i> = 7.2 Hz, 2H), 7.51 (d, <i>J</i> = 7.1 Hz, 2H), 3.97 (s, 3H), 3.63 (s, 3.73 (s, 2H), 2.58 (b, 8H), 2.34 (s, 3H), 1.37 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 328.2; found, 328.1.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-((5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)-4-phenethylpiperazine (<b>6</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Lightly yellow solid; yield 13.4%; purity 99.1%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.62 (d, <i>J</i> = 7.2 Hz, 2H), 7.51 (d, <i>J</i> = 7.1 Hz, 2H), 7.25 (m, 4H), 3.98 (s, 3H), 3.73 (b, 2H), 3.27 (b, 4H), 2.81 (b, 4H), 1.26 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 390.3; found, 390.2.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-((5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)-4-phenethylpiperazine (<b>7</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Off-white solid; yield 14.6%; purity 98.3%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.59 (d, <i>J</i> = 7.2 Hz, 2H), 7.50 (d, <i>J</i> = 7.1 Hz, 2H), 7.29 (m, 2H), 7.20 (s, 3H), 4.13 (s, 3H), 3.93 (b, 2H), 3.12 (b, 2H), 2.66 (B, 10H),1.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 418.3; found, 418.2.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Benzyl-4-((5-(4-(<i>tert</i>-butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)piperazine (<b>8</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Lightly yellow solid; yield 14.3%; purity 98.6%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 7.53 (d, <i>J</i> = 7.7 Hz, 2H), 7.32 (m, 4H), 7.26 (s, 1H), 3.98 (s, 3H), 3.71 (s, 2H), 3.56 (m, 2H), 2.66 (b, 8H), 1.37 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 404.3; found, 404.4.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Benzyl-1-((5-(4-(<i>tert</i>-butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)methyl)piperidine (<b>9</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Light-yellow oil; yield 13.6%; purity 98.7%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 7.60 (d, <i>J</i> = 7.2 Hz, 2H), 7.52 (m, 3H), 7.14 (m, 2H), 3.97 (s, 3H), 3.66 (s, 2H),3.05 (m, 2H), 2.55 (d, <i>J</i> = 3.5 Hz, 2H), 2.34 (m, 2H), 1.68 (m, 2H), 1.59 (b, 1H), 1.39 (m, 2H), 1.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 403.3; found, 403.5.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(5-(4-(<i>tert</i>-Butyl)phenyl)-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)-<i>N</i>-(cyclopropylmethyl)-<i>N</i>-methylmethanamine (<b>11</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Light-yellow oil; yield 12.2%; purity 99.3%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 7.52 (d, <i>J</i> = 7.1 Hz, 2H), 3.97 (s, 3H), 3.82 (b, 2H), 2.49 (b, 5H), 1.37 (s, 9H), 1.04 (b, 1H), 0.55 (b, 2H), 0.19 (b, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd 313.2; found, 313.3.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(4-(<i>tert</i>-Butyl)phenyl)-1-ethyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>33</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Colorless oil; yield 10.2%; purity 98.1%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.97 (br s, 1H), 7.56–7.70 (m, 4H), 4.48 (d, <i>J</i> = 5.01 Hz, 2H), 4.27 (q, <i>J</i> = 7.21 Hz, 2H), 3.45–3.64 (m, 2H), 3.16–3.26 (m, 2H), 1.81–2.05 (m, 4H), 1.41 (t, <i>J</i> = 7.15 Hz, 3H), 1.33 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 313.2; found, 313.2.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(4-(<i>tert</i>-Butyl)phenyl)-1-isopropyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>34</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. Colorless crystal; yield 11.3%; purity 98.2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.99–11.19 (m, 1H), 7.57–7.63 (m, 4H), 4.70 (quin, <i>J</i> = 6.56 Hz, 1H), 4.48 (d, <i>J</i> = 5.07 Hz, 2H), 3.55 (br dd, <i>J</i> = 10.25, 4.96 Hz, 2H), 3.14–3.27 (m, 2H), 1.83–2.03 (m, 4H), 1.44 (d, J = 6.39 Hz, 6H), 1.33 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd 327.2; found, 327.2.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(4-(<i>tert</i>-Butyl)phenyl)-1-cyclopropyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>35</b>)</h3><div class="NLM_p">This compound was obtained using the same procedure used to synthesize compound <b>10</b>. White powder; yield 10.5%; purity 98.6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.27 (br s, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (d, <i>J</i> = 8.6 Hz, 2H), 4.42 (d, <i>J</i> = 4.9 Hz, 2H), 3.90–3.97 (m, 1H), 3.54 (br dd, <i>J</i> = 5.0, 10.3 Hz, 2H), 3.14–3.22 (m, 2H), 1.85–2.00 (m, 4H), 1.31–1.35 (m, 9H), 1.03–1.14 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 325.2; found, 325.2.</div><div class="NLM_p last">Representative synthetic procedures of 1<i>H</i>-1,2,4-triazole derivatives for compounds are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a><i>via</i><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>12</b>)</h3><div id="sec4_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Step a: Methyl 5-Bromo-1-methyl-1<i>H</i>-1,2,4-triazole-3-carboxylate (<b>II-b</b>)</h4><div class="NLM_p last">NaH (4.3 g, 106.3 mmol, 60% purity, 3.0 equiv) was added to the solution of compound <b>II-a</b> (5.0 g, 35.4 mmol, 1.0 equiv) in THF (150 mL) at 0 °C. After stirring for 40 min at 0 °C, NBS (31.5 g, 177.1 mmol, 5.0 equiv) was added to the mixture, followed by stirring at 20 °C for 15 h. TLC showed that starting materials were all consumed. The reaction mixture was poured into saturated NH<sub>4</sub>Cl (200 mL) and extracted with ethyl acetate (200 mL). The combined organic layers were washed with saturated NaCl (200 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was loaded onto a silica gel column and eluted with petroleum ether: ethyl acetate = 10:1 to 3:1 to get compound <b>II-b</b> (2.5 g, 11.3 mmol, 32.1% yield) as yellow solid. <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 13.53 (s, 1H), 3.90 (s, 3H).</div></div><div id="sec4_15_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step b: 5-Bromo-1-methyl-1<i>H</i>-1,2,4-triazole-3-carboxylic Acid (<b>II-c</b>)</h4><div class="NLM_p last">LiOH·H<sub>2</sub>O (5.7 g, 136.3 mmol, 1.5 equiv) was added to a solution of compound <b>II-b</b> (20.0 g, 90.9 mmol, 1.0 equiv) in the mixture of THF (200 mL) and H<sub>2</sub>O (40 mL) at 0 °C. The reaction was stirred for 12 h at 20 °C. TLC showed that compound <b>II-b</b> was consumed completely; the reaction mixture was filtered and THF was removed under reduced pressure. Diluted hydrochloride acid was then added to acidify the mixture to pH = 2 to produce white solid precipitates, which were filtered and washed with water (25 mL) and dried in vacuum to yield <b>II-c</b> (17.2 g, 83.5 mmol, 91.8% yield). It was used for the next step without further purification. <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 13.53 (s, 1H), 3.90 (s, 3H).</div></div><div id="sec4_15_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step c: (5-Bromo-1-methyl-1<i>H</i>-1,2,4-triazol-3-yl) (pyrrolidin-1-yl)methanone (<b>II-d</b>)</h4><div class="NLM_p last">Pyrrolidine (3.8 g, 53.6 mmol, 4.5 mL, 1.3 equiv) was added to a solution of compound <b>II-c</b> (8.5 g, 41.3 mmol, 1.0 equiv) in DMF (150 mL), and the solution was cooled to 0 °C. Hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU, 20.4 g, 53.6 mmol, 1.3 equiv) was added at 0 °C, followed by the addition of DIEA (10.7 g, 82.5 mmol, 14.4 mL, 2.0 equiv). The reaction was allowed to warm up to 25 °C while stirring and was stirred for additional 12 h at room temperature. The reaction mixture was then concentrated and the residue was directly loaded on a silica gel column and eluted with petroleum ether: ethyl acetate = 5:1 to 0:1. The product was further purified by prep-HPLC (water (containing 0.1%TFA)-acetonitrile) to give Compound <b>II-d</b> as a yellow oil (12.4 g, 35.2 mmol, 42.7% yield). <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 3.89 (s, 3H), 3.66 (s, 2H), 3.45 (d, 2H), 1.84 (s, 4H).</div></div><div id="sec4_15_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step d: (1-Methyl-5-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)-1<i>H</i>-1,2,4-triazol-3-yl) (Pyrrolidin-1-yl) Methanone (<b>II-f</b>, R<sub>2</sub> = 4-(1-(trifluoromethyl)cyclopropyl))</h4><div class="NLM_p last">A dioxaborolane coupling reagent, 4,4,5,5-tetramethyl-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]-1,3,2-dioxaborolane, was prepared following the previously reported procedure.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Dioxane (9 mL) and H<sub>2</sub>O (3 mL) were added into a reaction tube (20 mL), followed by the addition of compound <b>II-d</b> (600 mg, 2.3 mmol, 1.0 equiv) and then 4,4,5,5-tetramethyl-2-[4-[1 (trifluoromethyl)cyclopropyl]phenyl]-1,3,2-dioxaborolane (790 mg, 1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (380 mg, 1.2 equiv), and Pd(dppf)Cl<sub>2</sub> (94 mg, 0.05 equiv). The reaction tube was sealed and heated at 80 °C for 12 h. LC–MS indicated that all starting material was consumed. The reaction tube was cooled to room temperature and the reaction mixture was poured into ice water (15 mL). The crude product was extracted with ethyl acetate (20 mL + 15 mL), and the solvents were removed. The residue was loaded on a silica gel column and eluted with petroleum ether: ethyl acetate = 5:1 to 0:1 to give a crude product. Product <b>II-f</b> was further purified by prep-HPLC (column: Nano-micro Kromasil C<sub>18</sub> 100 × 30 mm, 5 μm; mobile phase: water(containing 0.1%TFA)–acetonitrile; 35%–55% B in 10 min) to give Compound <b>II-f</b> (0.3 g, 35.9% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): δ 37.71–7.69 (m, 2H), 7.62 (d, <i>J</i> = 8 Hz, 2H), 4.04 (s, 3H), 3.96 (d, <i>J</i> = 8 Hz, 2H), 3.69 (s, 2H), 1.97–1.91 (m, 4H), 1.43 (t, <i>J</i> = 8 Hz, 2H), 1.08 (s, 2H).</div></div><div id="sec4_15_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Step e: 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)-1<i>H</i>-1,2,4-triazole Hydrogen chloride (<b>12</b>)</h4><div class="NLM_p last">Compound <b>II-f</b> (0.1 g, 0.27 mmol, 1.0 equiv) was dissolved in THF (10 mL), and the solution was cooled to 0 °C. DIBAL-H (1 M, 0.68 mL, 2.5 equiv) was added to the solution while stirring, and the resulting mixture was stirred at 0 °C for additional 6 h. HCl (3 N, 20 mL) was added slowly to adjust the basicity to pH = 1. Ethyl acetate (20 mL) was added to extract neutral impurities, and then, the acidic aqueous solution was lyophilized to give the crude product as a yellow solid, which was further purified by prep-HPLC (column: Phenomenex Luna C<sub>18</sub> 150 × 30 mm, 5 μm; mobile phase: [water (containing 0.04% HCl)–acetonitrile]; 5%–40% B in 10 min) to yield compound <b>12</b> (8.0 mg, 83.9% yield, purity 99.6%) as a light-yellow solid. The total yield was 3.8%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): δ 7.68–7.63 (m, 4H), 4.36 (s, 2H), 4.03 (s, 3H), 3.76 (d, <i>J</i> = 8 Hz, 2H), 3.31 (t, <i>J</i> = 8 Hz, 2H), 2.81 (t, <i>J</i> = 8 Hz, 2H), 1.91 (s, 2H), 1.44 (t, <i>J</i> = 8 Hz, 2H), 1.09 (s, 2H). <sup>13</sup>C (101 MHz, CDCl<sub>3</sub>): δ 153.66, 150.49, 139.67, 131.79, 128.82, 125.50 (q, <i>J</i> = 271.9 Hz), 123.71, 52.41, 47.27, 37.83, 27.70 (q, <i>J</i> = 33.5 Hz), 23.28, 9.60. HRMS (ESI) <i>m</i>/<i>z</i>: for C<sub>18</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub> calcd [M + H]<sup>+</sup>, 351.1718; found, 351.1720.</div></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-(3,4-Dichlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>13</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 9.2%; purity 99.6%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): δ 7.82 (d, <i>J</i> = 8 Hz, 1H), 7.64 (d, <i>J</i> = 8 Hz, 1H), 7.55–7.52 (m, 1H), 4.35 (s, 2H), 4.04 (s, 3H), 3.79 (t, <i>J</i> = 4 Hz, 2H), 3.28–3.26 (m, 2H), 2.21 (d, <i>J</i> = 4 Hz, 2H), 1.93 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 311.1; found, 311.2.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>14</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Off-white solid; yield 9.8%; purity 99.8%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.83 (s, 4H), 4.37 (s, 2H), 4.06 (s, 3H), 3.79 (t, <i>J</i> = 8 Hz, 2H), 3.30–3.28 (m, 2H), 2.22 (t, <i>J</i> = 4 Hz, 2H), 1.94 (t, <i>J</i> = 8 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 311.1; found, 311.2.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-Methyl-5-(3-methyl-4-(trifluoromethyl)phenyl)-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>15</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light yellow solid; yield 13.2%; purity 99.3%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.79 (d, <i>J</i> = 8 Hz, 1H), 7.64 (s, 1H), 7.58 (t, <i>J</i> = 8 Hz, 1H), 4.36 (s, 2H), 4.04 (s, 3H), 3.30–3.27 (m, 2H), 2.21–2.19 (m, 2H), 2.59 (s, 3H), 2.21–2.19 (m, 2H), 1.95–1.91 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 325.2; found, 325.1.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(4-<i>iso</i>-Propylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>16</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 8.7%; purity 99.8%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.63 (d, <i>J</i> = 8 Hz, 2H), 7.42 (d, <i>J</i> = 8 Hz, 2H), 4.42 (s, 2H), 4.05 (s, 3H), 3.77 (s, 2H), 3.35 (s, 2H), 3.04–2.97 (m, 1H), 2.19 (s, 2H), 1.95 (s, 2H), 1.30 (d, <i>J</i> = 8 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 284.2; found, 285.2.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>17</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 8.3%; purity 99.3%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.37 (t, <i>J</i> = 8 Hz, 2H), 7.24 (t, <i>J</i> = 8 Hz, 1H), 4.37 (s, 2H), 4.01 (s, 3H), 3.75 (t, <i>J</i> = 4 Hz, 2H), 3.34 (d, <i>J</i> = 4 Hz, 2H), 2.85 (s, 4H), 2.18 (d, <i>J</i> = 4 Hz, 2H), 1.92 (s, 2H), 1.85 (s, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 297.2; found, 297.1.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-(3-(<i>tert</i>-Butyl)phenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>18</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 7.2%; purity 99.6%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.66 (s, 1H), 7.59 (d, <i>J</i> = 8 Hz, 1H), 7.55–7.27 (m, 2H), 4.37 (s, 2H), 4.01 (s, 3H), 3.78–3.74 (m, 2H), 3.34 (t, <i>J</i> = 8 Hz, 2H), 2.19 (t, <i>J</i> = 8 Hz, 2H), 1.93 (t, <i>J</i> = 8 Hz, 2H), 1.38 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 299.2; found, 299.3.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(3-(1-(trifluoromethyl)cyclopropyl)phenyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>19</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 6.9%; purity 99.4%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.76 (s, 1H), 7.64 (t, <i>J</i> = 8 Hz, 2H), 7.54 (t, <i>J</i> = 8 Hz, 1H), 4.36 (s, 2H), 4.02 (s, 3H), 3.76 (s, 2H), 3.31 (t, <i>J</i> = 4 Hz, 2H), 2.20 (d, <i>J</i> = 4 Hz, 2H), 1.93 (s, 2H), 1.46 (t, <i>J</i> = 4 Hz, 2H), 1.11 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 351.2; found, 351.3.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-(4-Chlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>20</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 8.8%; purity 99.1%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.64 (d, <i>J</i> = 8 Hz, 2H), 7.54 (d, <i>J</i> = 8 Hz, 2H), 4.36 (s, 2H), 4.02 (s, 3H), 3.79–3.75 (m, 2H), 3.31–3.27 (m, 2H), 2.21–2.18 (m, 2H), 1.94–1.90 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 277.1; found, 277.1.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-(3,4-Dimethylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>21</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 8.1%; purity 99.7%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.49 (s, 1H), 7.41 (d, <i>J</i> = 9.2 Hz, 1H), 7.32 (d, <i>J</i> = 9.2 Hz, 1H), 4.43 (s, 2H), 4.04 (s, 3H), 3.78–3.82 (m, 2H), 3.33–3.36 (m, 2H), 2.36 (s, 6H), 1.99 (s, 2H), 1.95–1.98 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 271.2; found, 271.1.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(<i>p</i>-tolyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>22</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 10.1%; purity 99.2%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.57 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (d, <i>J</i> = 7.6 Hz, 2H), 4.36 (s, 2H), 4.01 (s, 3H), 3.74–3.76 (m, 2H), 3.31–3.35 (m, 2H), 2.45 (s, 3H), 2.16–2.20 (m, 2H), 1.91 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 257.2; found, 257.1.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-(4-Cyclopropylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>23</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 12.3%; purity 99.3%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.65 (d, <i>J</i> = 8 Hz, 2H), 7.25 (s, 2H) 4.52 (s, 2H), 4.09 (s, 3H), 3.79 (s, 2H), 3.36 (s, 2H), 2.21–2.22 (d, <i>J</i> = 8.4 Hz, 2H), 1.98–2.02 (m, 3H), 1.10–1.13 (m, 2H), 0.80–0.81 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 283.2; found, 283.2.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-(2,3-Dihydro-1<i>H</i>-inden-5-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>24</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 10.6%; purity 99.7%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.56 (s, 2H), 7.39–7.46 (m, 2H), 4.44 (s, 2H), 4.05 (s, 3H), 3.76–3.78 (d, <i>J</i> = 5.2 Hz, 2H) 3.37–3.38 (d, <i>J</i> = 5.2 Hz, 2H), 2.99–3.02 (m, 4H), 2.12–2.20 (m, 4H), 1.97 (S, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 283.2; found, 283.3.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-(Benzo[<i>b</i>]thiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>25</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 8.6%; purity 99.5%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 8.22 (s, 1H), 7.97–7.99 (d, <i>J</i> = 8 Hz, 1H), 7.66 (t, <i>J</i> = 4 Hz, 1H), 7.44–7.45 (d, <i>J</i> = 5.6 Hz, 1H), 4.39 (s, 2H), 4.08 (s, 3H), 3.77 (s, 2H), 3.34 (s, 2H), 2.18–2.21 (d, <i>J</i> = 4.8 Hz, 2H), 1.93 (s, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 299.1; found, 299.0.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(2,3′,4′-trichloro-[1,1′-biphenyl]-4-yl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>26</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Light-yellow solid; yield 9.6%; purity 99.2%. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>): 7.84 (s, 1H), 7.64–7.65 (d, <i>J</i> = 2.4 Hz, 1H), 7.55–7.57 (d, <i>J</i> = 8 Hz, 2H), 7.49–7.51 (d, <i>J</i> = 8 Hz, 1H), 7.32–7.34 (m, 1H), 4.35–4.37 (d, <i>J</i> = 9.2 Hz, 2H), 4.04–4.08 (d, <i>J</i> = 16 Hz, 3H), 3.78 (s, 2H), 3.29 (s, 2H), 2.21 (s, 2H), 1.94–1.95 (d, <i>J</i> = 5.6 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 421.1; found, 421.0.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-(2-Chlorobenzo[<i>b</i>]thiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>27</b>)</h3><div class="NLM_p last">This compound was synthesized from compound <b>25,</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <i>n</i>-BuLi (2.5 M, 804 μL, 1.5 equiv) was added to a mixture of compound <b>25</b> (0.4 g, 1.3 mmol, 1.0 equiv) in THF (20 mL) at −78 °C under N<sub>2</sub>, followed by the addition of NCS (357 mg, 2.6 mmol, 2.0 equiv). The mixture was stirred at −78 °C for 2 h and then poured into ice water (100 mL) and stirred for 10 min. The aqueous phase was extracted with ethyl acetate (50 mL × 3). The combined organic phase was washed with brine (100 mL), dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified first by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 20:1 to 0:1) and then by prep-HPLC (column: Waters Prep OBD C<sub>18</sub> 150 × 40 mm; mobile phase: water (containing 0.05% HCl)–acetonitrile; B %: 5%–35%, 10 min) to give the desired compound (100 mg) as a white oil, which was further separated by SFC (column: DAICEL CHIRALCEL OD (250 × 30 mm); mobile phase: water (containing 0.1% NH<sub>3</sub>)–MeOH; B %: 33%–33%, 10 min) to obtain the final product <b>27</b> as a light-yellow solid (40 mg, yield 8.9%; purity 99.3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.97 (br s, 1H), 8.47 (s, 1H), 7.98 (d, <i>J</i> = 8.44 Hz, 1H), 7.84 (d, <i>J</i> = 8.31 Hz, 1H), 7.67 (s, 1H), 4.49 (br d, <i>J</i> = 5.01 Hz, 2H), 4.05 (s, 3H), 3.57 (br d, <i>J</i> = 5.01 Hz, 2H), 3.22 (br d, <i>J</i> = 7.21 Hz, 2H), 1.86–2.03 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 333.1; found, 333.2.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-([1,1′-Biphenyl]-4-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>28</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 13.1%; purity 99.1%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.98–11.08 (m, 1H), 7.88–7.94 (m, 4H), 7.77 (d, <i>J</i> = 7.3 Hz, 2H), 7.52 (t, <i>J</i> = 7.6 Hz, 2H), 7.41–7.46 (m, 1H), 4.49 (br d, <i>J</i> = 5.1 Hz, 2H), 4.05 (s, 3H), 3.54–3.61 (m, 2H), 3.18–3.26 (m, 2H), 1.88–2.04 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 319.2; found, 319.2.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-([1,1′-Biphenyl]-3-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>29</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 12.9%; purity 99.9%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.04 (br s, 1H), 8.04 (s, 1H), 7.88 (d, <i>J</i> = 7.83 Hz, 1H), 7.66–7.82 (m, 4H), 7.51 (t, <i>J</i> = 7.16 Hz, 2H), 7.40–7.46 (m, 1H), 4.42–4.58 (m, 2H), 4.06 (s, 3H), 3.51–3.62 (m, 2H), 3.16–3.27 (m, 2H), 2.00 (br s, 2H), 1.84–1.97 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 319.2; found, 319.1.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-Methyl-5-(4-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>30</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 13.1%; purity 99.9%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.24 (br s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 7.46 (t, <i>J</i> = 7.8 Hz, 2H), 7.20–7.26 (m, 1H), 7.09–7.17 (m, 4H), 4.44 (br d, <i>J</i> = 4.9 Hz, 2H), 3.94–4.01 (m, 3H), 3.54 (br d, <i>J</i> = 5.3 Hz, 2H), 3.19 (br dd, <i>J</i> = 6.7, 10.5 Hz, 2H), 1.85–2.02 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 335.2; found, 335.2.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-Methyl-5-(3-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>31</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. White solid; yield 14.5%; purity 99.8%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.11 (br s, 1H), 7.51–7.66 (m, 2H), 7.39–7.46 (m, 3H), 7.15–7.26 (m, 2H), 7.09 (d, <i>J</i> = 7.83 Hz, 2H), 4.41–4.48 (m, 2H), 3.99 (s, 3H), 3.52 (br dd, <i>J</i> = 4.89, 10.27 Hz, 2H), 3.11–3.23 (m, 2H), 1.82–2.02 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 335.2; found, 335.2.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-(4-(Benzyloxy)phenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1<i>H</i>-1,2,4-triazole Hydrogen Chloride (<b>32</b>)</h3><div class="NLM_p last">This compound was obtained using the same procedure used to synthesize compound <b>12</b>. Colorless solid; yield 13.2%; purity 99.1%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.41 (br s, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H), 7.41 (d, <i>J</i> = 8.2 Hz, 2H), 4.43 (br d, <i>J</i> = 4.4 Hz, 2H), 3.94–4.01 (m, 3H), 3.54 (br d, <i>J</i> = 5.1 Hz, 2H), 3.15–3.24 (m, 2H), 2.54–2.62 (m, 1H), 1.85–2.01 (m, 4H), 1.80 (br d, <i>J</i> = 7.7 Hz, 4H), 1.70 (br d, <i>J</i> = 12.3 Hz, 1H), 1.32–1.49 (m, 4H), 1.19–1.29 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd, 325.2; found, 325.3.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> S1R Radiolabeled Binding Assay</h3><div class="NLM_p">Compounds <b>3–11</b> were assayed using the guinea pig (g.p.) whole brain according to the previously reported protocol.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The membrane preparation was resuspended in 50 mM Tris-HCl at pH = 7.4 using [<sup>3</sup>H]-(+)-pentazocine as the radioligand. Following 1 h of incubation at 25 °C, the binding assay was terminated by addition of cold buffer. The mixture was then filtered through Whatman GF/B filters and washed with cold buffer. Radioactivity was measured using the TopCount NTX liquid scintillation counter (PerkinElmer, Waltham, MA). Nonspecific binding for S1R was measured in the presence of 10 μM unlabeled (+)-pentazocine. Compounds were tested at least two times in duplicate. (+)-Pentazocine was used as the positive control for this assay.</div><div class="NLM_p last">Compounds <b>12–35</b> were assayed using human Jurkat cells according to the previously reported protocol.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The membrane preparation was incubated in 50 mM Tris-HCl at pH = 8.0 for 2 h at 37 °C using [<sup>3</sup>H]-pentazocine as the radioligand. Radioactivity was identified using the TopCount NTX liquid scintillation counter. Nonspecific binding for S1R is measured in the presence of 10 μM unlabeled haloperidol. Compounds were tested at least two times in duplicate. Haloperidol was used as the positive control for this assay.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> S2R Radiolabeled Binding Assay</h3><div class="NLM_p">Compounds <b>3–11</b> were assayed using the guinea pig (g.p.) whole brain, while compounds <b>12–35</b> were assayed using human Jurkat cells according to previously reported methods.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> The membrane preparation was incubated in 50 mM Tris-HCl at pH = 7.4 for 1 h at 25 °C using [<sup>3</sup>H]-DTG as the radioligand. Radioactivity was measured using the TopCount NTX liquid scintillation counter. Nonspecific binding for the S2R was measured in the presence of 10 μM unlabeled haloperidol. The S1R binding was masked using 1 μM (+)-pentazocine. Compounds were tested at least two times in duplicate. Haloperidol was used as the positive control for this assay.</div><div class="NLM_p last">Receptor binding data were analyzed by nonlinear regression of saturation and competition curves using GraphPad Prism 8.0 software (GraphPad Software, La Jolla, CA).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> S1R Functional Assay</h3><div class="NLM_p last">The functionality of our compounds on S1R was determined using the same radiolabeled binding assay for the S1R in the presence of phenytoin (250 μM), a low-potent allosteric modulator of the S1R, according to the previously established method.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> If the <i>K</i><sub>i</sub> ratios without phenytoin <i>versus</i> with phenytoin are >1, the test compounds act as S1R agonists. However, if the <i>K</i><sub>i</sub> ratios without phenytoin <i>versus</i> with phenytoin are ≤1, the compounds act as S1R antagonists.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Selectivity Profiling</h3><div class="NLM_p last">The selectivity profile of compound <b>10</b> was assessed at 1 μM in a panel of 87 recognized human targets and antitargets (SafetyScreen87) by Eurofins Panlabs Discovery Services according to their standard assay protocols.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Metabolic Stability</h3><div class="NLM_p last"><i>In vitro</i> metabolic stability studies were performed by BioDuro, Inc. (Shanghai, China) using rat and human liver microsome fractions (BioIVT, Westbury, NY). Each test compound at 10 μM was incubated with 0.1 mg/mL liver microsomes and 5 mM NADPH in phosphate buffer (50 mM K<sub>2</sub>HPO<sub>4</sub>, pH 7.4). The reactions were sampled at predetermined time points (<i>e.g.</i>, 5 min, 15 min, 30 min, and 1 h), and the resulting samples were analyzed by LC–MS/MS with models of LC-20AD (Shimadzu, Kyoto, Japan) and AB Sciex 4500 (AB Sciex LLC, Toronto, Canada). Metabolic stability was determined by the disappearance of test compounds over time. The linear plots of the natural logarithm (Ln) of the remaining compound percentage (%) at each time point <i>versus</i> time were generated, and the slope was calculated by linear fitting of the curve. The <i>in vitro</i> metabolic half-life (<i>T</i><sub>1/2</sub>) was calculated using (Ln2)/<i>k</i>, where <i>k</i> is the biotransformation rate constant and corresponds to the slope of the Ln-linear plot. The microsomal intrinsic clearance (Cl<sub>int</sub>) was estimated using the equation Cl<sub>int</sub> = (Ln2)/(<i>T</i><sub>1/2</sub>) (μL/min/mg protein). Compounds were tested at least two times in duplicate. Midazolam, dextromethorphan, diclofenac, omeprazole, and phenacetin were used as controls in this assay.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Pharmacokinetic Study in Rats</h3><div class="NLM_p last">This study was performed by BioDuro, Inc., in accordance with the “Guide for the Care and Use of Laboratory Animals: Eighth Edition” in the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited laboratory animal facility. Compound <b>10</b> at 10 mg/kg (in sterile water) was administered (i.p.) to SD male rats weighing around 250 g (N = 3 per group). Plasma samples were collected at the following time points, predose, 0.25, 0.5, 1, 2, and 4 h, while brain samples were collected at 0.5, 1, 2, and 4 h. Aliquots (50 μL) of plasma and brain homogenate samples were mixed with 5 μL of methanol and 200 μL of 50 ng/mL internal standard terfenadine in acetonitrile. After vortexed for 1 min and centrifuged at 4000 rpm for 15 min, the supernatant was diluted with water by fivefold (plasma samples) and twofold (brain samples) for the analysis by LC–MS/MS with models of LC-20AD (Shimadzu, Kyoto, Japan) and AB Sciex 4500 (AB Sciex LLC, Toronto, Canada). Parameters were calculated using the WinNonlin pharmacokinetic software package (Certara, Princeton, NJ).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>In Vivo</i> Safety and Efficacy Studies</h3><div class="NLM_p last">These studies were conducted by Eurofins Pharmacology Discovery Services (Taibei, Taiwan). All aspects of the <i>in vivo</i> behavioral studies conformed to the “Guide for the Care and Use of Laboratory Animals: Eighth Edition” in the AAALAC-accredited laboratory animal facility.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Rotarod and Formalin Tests</h3><div class="NLM_p">Groups of six SD male rats each weighing around 180 g were included to study motor coordination. Rats were trained on a rod at a continuous accelerating speed from 4 to 30 rpm during a time period of 4 min at least three times before the study and then randomly assigned to different groups with a similar baseline. Vehicle (sterile water) and test articles were administered by i.p. injection. The rats were placed on the accelerating rotarod at 30, 60, 90, and 120 min post dosing, and the time (in seconds) that rats remained on the rotarod was recorded. Compound <b>10</b> (in sterile water) was dosed at 20 mg/kg and 40 mg/kg. Gabapentin at 100 mg/kg (i.p.) was used as the positive control in this test.</div><div class="NLM_p last">One day after the rotarod test, the rats were rerandomized to groups of six and treated with the vehicle (sterile water), positive control, and test articles (i.p.). After a period of 30 min, formalin (0.05 mL, 2% solution) was injected to the subplantars. The hind paw licking time was recorded during a 0–35 min period at 5 min intervals after the formalin challenge as a measure of analgesic activity of the test compound.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Paclitaxel-Induced Neuropathy Pain</h3><div class="NLM_p">A cohort of male SD rats, each weighing around 240 g, was used for this study and was housed individually under constant temperature, humidity, and a 12 h light–dark cycle. Mechanical allodynia and cold hyperalgesia were measured to assess the behavioral changes in these rats.</div><div class="NLM_p">Mechanical allodynia was assessed by the manual von Frey test.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The animals were given 20–30 min to acclimatize prior to testing. The paw was touched with a series of eight manual von Frey monofilaments with logarithmically incremental stiffness (0.4 g, 0.6 g, 1.0 g, 2.0 g, 4.0 g, 6.0 g, 8.0 g, and 15.0 g). The manual von Frey monofilament was applied perpendicularly from underneath the mesh floor to the central plantar surface with sufficient force to cause a slight buckling against the paw and held for approximately 6–8 s. A positive (<i>i.e.</i>, painful) response was noted, if the paw was sharply withdrawn. Ambulation was considered an ambiguous response, where the stimulus was reapplied. Mechanical threshold (50% threshold) was assessed using the up and down method following the procedure described previously.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Cold hyperalgesia was measured by placing rats in an ice water bath (0–2 °C) of 2.5 cm depth in a Plexiglas arena 32 cm × 32 cm × 27 cm. Withdrawal latency of the left paw was recorded and averaged twice as cold hyperalgesia assessment. A cutoff time of 30 s was used to ensure an adequate response window and to prevent permanent tissue damage. Longer times <i>versus</i> vehicle are indicative of the treatment’s analgesic effect.</div><div class="NLM_p">Mechanical allodynia and cold hyperalgesia were measured to get the baseline values prior to the paclitaxel (Taxol) injection on day 0 (prepaclitaxel). Paclitaxel was then injected (i.p.) at 2 mg/kg on days 1, 3, 5, and 7 with a total cumulative dose of 8 mg/kg to induce neuropathic pain. Mechanical allodynia and cold hyperalgesia were measured again on day 13 (pretreatment). The animals were randomized into groups of four based on pretreatment mechanical allodynia and cold hyperalgesia values on day 13. Compound <b>10</b> (20 mg/kg), the vehicle (sterile water), and gabapentin (100 mg/kg) were administered (i.p.) on day 14, followed by the measurements of mechanical allodynia at 0.5 h and 1.5 h post dosing and the measurements of cold hyperalgesia at 1.0 h and 2.0 h post dosing.</div><div class="NLM_p last">The paclitaxel-induced hypersensitivity to mechanical and cold stimuli lasts for at least several weeks and does not change significantly during the first week after the development of peripheral neuropathy on day 13 in rats.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In order to save animals and costs, rats were reused after a 1 week washout period following the first dosing. The animals were measured on day 20 again and rerandomized to groups of four based on the mechanical allodynia and cold hyperalgesia values. Then, on day 21, animals were redosed and measured for mechanical allodynia at 0.5 h and 1.5 h post dosing and for cold hyperalgesia at 1.0 h and 2.0 h post dosing. The measurements on days 13 and 20 were combined as the pretreatment values (<i>N</i> = 8). Additionally, the measurements on days 14 and 21 were combined as the post-treatment values (<i>N</i> = 8).</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Statistical Analysis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">One-way ANOVA was used to compare the vehicle control and test article groups. <i>p</i> value <0.05 is considered significant.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01964" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01964?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01964</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Selectivity profiling of compound <b>10</b> in SafetyScreen 87; molecular formula strings (SMILES); <sup>1</sup>H NMR of all final compounds; <sup>13</sup>C NMR and HRMS spectra of compounds <b>10</b> and <b>12</b>; and purity report for compound <b>10</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_001.pdf">jm0c01964_si_001.pdf (7.41 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_002.csv">jm0c01964_si_002.csv (2.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01964" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youyi Peng</span> - <span class="hlFld-Affiliation affiliation">Biomedical
Informatics Shared Resource, Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4797-995X" title="Orcid link">http://orcid.org/0000-0003-4797-995X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5a2a3f343d23351a3933343074282f2e3d3f2829743f3e2f"><span class="__cf_email__" data-cfemail="38485d565f4157785b515652164a4d4c5f5d4a4b165d5c4d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William J. Welsh</span> - <span class="hlFld-Affiliation affiliation">Biomedical
Informatics Shared Resource, Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, 661 Hoes Lane West, Piscataway, New Jersey 08854, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5618-2072" title="Orcid link">http://orcid.org/0000-0002-5618-2072</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5a2d3f3629322d301a282d30372974282f2e3d3f2829743f3e2f"><span class="__cf_email__" data-cfemail="6a1d0f0619021d002a181d00071944181f1e0d0f1819440f0e1f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, 661 Hoes Lane West, Piscataway, New Jersey 08854, United States</span>; 
    <span>Present Address:
                        Intra-Cellular Therapies, Inc., 430 East 29th Street, Suite 900, New York, NY 10016, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research has been supported in part with a grant from the New Jersey Health Foundation, from the Rutgers TechAdvance/TechXpress fund, and from Rutgers-Cancer Institute of New Jersey Biomedical Informatics Shared Resource of the (P30CA072720-5917). We gratefully acknowledge access to the high-performance Computing facilities and support of the computational STEM at the Rutgers Office of Advanced Research Computing (OARC, URL: <a href="http://oarc.rutgers.edu" class="extLink">http://oarc.rutgers.edu</a>).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AAALAC</td><td class="NLM_def"><p class="first last">Assessment and Accreditation of Laboratory Animal Care</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BuLi</td><td class="NLM_def"><p class="first last"><i>n</i>-butyllithium</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">N</td><td class="NLM_def"><p class="first last"><i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DIBAL-H</td><td class="NLM_def"><p class="first last">di-<i>iso</i>-butylalumnium hydride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">g.p</td><td class="NLM_def"><p class="first last">guinea pig</p></td></tr><tr><td class="NLM_term">GPCRs</td><td class="NLM_def"><p class="first last">G-protein-coupled receptors</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">hexafluorophosphate azabenzotriazole tetramethyl uronium</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectra</p></td></tr><tr><td class="NLM_term">i.p</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">Pfp-OH</td><td class="NLM_def"><p class="first last">pentafluorophenol</p></td></tr><tr><td class="NLM_term">S1R</td><td class="NLM_def"><p class="first last">sigma 1 receptor</p></td></tr><tr><td class="NLM_term">S2R</td><td class="NLM_def"><p class="first last">sigma 2 receptor</p></td></tr><tr><td class="NLM_term">SARs</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague Dawley</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eades, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, P. E.</span></span> <span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-+like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lgYWWeDHX7Zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-%2520like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khazan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fakany, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1016/0028-3908(84)90015-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0028-3908%2884%2990015-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=6090969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVert7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=983-987&author=N.+Khazanauthor=G.+A.+Youngauthor=E.+E.+El-Fakanyauthor=O.+Hongauthor=D.+Calligaro&title=Sigma+receptors+mediated+the+psychotomimetic+effects+of+N-allylnormetazocine+%28SKF-10%2C047%29%2C+but+not+its+opioid+agonistic-antagonistic+properties&doi=10.1016%2F0028-3908%2884%2990015-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors mediate the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties</span></div><div class="casAuthors">Khazan, N.; Young, G. A.; El-Fakany, E. E.; Hong, O.; Calligaro, D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">983-7</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    </div><div class="casAbstract">SKF-10047 (I)  [14198-28-8] the prototype σ-agonist, has its opioid entity residing with its (-)-isomer  [14198-28-8], whereas both its (+)-  [58640-82-7] and (-) isomers possess psychotogenic properties similar to those produced by phenyldidine.  (-)-SKF-10047 blocks EEG and behavioral effects of morphine in the naive rat, ppts. withdrawal in morphine-dependent rats, produces phys. dependence as evidenced by naloxone-induced withdrawal, and displaces [3H]dihydromorphine from brain homogenates.  (+)-SKF-10047 did not produce dependence upon chronic treatment, and it did not displace [3H]dihydromorphine from brain homogenates.  Such pharmacodynamic dissocn. with SKF-10047 suggests an assocn. of σ-receptors with psychogenic, but not opioid effects.  The latter are most likely mediated by μ or κ-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZwPMX2KZ-rVg90H21EOLACvtfcHk0lgYWWeDHX7Zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVert7s%253D&md5=5370cf550fed684c93fba77dd5fd2464</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0028-3908%2884%2990015-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0028-3908%252884%252990015-7%26sid%3Dliteratum%253Aachs%26aulast%3DKhazan%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DG.%2BA.%26aulast%3DEl-Fakany%26aufirst%3DE.%2BE.%26aulast%3DHong%26aufirst%3DO.%26aulast%3DCalligaro%26aufirst%3DD.%26atitle%3DSigma%2520receptors%2520mediated%2520the%2520psychotomimetic%2520effects%2520of%2520N-allylnormetazocine%2520%2528SKF-10%252C047%2529%252C%2520but%2520not%2520its%2520opioid%2520agonistic-antagonistic%2520properties%26jtitle%3DNeuropharmacology%26date%3D1984%26volume%3D23%26spage%3D983%26epage%3D987%26doi%3D10.1016%2F0028-3908%2884%2990015-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flandorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striessnig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span> <span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">8072</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=8755605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma1-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span></div><div class="casAuthors">Hanner, Markus; Moebius, Fabian F.; Flandorfer, Astrid; Knaus, Hans-Guenther; Striessnig, Joerg; Kempner, Ellis; Glossman, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8072-8077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sigma-ligands comprise several chem. unrelated drugs such as haloperidol, pentazocine, and ditolylguanidine, which bind to a family of low mol. mass proteins in the endoplasmic reticulum.  These so-called sigma-receptors are believed to mediate various pharmacol. effects of sigma-ligands by as yet unknown mechanisms.  Based on their opposite enantioselectivity for benzomorphans and different mol. masses, two subtypes are differentiated.  We purified the sigma1-binding site as a single 30-kDa protein from guinea pig liver employing the benzomorphan (+)[3H]pentazocine and the aryladize (-)[3H]azidopamil as specific probes.  The purified (+)[3H]pentazocine-binding protein retained its high affinity for haloperidol, pentazocine, and ditolylguanidine.  Partial amino acid sequence obtained after trypsinolysis revealed no homol. to known proteins.  Radiation inactivation of the pentazocine-labeled sigma1-binding site yielded a mol. mass of 24 kDa.  The corresponding cDNA was cloned using degenerate oligonucleotides and cDNA library screening.  Its open reading frame encoded a 25.3-kDa protein with at least one putative transmembrane segment.  The protein expressed in yeast cells transformed with the cDNA showed the pharmacol. characteristics of the brain and liver sigma1-binding site.  The deduced amino acid sequence was structurally unrelated to known mammalian proteins but it shared homol. with fungal proteins involved in sterol synthesis.  Northern blots showed high densities of the sigma1-binding site mRNA in sterol-producing tissues.  This is also in agreement with the known ability of sigma1-binding sites to interact with steroids, such as progesterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kp2l6ZPKdrVg90H21EOLACvtfcHk0lhAtgsVvtgjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D&md5=01c7d3bbab83dd5d18531845213bf267</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma1-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional characterization of a sigma receptor from rat brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.70030922.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1046%2Fj.1471-4159.1998.70030922.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9489711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1cXht1yrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=922-931&author=P.+Sethauthor=Y.+J.+Feiauthor=H.+W.+Liauthor=W.+Huangauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+functional+characterization+of+a+sigma+receptor+from+rat+brain&doi=10.1046%2Fj.1471-4159.1998.70030922.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional characterization of a σ receptor from rat brain</span></div><div class="casAuthors">Seth, Pankaj; Fei, You-Jun; Li, Hui W.; Huang, Wei; Leibach, Frederick H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">922-931</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">The authors have cloned a σ receptor from rat brain and established its functional identity using a heterologous expression system.  The cloned cDNA (1582 bp long) codes for a protein of 223 amino acids that possesses a single putative transmembrane domain.  The amino acid sequence of the rat brain σ receptor is highly homologous to that of the σ receptor recently cloned from guinea pig liver and a human placental cell line but is not related to any other known mammalian receptors.  When expressed in HeLa cells, the rat brain σ receptor cDNA leads to a two- to threefold increase in haloperidol binding, and this cDNA-induced binding is sensitive to inhibition by several σ receptor-specific ligands.  Kinetic anal. using the heterologous expression system has revealed that the rat brain σ receptor interacts with haloperidol with an apparent dissocn. const. (KD) of 3 nM.  Functional expression of the cloned rat brain σ receptor in HeLa cells also leads to an increase in the binding of two other σ ligands, namely, (+)-pentazocine and (+)-3-(3-hydroxyphenyl)-N-(1-propyl) piperidine (PPP).  Pharmacol. characterization of the cloned rat brain σ receptor reveals that it exhibits severalfold higher affinity for clorgyline than for 1,3-di(2-tolyl)guanidine, it interacts with progesterone and testosterone, and its interaction with PPP is markedly enhanced by phenytoin.  In addn., transfection of MCF-7 cells, which do not express type 1 σ receptor mRNA or activity, with the cloned rat brain cDNA leads to the appearance of haloperidol-sensitive binding of (+)-pentazocine, a selective type 1 σ receptor ligand.  These data show that the cloned rat brain cDNA codes for a functional type 1 σ receptor.  Northern blot anal. with poly(A)+ RNA isolated from various rat tissues has indicated that the σ receptor-specific transcript, 1.6 kb in size, is expressed abundantly in liver and moderately in intestine, kidney, brain, and lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0r0iO7VHT7Vg90H21EOLACvtfcHk0lhAtgsVvtgjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1yrt7c%253D&md5=d61a346c8a8f6d1cebd5747c7b652a07</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70030922.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70030922.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DFei%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DH.%2BW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520of%2520a%2520sigma%2520receptor%2520from%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D70%26spage%3D922%26epage%3D931%26doi%3D10.1046%2Fj.1471-4159.1998.70030922.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a mouse sigma1 receptor</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">2279</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.70062279.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1046%2Fj.1471-4159.1998.70062279.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9603192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1cXjsVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=2279-2285&author=Y.+X.+Panauthor=J.+Meiauthor=J.+Xuauthor=B.+L.+Wanauthor=A.+Zuckermanauthor=G.+W.+Pasternak&title=Cloning+and+characterization+of+a+mouse+sigma1+receptor&doi=10.1046%2Fj.1471-4159.1998.70062279.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a mouse σ1 receptor</span></div><div class="casAuthors">Pan, Ying-Xian; Mei, Jianfeng; Xu, Jin; Wan, Ban-Lin; Zickerman, Amy; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2279-2285</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">A cDNA clone (S2-1a) isolated from a mouse brain cDNA library, using a guinea pig σ1 cDNA as probe, has high homol. to the predicted protein sequence of the guinea pig (88%) and human (90%) σ1 receptors.  Northern anal. revealed a major mRNA of ∼1.8 kb in a wide range of mouse tissues, with highest levels in brain, liver, kidney, and thymus.  Southern anal. and chromosomal mapping in the mouse suggested a single-copy gene in region A5-B2 of chromosome 4.  Expression of the clone in MCF-7 and CHO cells led to a pronounced increase in (+)-[3H] pentazocine binding with a selectivity profile consistent with σ1 receptors.  In vitro translation yielded a protein of ∼28 kDa, as did transfection of a probe contg. the hemagglutinin (HA) epitope (S2-1a.HA) into CHO cells, as detd. by western anal. using an antibody directed against HA.  (+)-[3H]-Pentazocine binding to immunopurified HA-tagged receptor demonstrated conclusively that S2-1a.HA encodes a high-affinity (+)-[3H]pentazocine binding site with characteristics of a murine σ1 receptor.  An antisense oligodeoxynucleotide designed from S2-1a potentiated opioid analgesia in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDPST5L1-NQrVg90H21EOLACvtfcHk0lhAtgsVvtgjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsVeqsbg%253D&md5=baed21424a67995e16e005956a047371</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70062279.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70062279.x%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DZuckerman%26aufirst%3DA.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520mouse%2520sigma1%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D70%26spage%3D2279%26epage%3D2285%26doi%3D10.1046%2Fj.1471-4159.1998.70062279.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsamba, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlsen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of adhesive binding by desmocollins and desmogleins</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7160</span>– <span class="NLM_lpage">7165</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606272113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1073%2Fpnas.1606272113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=27298358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps12htrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=7160-7165&author=O.+J.+Harrisonauthor=J.+Braschauthor=G.+Lassoauthor=P.+S.+Katsambaauthor=G.+Ahlsenauthor=B.+Honigauthor=L.+Shapiro&title=Structural+basis+of+adhesive+binding+by+desmocollins+and+desmogleins&doi=10.1073%2Fpnas.1606272113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of adhesive binding by desmocollins and desmogleins</span></div><div class="casAuthors">Harrison, Oliver J.; Brasch, Julia; Lasso, Gorka; Katsamba, Phinikoula S.; Ahlsen, Goran; Honig, Barry; Shapiro, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7160-7165</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Desmosomes are intercellular adhesive junctions that impart strength to vertebrate tissues.  Their dense, ordered intercellular attachments are formed by desmogleins (Dsgs) and desmocollins (Dscs), but the nature of trans-cellular interactions between these specialized cadherins is unclear.  Here, using soln. biophysics and coated-bead aggregation expts., we demonstrate family-wise heterophilic specificity: All Dsgs form adhesive dimers with all Dscs, with affinities characteristic of each Dsg:Dsc pair.  Crystal structures of ectodomains from Dsg2 and Dsg3 and from Dsc1 and Dsc2 show binding through a strand-swap mechanism similar to that of homophilic classical cadherins.  However, conserved charged amino acids inhibit Dsg:Dsg and Dsc:Dsc interactions by same-charge repulsion and promote heterophilic Dsg:Dsc interactions through opposite-charge attraction.  These findings show that Dsg:Dsc heterodimers represent the fundamental adhesive unit of desmosomes and provide a structural framework for understanding desmosome assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7Ca1Ou2hFLVg90H21EOLACvtfcHk0lhF-itEJMI2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps12htrc%253D&md5=dfd98c8fed7b69cadb8168387ab9b145</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606272113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606272113%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DO.%2BJ.%26aulast%3DBrasch%26aufirst%3DJ.%26aulast%3DLasso%26aufirst%3DG.%26aulast%3DKatsamba%26aufirst%3DP.%2BS.%26aulast%3DAhlsen%26aufirst%3DG.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DL.%26atitle%3DStructural%2520basis%2520of%2520adhesive%2520binding%2520by%2520desmocollins%2520and%2520desmogleins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3D7160%26epage%3D7165%26doi%3D10.1073%2Fpnas.1606272113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca%282%2B%29+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0lhF-itEJMI2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca%25282%252B%2529%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anoal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/s0306-4522(00)00014-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0306-4522%2800%2900014-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10771347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=155-170&author=G.+Alonsoauthor=V.-L.+Phanauthor=I.+Guillemainauthor=M.+Saunierauthor=A.+Legrandauthor=M.+Anoalauthor=T.+Maurice&title=Immunocytochemical+localization+of+the+sigma%281%29+receptor+in+the+adult+rat+central+nervous+system&doi=10.1016%2Fs0306-4522%2800%2900014-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system</span></div><div class="casAuthors">Alonso, G.; Phan, V.-L.; Guillemain, I.; Saunier, M.; Legrand, A.; Anoal, M.; Maurice, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-170</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">To characterize the localization of the sigma1 receptor in the adult rat central nervous system, a polyclonal antibody was raised against a 20 amino acid peptide, corresponding to the fragment 143-162 of the cloned sigma1 receptor protein.  Throughout the rostrocaudal regions of the central nervous system extending from the olfactory bulb to the spinal cord, intense to moderate immunostaining was found to be assocd. with: (i) ependymocytes bordering the entire ventricular system, and (ii) neuron-like structures located within the parenchyma.  Double fluorescence studies confirmed that, throughout the parenchyma, sigma1 receptor-immunostaining was essentially assocd. with neuronal structures immunostained for the neuronal marker βIII-tubulin.  In all rats examd., high levels of immunostaining were always assocd. with neurons located within specific regions including the granular layer of the olfactory bulb, various hypothalamic nuclei, the septum, the central gray, motor nuclei of the hindbrain and the dorsal horn of the spinal cord.  In contrast, only faint immunostaining was assocd. with neurons located in the caudate-putamen and the cerebellum.  Electron microscope studies indicated that sigma1 receptor immunostaining was mostly assocd. with neuronal perikarya and dendrites, where it was localized to the limiting plasma membrane, the membrane of mitochondria and of some cisternae of the endoplasmic reticulum.  At the level of synaptic contacts, intense immunostaining was assocd. with postsynaptic structures including the postsynaptic thickening and some polymorphous vesicles, whereas the presynaptic axons were devoid of immunostaining.  These data indicate that the sigma1 receptor antibody prepd. here, represents a promising tool for further investigating the role of σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsAacDelSDfbVg90H21EOLACvtfcHk0lhF-itEJMI2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGhurg%253D&md5=2df1ba6a60488364ad458069e059354d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2800%2900014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252800%252900014-2%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DG.%26aulast%3DPhan%26aufirst%3DV.-L.%26aulast%3DGuillemain%26aufirst%3DI.%26aulast%3DSaunier%26aufirst%3DM.%26aulast%3DLegrand%26aufirst%3DA.%26aulast%3DAnoal%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DImmunocytochemical%2520localization%2520of%2520the%2520sigma%25281%2529%2520receptor%2520in%2520the%2520adult%2520rat%2520central%2520nervous%2520system%26jtitle%3DNeuroscience%26date%3D2000%26volume%3D97%26spage%3D155%26epage%3D170%26doi%3D10.1016%2Fs0306-4522%2800%2900014-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bangaru, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihrauch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. E.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1744-8069-9-47</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-9-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1186%2F1744-8069-9-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1744-8069-9-47&author=M.+L.+Bangaruauthor=D.+Weihrauchauthor=Q.+B.+Tangauthor=V.+Zogaauthor=Q.+Hoganauthor=H.+E.+Wu&title=Sigma-1+receptor+expression+in+sensory+neurons+and+the+effect+of+painful+peripheral+nerve+injury&doi=10.1186%2F1744-8069-9-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-9-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-9-47%26sid%3Dliteratum%253Aachs%26aulast%3DBangaru%26aufirst%3DM.%2BL.%26aulast%3DWeihrauch%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DQ.%2BB.%26aulast%3DZoga%26aufirst%3DV.%26aulast%3DHogan%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DH.%2BE.%26atitle%3DSigma-1%2520receptor%2520expression%2520in%2520sensory%2520neurons%2520and%2520the%2520effect%2520of%2520painful%2520peripheral%2520nerve%2520injury%26jtitle%3DMol.%2520Pain%26date%3D2013%26volume%3D9%26spage%3D1744-8069-9-47%26doi%3D10.1186%2F1744-8069-9-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, A.</span></span> <span> </span><span class="NLM_article-title">σ-1 receptors in major depression and anxiety</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=%CF%83-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0liqCicFXDE7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3D%25CF%2583-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4808</span>– <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.+L.+Jinauthor=M.+Fangauthor=Y.+X.+Zhaoauthor=X.+Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2eaBV_Xr5bN28rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%2BL.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke-Wold, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookerjee, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavendish, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandinaro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span> <span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0liqCicFXDE7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones and diseases</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.2174%2F1871524910909030184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=20021352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=184-189&author=S.-Y.+Tsaiauthor=T.+Hayashiauthor=T.+Moriauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+and+diseases&doi=10.2174%2F1871524910909030184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones and diseases</span></div><div class="casAuthors">Tsai, Shang-Yi; Hayashi, Teruo; Mori, Tomohisa; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chaperones are proteins that assist the correct folding of other protein clients either when the clients are being synthesized or at their functional localities.  Chaperones are responsible for certain diseases.  The sigma-1 receptor is recently identified as a receptor chaperone whose activity can be activated/deactivated by specific ligands.  Under physiol. conditions, the sigma-1 receptor chaperones the functional IP3 receptor at the endoplasmic reticulum and mitochondrion interface to ensure proper Ca2+ signaling from endoplasmic reticulum into mitochondrion.  However, under pathol. conditions whereby cells encounter enormous stress that results in the endoplasmic reticulum losing its global Ca2+ homeostasis, the sigma-1 receptor translocates and counteracts the arising apoptosis.  Thus, the sigma-1 receptor is a receptor chaperone essential for the metabotropic receptor signaling and for the survival against cellular stress.  The sigma-1 receptor has been implicated in many diseases including addiction, pain, depression, stroke, and cancer.  Whether the chaperone activity of the sigma-1 receptor attributes to those diseases awaits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHVqBwWpruLVg90H21EOLACvtfcHk0lgN8QdQy9iZ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM&md5=2a24b524318a17026caadb8e64e908c6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030184%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520and%2520diseases%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D184%26epage%3D189%26doi%3D10.2174%2F1871524910909030184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasuriya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. M.</span></span> <span> </span><span class="NLM_article-title">The -1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">18219</span>– <span class="NLM_lpage">18224</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3360-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1523%2FJNEUROSCI.3360-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=24227730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=18219-18224&author=D.+Balasuriyaauthor=A.+P.+Stewartauthor=J.+M.+Edwardson&title=The+-1+Receptor+Interacts+Directly+with+GluN1+But+Not+GluN2A+in+the+GluN1%2FGluN2A+NMDA+Receptor&doi=10.1523%2Fjneurosci.3360-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The σ-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor</span></div><div class="casAuthors">Balasuriya, Dilshan; Stewart, Andrew P.; Edwardson, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18219-18224</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The σ-1 receptor (Sig1R) is widely expressed in the CNS, where it has a neuroprotective role in ischemia and stroke and an involvement in schizophrenia.  The Sig1R interacts functionally with a variety of ion channels, including the NMDA receptor (NMDAR).  Here, we used at. force microscopy (AFM) imaging to investigate the interaction between the Sig1R and the NMDAR.  The Sig1R bound directly to GluN1/GluN2A NMDAR heterotetramers.  Furthermore, the mean angle between pairs of bound Sig1Rs was 72°.  This result suggested that the Sig1R interacts with either GluN1 or GluN2A, but not both, and supports our recent demonstration that the NMDAR subunits adopt an adjacent (i.e., 1/1/2/2) arrangement.  The Sig1R could be coisolated with GluN1 but not with GluN2A, indicating that GluN1 is its specific target within the NMDAR.  Consistent with this conclusion, AFM imaging of coisolated Sig1R and GluN1 revealed GluN1 dimers decorated with Sig1Rs.  In situ proximity ligation assays demonstrated that the Sig1R interacts with GluN1 (but not with GluN2A) within intact cells and also that its C terminus is extracellular.  We conclude that the Sig1R binds to the GluN1/GluN2A NMDAR specifically via the GluN1 subunit.  This interaction likely accounts for at least some of the modulatory effects of Sig1R ligands on the NMDAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBf9xfFdqFgbVg90H21EOLACvtfcHk0lgN8QdQy9iZ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmu7zI&md5=d4aa9bfc018939547e0d35d7f6da37d9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3360-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3360-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DBalasuriya%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DA.%2BP.%26aulast%3DEdwardson%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520-1%2520Receptor%2520Interacts%2520Directly%2520with%2520GluN1%2520But%2520Not%2520GluN2A%2520in%2520the%2520GluN1%252FGluN2A%2520NMDA%2520Receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D18219%26epage%3D18224%26doi%3D10.1523%2Fjneurosci.3360-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Muñoz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Blázquez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero-Labrador, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Murillo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garzón, J.</span></span> <span> </span><span class="NLM_article-title">The sigma1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.5993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1089%2Fars.2014.5993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=25557043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1OqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=799-818&author=M.+Rodr%C3%ADguez-Mu%C3%B1ozauthor=P.+S%C3%A1nchez-Bl%C3%A1zquezauthor=R.+Herrero-Labradorauthor=R.+Mart%C3%ADnez-Murilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=J.+Garz%C3%B3n&title=The+sigma1+receptor+engages+the+redox-regulated+HINT1+protein+to+bring+opioid+analgesia+under+NMDA+receptor+negative+control&doi=10.1089%2Fars.2014.5993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control</span></div><div class="casAuthors">Rodriguez-Munoz, Maria; Sanchez-Blazquez, Pilar; Herrero-Labrador, Raquel; Martinez-Murillo, Ricardo; Merlos, Manuel; Vela, Jose Miguel; Garzon, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">799-818</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The in vivo pharmacol. of the sigma 1 receptor (σ1R) is certainly complex; however, σ1R antagonists are of therapeutic interest, because they enhance mu-opioid receptor (MOR)-mediated antinociception and reduce neuropathic pain.  Thus, we investigated whether the σ1R is involved in the neg. control that glutamate N-methyl-d-aspartate acid receptors (NMDARs) exert on opioid antinociception.  Results: The MOR C terminus carries the histidine triad nucleotide-binding protein 1 (HINT1) coupled to the regulator of G-protein signaling RGSZ2-neural nitric oxide synthase assembly.  Activated MORs stimulate the prodn. of nitric oxide (NO), and the redox zinc switch RGSZ2 converts this signal into free zinc ions that are required to recruit the redox sensor PKCγ to HINT1 proteins.  Then, PKCγ impairs HINT1-RGSZ2 assocn. and enables σ1R-NR1 interaction with MOR-HINT1 complexes to restrain opioid signaling.  The inhibition of NOS or the absence of σ1Rs prevents HINT1-PKCγ interaction, and MOR-NMDAR cross-regulation fails.  The σ1R antagonists transitorily remove the binding of σ1Rs to NR1 subunits, facilitate the entrance of neg. regulators of NMDARs, likely Ca2+-CaM, and prevent NR1 interaction with HINT1, thereby impairing the neg. feedback of glutamate on opioid analgesia.  Innovation: A redox-regulated process situates MOR signaling under NMDAR control, and in this context, the σ1R binds to the cytosolic C terminal region of the NMDAR NR1 subunit.  Conclusion: The σ1R antagonists enhance opioid analgesia in naive mice by releasing MORs from the neg. influence of NMDARs, and they also reset antinociception in morphine tolerant animals.  Moreover, σ1R antagonists alleviate neuropathic pain, probably by driving the inhibition of up-regulated NMDARs.  Antioxid. Redox Signal. 22, 799-818.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGgPbrrTqQLVg90H21EOLACvtfcHk0lgN8QdQy9iZ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1OqtL4%253D&md5=b0896c51a92e9bd8ecff8029f09c6f97</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.5993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.5993%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Mu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DS%25C3%25A1nchez-Bl%25C3%25A1zquez%26aufirst%3DP.%26aulast%3DHerrero-Labrador%26aufirst%3DR.%26aulast%3DMart%25C3%25ADnez-Murillo%26aufirst%3DR.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DGarz%25C3%25B3n%26aufirst%3DJ.%26atitle%3DThe%2520sigma1%2520receptor%2520engages%2520the%2520redox-regulated%2520HINT1%2520protein%2520to%2520bring%2520opioid%2520analgesia%2520under%2520NMDA%2520receptor%2520negative%2520control%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2015%26volume%3D22%26spage%3D799%26epage%3D818%26doi%3D10.1089%2Fars.2014.5993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalyshyn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1124/mol.109.057083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1124%2Fmol.109.057083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=20089882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=695-703&author=F.+J.+Kimauthor=I.+Kovalyshynauthor=M.+Burgmanauthor=C.+Neilanauthor=C.-C.+Chienauthor=G.+W.+Pasternak&title=Sigma+1+receptor+modulation+of+G-protein-coupled+receptor+signaling%3A+potentiation+of+opioid+transduction+independent+from+receptor+binding&doi=10.1124%2Fmol.109.057083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">σ1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding</span></div><div class="casAuthors">Kim, Felix J.; Kovalyshyn, Ivanka; Burgman, Maxim; Neilan, Claire; Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">695-703</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">σ Ligands modulate opioid actions in vivo, with agonists diminishing morphine analgesia and antagonists enhancing the response.  Using human BE(2)-C neuroblastoma cells that natively express opioid receptors and human embryonic kidney (HEK) cells transfected with a cloned μ opioid receptor, we now demonstrate a similar modulation of opioid function, as assessed by guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding, by σ1 receptors.  σ Ligands do not compete opioid receptor binding.  Administered alone, neither σ agonists nor antagonists significantly stimulated [35S]GTPγS binding.  Yet σ receptor selective antagonists, but not agonists, shifted the EC50 of opioid-induced stimulation of [35S]GTPγS binding by 3- to 10-fold to the left.  This enhanced potency was seen without a change in the efficacy of the opioid, as assessed by the maximal stimulation of [35S]GTPγS binding.  σ1 Receptors phys. assoc. with μ opioid receptors, as shown by coimmunopptn. studies in transfected HEK cells, implying a direct interaction between the proteins.  Thus, σ receptors modulate opioid transduction without influencing opioid receptor binding.  RNA interference knockdown of σ1 in BE(2)-C cells also potentiated μ opioid-induced stimulation of [35S]GTPγS binding.  These modulatory actions are not limited to μ and δ opioid receptors.  In mouse brain membrane prepns., σ1-selective antagonists also potentiated both opioid receptor and muscarinic acetylcholine receptor-mediated stimulation of [35S]GTPγS binding, suggesting a broader role for σ receptors in modulating G-protein-coupled receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBczr3LWvgF7Vg90H21EOLACvtfcHk0liq2zpoO6R7AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7s%253D&md5=0317009efe9b9e3fc138c5c1371e1953</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.057083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.057083%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DF.%2BJ.%26aulast%3DKovalyshyn%26aufirst%3DI.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DNeilan%26aufirst%3DC.%26aulast%3DChien%26aufirst%3DC.-C.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%25201%2520receptor%2520modulation%2520of%2520G-protein-coupled%2520receptor%2520signaling%253A%2520potentiation%2520of%2520opioid%2520transduction%2520independent%2520from%2520receptor%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D695%26epage%3D703%26doi%3D10.1124%2Fmol.109.057083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2879</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.87.6.2867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1152%2Fjn.2002.87.6.2867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=12037190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2002&pages=2867-2879&author=H.+Zhangauthor=J.+Cuevas&title=Sigma+receptors+inhibit+high-voltage-activated+calcium+channels+in+rat+sympathetic+and+parasympathetic+neurons&doi=10.1152%2Fjn.2002.87.6.2867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span></div><div class="casAuthors">Zhang, Hongling; Cuevas, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2867-2879</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia.  Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 receptor using single-cell RT-PCR techniques.  The relationship between sigma receptors and calcium channels was studied in isolated neurons of these ganglia under voltage-clamp mode using the perforated-patch configuration of the whole cell patch-clamp recording technique.  Bath application of sigma receptor agonists was shown to rapidly depress peak calcium channel currents in a reversible manner in both SCG and intracardiac ganglion neurons.  The inhibition of barium (IBa) currents was dose-dependent, and half-maximal inhibitory concn. (IC50) values for haloperidol, ibogaine, (+)-pentazocine, and 1,3-Di-O-tolylguanidine (DTG) were 6, 31, 61, and 133 μM, resp.  The rank order potency of haloperidol > ibogaine > (+)-pentazocine > DTG is consistent with the effects on calcium channels being mediated by a sigma-2 receptor.  Preincubation of neurons with the irreversible sigma receptor antagonist, metaphit, blocked DTG-mediated inhibition of Ca2+ channel currents.  Maximum inhibition of calcium channel currents was ≥95%, suggesting that sigma receptors block all calcium channel subtypes found on the cell body of these neurons, which includes N-, L-, P/Q-, and R-type calcium channels.  In addn. to depressing peak Ca2+ channel current, sigma receptors altered the biophys. properties of these channels.  Following sigma receptor activation, Ca2+ channel inactivation rate was accelerated, and the voltage dependence of both steady-state inactivation and activation shifted toward more neg. potentials.  Expts. on the signal transduction cascade coupling sigma receptors and Ca2+ channels demonstrated that neither cell dialysis nor intracellular application of 100 μM guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) abolished the modulation of IBa by sigma receptor agonists.  These data suggest that neither a diffusible cytosolic second messenger nor a G protein is involved in this pathway.  Activation of sigma receptors on sympathetic and parasympathetic neurons is likely to modulate cell-to-cell signaling in autonomic ganglia and thus the regulation of cardiac function by the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TEGVj60pJLVg90H21EOLACvtfcHk0liq2zpoO6R7AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D&md5=7d0aebce61514d66065e60dda149e038</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.87.6.2867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.87.6.2867%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCuevas%26aufirst%3DJ.%26atitle%3DSigma%2520receptors%2520inhibit%2520high-voltage-activated%2520calcium%2520channels%2520in%2520rat%2520sympathetic%2520and%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D87%26spage%3D2867%26epage%3D2879%26doi%3D10.1152%2Fjn.2002.87.6.2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujalte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0liq2zpoO6R7AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0ljOIMwVwJQPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejada, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2012.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.jpain.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23063344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1107-1121&author=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=M.+A.+Tejadaauthor=D.+Zamanilloauthor=J.+M.+Velaauthor=J.+M.+Baeyens&title=Role+of+sigma-1+receptors+in+paclitaxel-induced+neuropathic+pain+in+mice&doi=10.1016%2Fj.jpain.2012.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span></div><div class="casAuthors">Nieto, Francisco Rafael; Cendan, Cruz Miguel; Sanchez-Fernandez, Cristina; Cobos, Enrique Jose; Entrena, Jose Manuel; Tejada, Miguel Angel; Zamanillo, Daniel; Vela, Jose Miguel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sigma-1 (σ1) receptors play a role in different types of pain and in central sensitization mechanisms; however, it is unknown whether they are involved in chemotherapy-induced neuropathic pain.  We compared the ability of paclitaxel to induce cold (acetone test) and mech. (electronic Von Frey test) allodynia in wild-type (WT) and σ1 receptor knockout (σ1-KO) mice.  We also tested the effect on paclitaxel-induced painful neuropathy of BD-1063 (16-64 mg/kg, s.c.) and S1RA (32-128 mg/kg, s.c.), 2 selective σ1 receptor antagonists that bind to the σ1 receptor with high affinity and competitively.  The responses to cold and mech. stimuli were similar in WT and σ1-KO mice not treated with paclitaxel; however, treatment with paclitaxel (2 mg/kg, i.p., once per day during 5 consecutive days) produced cold and mech. allodynia and an increase in spinal cord diphosphorylated extracellular signal-regulated kinase (pERK) in WT but not in σ1-KO mice.  The administration of BD-1063 or S1RA 30 min before each paclitaxel dose prevented the development of cold and mech. allodynia in WT mice.  Moreover, the acute administration of both σ1 receptor antagonists dose dependently reversed both types of paclitaxel-induced allodynia after they had fully developed.  These results suggest that σ1 receptors play a key role in paclitaxel-induced painful neuropathy.  Perspective: Antagonists of the σ1 receptor may have therapeutic value for the treatment and/or prevention of paclitaxel-induced neuropathic pain.  This possibility is esp. interesting in the context of chemotherapy-induced neuropathy, where the onset of nerve damage is predictable and preventive treatment could be administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHYCYBeIn__bVg90H21EOLACvtfcHk0ljOIMwVwJQPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I&md5=798467267c69e426eae9df6cde797d6d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DTejada%26aufirst%3DM.%2BA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520paclitaxel-induced%2520neuropathic%2520pain%2520in%2520mice%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D1107%26epage%3D1121%26doi%3D10.1016%2Fj.jpain.2012.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canizares, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubero, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Segura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1744-8069-10-11</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-10-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1186%2F1744-8069-10-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1744-8069-10-11&author=F.+R.+Nietoauthor=C.+M.+Cendanauthor=F.+J.+Canizaresauthor=M.+A.+Cuberoauthor=J.+M.+Velaauthor=E.+Fernandez-Seguraauthor=J.+M.+Baeyens&title=Genetic+inactivation+and+pharmacological+blockade+of+sigma-1+receptors+prevent+paclitaxel-induced+sensory-nerve+mitochondrial+abnormalities+and+neuropathic+pain+in+mice&doi=10.1186%2F1744-8069-10-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-10-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-10-11%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DCanizares%26aufirst%3DF.%2BJ.%26aulast%3DCubero%26aufirst%3DM.%2BA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DFernandez-Segura%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DGenetic%2520inactivation%2520and%2520pharmacological%2520blockade%2520of%2520sigma-1%2520receptors%2520prevent%2520paclitaxel-induced%2520sensory-nerve%2520mitochondrial%2520abnormalities%2520and%2520neuropathic%2520pain%2520in%2520mice%26jtitle%3DMol.%2520Pain%26date%3D2014%26volume%3D10%26spage%3D1744-8069-10-11%26doi%3D10.1186%2F1744-8069-10-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of Peripheral μ-Opioid Analgesia by σ1 Receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.208272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1124%2Fjpet.113.208272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=24155346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=32-45&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=R.+Gonz%C3%A1lez-Canoauthor=F.+R.+Nietoauthor=L.+Romeroauthor=A.+Artacho-Cord%C3%B3nauthor=R.+Montesauthor=B.+Fern%C3%A1ndez-Pastorauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Modulation+of+Peripheral+%CE%BC-Opioid+Analgesia+by+%CF%831+Receptors&doi=10.1124%2Fjpet.113.208272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of peripheral μ-opioid analgesia by σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Montilla-Garcia, Angeles; Gonzalez-Cano, Rafael; Nieto, Francisco Rafael; Romero, Lucia; Artacho-Cordon, Antonia; Montes, Rosa; Fernandez-Pastor, Begona; Merlos, Manuel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We evaluated the effects of σ1-receptor inhibition on μ-opioid-induced mech. antinociception and constipation. σ1-Knockout mice exhibited marked mech. antinociception in response to several μ-opioid analgesics (fentanyl, oxycodone, morphine, buprenorphine, and tramadol) at systemic (s.c.) doses that were inactive in wild-type mice and even unmasked the antinociceptive effects of the peripheral μ-opioid agonist loperamide.  Likewise, systemic (s.c.) or local (intraplantar) treatment of wild-type mice with the selective σ1 antagonists BD-1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine dihydrochloride] or S1RA [4-[2-[[5-methyl-1-(2-naphthalenyl)1H-pyrazol-3-yl]oxy]ethyl] morpholine hydrochloride] potentiated μ-opioid antinociception; these effects were fully reversed by the σ1 agonist PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate) hydrochloride], showing the selectivity of the pharmacol. approach.  The μ-opioid antinociception potentiated by σ1 inhibition (by σ1-receptor knockout or σ1-pharmacol. antagonism) was more sensitive to the peripherally restricted opioid antagonist naloxone methiodide than opioid antinociception under normal conditions, indicating a key role for peripheral opioid receptors in the enhanced antinociception.  Direct interaction between the opioid drugs and σ1 receptor cannot account for our results, since the former lacked affinity for σ1 receptors (labeled with [3H](+)-pentazocine).  A peripheral role for σ1 receptors was also supported by their higher d. (Western blot results) in peripheral nervous tissue (dorsal root ganglia) than in several central areas involved in opioid antinociception (dorsal spinal cord, basolateral amygdala, periaqueductal gray, and rostroventral medulla).  In contrast to its effects on nociception, σ1-receptor inhibition did not alter fentanyl- or loperamide-induced constipation, a peripherally mediated nonanalgesic opioid effect.  Therefore, σ1-receptor inhibition may be used as a systemic or local adjuvant to enhance peripheral μ-opioid analgesia without affecting opioid-induced constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXDUF69QHTL7Vg90H21EOLACvtfcHk0li763rG1jibIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D&md5=3448ecaf8c215210a48a8413b89db2a5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.208272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.208272%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DMontes%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DModulation%2520of%2520Peripheral%2520%25CE%25BC-Opioid%2520Analgesia%2520by%2520%25CF%25831%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D32%26epage%3D45%26doi%3D10.1124%2Fjpet.113.208272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.neuropharm.2013.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23524304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=348-358&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=F.+R.+Nietoauthor=R.+Gonz%C3%A1lez-Canoauthor=A.+Artacho-Cord%C3%B3nauthor=L.+Romeroauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=D.+Zamanilloauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Potentiation+of+morphine-induced+mechanical+antinociception+by+%CF%831+receptor+inhibition%3A+Role+of+peripheral+%CF%831+receptors&doi=10.1016%2Fj.neuropharm.2013.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Nieto, Francisco Rafael; Gonzalez-Cano, Rafael; Artacho-Cordon, Antonia; Romero, Lucia; Montilla-Garcia, Angeles; Zamanillo, Daniel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-358</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the modulation of morphine-induced mech. antinociception and side effects by σ1 receptor inhibition.  Both wild-type (WT) and σ1 receptor knockout (σ1-KO) mice showed similar responses to paw pressure (100-600 g).  The systemic (s.c.) or local (intraplantar) administration of σ1 antagonists (BD-1063, BD-1047, NE-100 and S1RA) was devoid of antinociceptive effects in WT mice.  However, σ1-KO mice exhibited an enhanced mech. antinociception in response to systemic morphine (1-16 mg/kg).  Similarly, systemic treatment of WT mice with σ1 antagonists markedly potentiated morphine-induced antinociception, and its effects were reversed by the selective σ1 agonist PRE-084.  Although the local administration of morphine (50-200 μg) was devoid of antinociceptive effects in WT mice, it induced dose-dependent antinociception in σ1-KO mice.  This effect was limited to the injected paw.  Enhancement of peripheral morphine antinociception was replicated in WT mice locally co-administered with σ1 antagonists and the opioid.  None of the σ1 antagonists tested enhanced morphine-antinociception in σ1-KO mice, confirming a σ1-mediated action.  Morphine-induced side-effects (hyperlocomotion and inhibition of gastrointestinal transit) were unaltered in σ1-KO mice.  These results cannot be explained by a direct interaction of σ1 ligands with μ-opioid receptors or adaptive changes of μ-receptors in σ1-KO mice, given that [3H]DAMGO binding in forebrain, spinal cord, and hind-paw skin membranes was unaltered in mutant mice, and none of the σ1 drugs tested bound to μ-opioid receptors.  These results show that σ1 receptor inhibition potentiates morphine-induced mech. analgesia but not its acute side effects, and that this enhanced analgesia can be induced at peripheral level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2KFSqih3HbVg90H21EOLACvtfcHk0li763rG1jibIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D&md5=d21562671453852a7e07c15232726ade</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DPotentiation%2520of%2520morphine-induced%2520mechanical%2520antinociception%2520by%2520%25CF%25831%2520receptor%2520inhibition%253A%2520Role%2520of%2520peripheral%2520%25CF%25831%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D348%26epage%3D358%26doi%3D10.1016%2Fj.neuropharm.2013.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocasalbas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touriño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreea Bura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuel Baeyens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>711</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Touri%C3%B1oauthor=S.+Andreea+Buraauthor=B.+Fern%C3%A1ndez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+Manuel+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lhLDkO-f26ChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTouri%25C3%25B1o%26aufirst%3DC.%26aulast%3DAndreea%2BBura%26aufirst%3DS.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DManuel%2BBaeyens%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrander, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span> <span> </span><span class="NLM_article-title">Sigma1 targeting to suppress aberrant androgen receptor signaling in prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2439</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-16-1055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1158%2F0008-5472.CAN-16-1055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=28235766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2439-2452&author=J.+D.+Thomasauthor=C.+G.+Longenauthor=H.+M.+Oyerauthor=N.+Chenauthor=C.+M.+Maherauthor=J.+M.+Salvinoauthor=B.+Kaniaauthor=K.+N.+Andersonauthor=W.+F.+Ostranderauthor=K.+E.+Knudsenauthor=F.+J.+Kim&title=Sigma1+targeting+to+suppress+aberrant+androgen+receptor+signaling+in+prostate+cancer&doi=10.1158%2F0008-5472.can-16-1055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer</span></div><div class="casAuthors">Thomas, Jeffrey D.; Longen, Charles G.; Oyer, Halley M.; Chen, Nan; Maher, Christina M.; Salvino, Joseph M.; Kania, Blase; Anderson, Kelsey N.; Ostrander, William F.; Knudsen, Karen E.; Kim, Felix J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2439-2452</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suppression of androgen receptor (AR) activity in prostate cancer by androgen depletion or direct AR antagonist treatment, although initially effective, leads to incurable castration-resistant prostate cancer (CRPC) via compensatory mechanisms including resurgence of AR and AR splice variant (ARV) signaling.  Emerging evidence suggests that Sigma1 (also known as sigma-1 receptor) is a unique chaperone or scaffolding protein that contributes to cellular protein homeostasis.  We reported previously that some Sigma1-selective small mols. can be used to pharmacol. modulate protein homeostasis pathways.  We hypothesized that these Sigma1-mediated responses could be exploited to suppress AR protein levels and activity.  Here we demonstrate that treatment with a small-mol. Sigma1 inhibitor prevented 5α- dihydrotestosterone-mediated nuclear translocation of AR and induced proteasomal degrdn. of AR and ARV, suppressing the transcriptional activity and protein levels of both full-length and splice-variant AR.  Consistent with these data, RNAi knockdown of Sigma1 resulted in decreased AR levels and transcriptional activity.  Furthermore, Sigma1 phys. assocd. with ARV7 and ARv567es as well as full-length AR.  Treatment of mice xenografted with ARV-driven CRPC tumors with a drug-like small-mol. Sigma1 inhibitor significantly inhibited tumor growth assocd. with elimination of AR and ARV7 in responsive tumors.  Together, our data show that Sigma1 modulators can be used to suppress AR/ARV-driven prostate cancer cells via regulation of pharmacol. responsive Sigma1-AR/ARV interactions, both in vitro and in vivo.  Cancer Res; 77(9); 2439-52. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRDgJkI_yvYrVg90H21EOLACvtfcHk0lhLDkO-f26ChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFarsrY%253D&md5=346376aba5fb75a7bf17502e78c02798</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1055%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DLongen%26aufirst%3DC.%2BG.%26aulast%3DOyer%26aufirst%3DH.%2BM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DMaher%26aufirst%3DC.%2BM.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DKania%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DK.%2BN.%26aulast%3DOstrander%26aufirst%3DW.%2BF.%26aulast%3DKnudsen%26aufirst%3DK.%2BE.%26aulast%3DKim%26aufirst%3DF.%2BJ.%26atitle%3DSigma1%2520targeting%2520to%2520suppress%2520aberrant%2520androgen%2520receptor%2520signaling%2520in%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D2439%26epage%3D2452%26doi%3D10.1158%2F0008-5472.can-16-1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule sigma1 modulator induces autophagic degradation of PD-L1</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-17-0166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1158%2F1541-7786.MCR-17-0166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=29117944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVeiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=243-255&author=C.+M.+Maherauthor=J.+D.+Thomasauthor=D.+A.+Haasauthor=C.+G.+Longenauthor=H.+M.+Oyerauthor=J.+Y.+Tongauthor=F.+J.+Kim&title=Small-molecule+sigma1+modulator+induces+autophagic+degradation+of+PD-L1&doi=10.1158%2F1541-7786.mcr-17-0166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1</span></div><div class="casAuthors">Maher, Christina M.; Thomas, Jeffrey D.; Haas, Derick A.; Longen, Charles G.; Oyer, Halley M.; Tong, Jane Y.; Kim, Felix J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-255</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging evidence suggests that Sigma1 (SIGMAR1, also known as sigma-1 receptor) is a unique ligand-regulated integral membrane scaffolding protein that contributes to cellular protein and lipid homeostasis.  Previously, we demonstrated that some small-mol. modulators of Sigma1 alter endoplasmic reticulum (ER)-assocd. protein homeostasis pathways in cancer cells, including the unfolded protein response and autophagy.  Programmed death-ligand 1 (PD-L1) is a type I integral membrane glycoprotein that is cotranslationally inserted into the ER and is processed and transported through the secretory pathway.  Once at the surface of cancer cells, PD-L1 acts as a T-cell inhibitory checkpoint mol. and suppresses antitumor immunity.  Here, we demonstrate that in Sigma1-expressing triple-neg. breast and androgen-independent prostate cancer cells, PD-L1 protein levels were suppressed by RNAi knockdown of Sigma1 and by small-mol. inhibition of Sigma1.  Sigma1-mediated action was confirmed by pharmacol. competition between Sigma1-selective inhibitor and activator ligands.  When administered alone, the Sigma1 inhibitor decreased cell surface PD-L1 expression and suppressed functional interaction of PD-1 and PD-L1 in a coculture of T cells and cancer cells.  Conversely, the Sigma1 activator increased PD-L1 cell surface expression, demonstrating the ability to pos. and neg. modulate Sigma1 assocd. PD-L1 processing.  We discovered that the Sigma1 inhibitor induced degrdn. of PD-L1 via autophagy, by a mechanism distinct from bulk macroautophagy or general ER stress-assocd. autophagy.  Finally, the Sigma1 inhibitor suppressed IFNγ-induced PD-L1.  Our data demonstrate that small-mol. Sigma1 modulators can be used to regulate PD-L1 in cancer cells and trigger its degrdn. by selective autophagy.  Implications: Sigma1 modulators sequester and eliminate PD-L1 by autophagy, thus preventing functional PD-L1 expression at the cell surface.  This posits Sigma1 modulators as novel therapeutic agents in PD-L1/PD-1 blockade strategies that regulate the tumor immune microenvironment.  Visual Overview: http//mcr.accrjournals.org/content/molcanres/16/02/243/F1.large.jpg.  Mol Cancer Res; 16(2); 243-55. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPoBdyWoswA7Vg90H21EOLACvtfcHk0lhLDkO-f26ChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVeiurc%253D&md5=84f9aee84ada0bb2b7ce13f2d210b52b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0166%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DC.%2BM.%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DHaas%26aufirst%3DD.%2BA.%26aulast%3DLongen%26aufirst%3DC.%2BG.%26aulast%3DOyer%26aufirst%3DH.%2BM.%26aulast%3DTong%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DF.%2BJ.%26atitle%3DSmall-molecule%2520sigma1%2520modulator%2520induces%2520autophagic%2520degradation%2520of%2520PD-L1%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2018%26volume%3D16%26spage%3D243%26epage%3D255%26doi%3D10.1158%2F1541-7786.mcr-17-0166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhaddou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obernier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezelj, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hüttenhain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaake, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutuncuoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foussard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polacco, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabius, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucheray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Kain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miorin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, Z. Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorba, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrio-Hernandez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Armenta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, C. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzberg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calviello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liboy-Lugo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wankowicz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugur, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savar, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shengjuler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuoglu-Ozturk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Enfert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ideker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floor, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogan, N. J.</span></span> <span> </span><span class="NLM_article-title">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>583</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2286-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fs41586-020-2286-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=32353859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlCqtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=583&publication_year=2020&pages=459-468&author=D.+E.+Gordonauthor=G.+M.+Jangauthor=M.+Bouhaddouauthor=J.+Xuauthor=K.+Obernierauthor=K.+M.+Whiteauthor=M.+J.+O%E2%80%99Mearaauthor=V.+V.+Rezeljauthor=J.+Z.+Guoauthor=D.+L.+Swaneyauthor=T.+A.+Tumminoauthor=R.+H%C3%BCttenhainauthor=R.+M.+Kaakeauthor=A.+L.+Richardsauthor=B.+Tutuncuogluauthor=H.+Foussardauthor=J.+Batraauthor=K.+Haasauthor=M.+Modakauthor=M.+Kimauthor=P.+Haasauthor=B.+J.+Polaccoauthor=H.+Brabergauthor=J.+M.+Fabiusauthor=M.+Eckhardtauthor=M.+Soucherayauthor=M.+J.+Bennettauthor=M.+Cakirauthor=M.+J.+McGregorauthor=Q.+Liauthor=B.+Meyerauthor=F.+Roeschauthor=T.+Valletauthor=A.+Mac+Kainauthor=L.+Miorinauthor=E.+Morenoauthor=Z.+Z.+C.+Naingauthor=Y.+Zhouauthor=S.+Pengauthor=Y.+Shiauthor=Z.+Zhangauthor=W.+Shenauthor=I.+T.+Kirbyauthor=J.+E.+Melnykauthor=J.+S.+Chorbaauthor=K.+Louauthor=S.+A.+Daiauthor=I.+Barrio-Hernandezauthor=D.+Memonauthor=C.+Hernandez-Armentaauthor=J.+Lyuauthor=C.+J.+P.+Mathyauthor=T.+Pericaauthor=K.+B.+Pillaauthor=S.+J.+Ganesanauthor=D.+J.+Saltzbergauthor=R.+Rakeshauthor=X.+Liuauthor=S.+B.+Rosenthalauthor=L.+Calvielloauthor=S.+Venkataramananauthor=J.+Liboy-Lugoauthor=Y.+Linauthor=X.-P.+Huangauthor=Y.+Liuauthor=S.+A.+Wankowiczauthor=M.+Bohnauthor=M.+Safariauthor=F.+S.+Ugurauthor=C.+Kohauthor=N.+S.+Savarauthor=Q.+D.+Tranauthor=D.+Shengjulerauthor=S.+J.+Fletcherauthor=M.+C.+O%E2%80%99Nealauthor=Y.+Caiauthor=J.+C.+J.+Changauthor=D.+J.+Broadhurstauthor=S.+Klippstenauthor=P.+P.+Sharpauthor=N.+A.+Wenzellauthor=D.+Kuzuoglu-Ozturkauthor=H.-Y.+Wangauthor=R.+Trenkerauthor=J.+M.+Youngauthor=D.+A.+Caveroauthor=J.+Hiattauthor=T.+L.+Rothauthor=U.+Rathoreauthor=A.+Subramanianauthor=J.+Noackauthor=M.+Hubertauthor=R.+M.+Stroudauthor=A.+D.+Frankelauthor=O.+S.+Rosenbergauthor=K.+A.+Verbaauthor=D.+A.+Agardauthor=M.+Ottauthor=M.+Emermanauthor=N.+Juraauthor=M.+von+Zastrowauthor=E.+Verdinauthor=A.+Ashworthauthor=O.+Schwartzauthor=C.+d%E2%80%99Enfertauthor=S.+Mukherjeeauthor=M.+Jacobsonauthor=H.+S.+Malikauthor=D.+G.+Fujimoriauthor=T.+Idekerauthor=C.+S.+Craikauthor=S.+N.+Floorauthor=J.+S.+Fraserauthor=J.+D.+Grossauthor=A.+Saliauthor=B.+L.+Rothauthor=D.+Ruggeroauthor=J.+Tauntonauthor=T.+Kortemmeauthor=P.+Beltraoauthor=M.+Vignuzziauthor=A.+Garc%C3%ADa-Sastreauthor=K.+M.+Shokatauthor=B.+K.+Shoichetauthor=N.+J.+Krogan&title=A+SARS-CoV-2+protein+interaction+map+reveals+targets+for+drug+repurposing&doi=10.1038%2Fs41586-020-2286-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span></div><div class="casAuthors">Gordon, David E.; Jang, Gwendolyn M.; Bouhaddou, Mehdi; Xu, Jiewei; Obernier, Kirsten; White, Kris M.; O'Meara, Matthew J.; Rezelj, Veronica V.; Guo, Jeffrey Z.; Swaney, Danielle L.; Tummino, Tia A.; Huttenhain, Ruth; Kaake, Robyn M.; Richards, Alicia L.; Tutuncuoglu, Beril; Foussard, Helene; Batra, Jyoti; Haas, Kelsey; Modak, Maya; Kim, Minkyu; Haas, Paige; Polacco, Benjamin J.; Braberg, Hannes; Fabius, Jacqueline M.; Eckhardt, Manon; Soucheray, Margaret; Bennett, Melanie J.; Cakir, Merve; McGregor, Michael J.; Li, Qiongyu; Meyer, Bjoern; Roesch, Ferdinand; Vallet, Thomas; Mac Kain, Alice; Miorin, Lisa; Moreno, Elena; Naing, Zun Zar Chi; Zhou, Yuan; Peng, Shiming; Shi, Ying; Zhang, Ziyang; Shen, Wenqi; Kirby, Ilsa T.; Melnyk, James E.; Chorba, John S.; Lou, Kevin; Dai, Shizhong A.; Barrio-Hernandez, Inigo; Memon, Danish; Hernandez-Armenta, Claudia; Lyu, Jiankun; Mathy, Christopher J. P.; Perica, Tina; Pilla, Kala Bharath; Ganesan, Sai J.; Saltzberg, Daniel J.; Rakesh, Ramachandran; Liu, Xi; Rosenthal, Sara B.; Calviello, Lorenzo; Venkataramanan, Srivats; Liboy-Lugo, Jose; Lin, Yizhu; Huang, Xi-Ping; Liu, YongFeng; Wankowicz, Stephanie A.; Bohn, Markus; Safari, Maliheh; Ugur, Fatima S.; Koh, Cassandra; Savar, Nastaran Sadat; Tran, Quang Dinh; Shengjuler, Djoshkun; Fletcher, Sabrina J.; O'Neal, Michael C.; Cai, Yiming; Chang, Jason C. J.; Broadhurst, David J.; Klippsten, Saker; Sharp, Phillip P.; Wenzell, Nicole A.; Kuzuoglu-Ozturk, Duygu; Wang, Hao-Yuan; Trenker, Raphael; Young, Janet M.; Cavero, Devin A.; Hiatt, Joseph; Roth, Theodore L.; Rathore, Ujjwal; Subramanian, Advait; Noack, Julia; Hubert, Mathieu; Stroud, Robert M.; Frankel, Alan D.; Rosenberg, Oren S.; Verba, Kliment A.; Agard, David A.; Ott, Melanie; Emerman, Michael; Jura, Natalia; von Zastrow, Mark; Verdin, Eric; Ashworth, Alan; Schwartz, Olivier; d'Enfert, Christophe; Mukherjee, Shaeri; Jacobson, Matt; Malik, Harmit S.; Fujimori, Danica G.; Ideker, Trey; Craik, Charles S.; Floor, Stephen N.; Fraser, James S.; Gross, John D.; Sali, Andrej; Roth, Bryan L.; Ruggero, Davide; Taunton, Jack; Kortemme, Tanja; Beltrao, Pedro; Vignuzzi, Marco; Garcia-Sastre, Adolfo; Shokat, Kevan M.; Shoichet, Brian K.; Krogan, Nevan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">583</span>
        (<span class="NLM_cas:issue">7816</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals and caused worldwide social and economic disruption1,2.  There are no antiviral drugs with proven clin. efficacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and efforts to develop drugs and vaccines are hampered by the limited knowledge of the mol. details of how SARS-CoV-2 infects cells.  Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identified the human proteins that phys. assocd. with each of the SARS-CoV-2 proteins using affinity-purifn. mass spectrometry, identifying 332 high-confidence protein-protein interactions between SARS-CoV-2 and human proteins.  Among these, we identify 66 druggable human proteins or host factors targeted by 69 compds. (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clin. trials and 28 are preclin. compds.).  We screened a subset of these in multiple viral assays and found two sets of pharmacol. agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.  Further studies of these host-factor-targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvJUIvi-Ws7Vg90H21EOLACvtfcHk0lggZU6dlPrTGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlCqtbrI&md5=ce8b172ae73aacd3b3d8bb64877f4435</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2286-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2286-9%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BE.%26aulast%3DJang%26aufirst%3DG.%2BM.%26aulast%3DBouhaddou%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DObernier%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DRezelj%26aufirst%3DV.%2BV.%26aulast%3DGuo%26aufirst%3DJ.%2BZ.%26aulast%3DSwaney%26aufirst%3DD.%2BL.%26aulast%3DTummino%26aufirst%3DT.%2BA.%26aulast%3DH%25C3%25BCttenhain%26aufirst%3DR.%26aulast%3DKaake%26aufirst%3DR.%2BM.%26aulast%3DRichards%26aufirst%3DA.%2BL.%26aulast%3DTutuncuoglu%26aufirst%3DB.%26aulast%3DFoussard%26aufirst%3DH.%26aulast%3DBatra%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DK.%26aulast%3DModak%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DPolacco%26aufirst%3DB.%2BJ.%26aulast%3DBraberg%26aufirst%3DH.%26aulast%3DFabius%26aufirst%3DJ.%2BM.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DSoucheray%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DCakir%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DVallet%26aufirst%3DT.%26aulast%3DMac%2BKain%26aufirst%3DA.%26aulast%3DMiorin%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DZ.%2BZ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKirby%26aufirst%3DI.%2BT.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DChorba%26aufirst%3DJ.%2BS.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DS.%2BA.%26aulast%3DBarrio-Hernandez%26aufirst%3DI.%26aulast%3DMemon%26aufirst%3DD.%26aulast%3DHernandez-Armenta%26aufirst%3DC.%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DMathy%26aufirst%3DC.%2BJ.%2BP.%26aulast%3DPerica%26aufirst%3DT.%26aulast%3DPilla%26aufirst%3DK.%2BB.%26aulast%3DGanesan%26aufirst%3DS.%2BJ.%26aulast%3DSaltzberg%26aufirst%3DD.%2BJ.%26aulast%3DRakesh%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DS.%2BB.%26aulast%3DCalviello%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DS.%26aulast%3DLiboy-Lugo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWankowicz%26aufirst%3DS.%2BA.%26aulast%3DBohn%26aufirst%3DM.%26aulast%3DSafari%26aufirst%3DM.%26aulast%3DUgur%26aufirst%3DF.%2BS.%26aulast%3DKoh%26aufirst%3DC.%26aulast%3DSavar%26aufirst%3DN.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BD.%26aulast%3DShengjuler%26aufirst%3DD.%26aulast%3DFletcher%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DM.%2BC.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DBroadhurst%26aufirst%3DD.%2BJ.%26aulast%3DKlippsten%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DWenzell%26aufirst%3DN.%2BA.%26aulast%3DKuzuoglu-Ozturk%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.-Y.%26aulast%3DTrenker%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DCavero%26aufirst%3DD.%2BA.%26aulast%3DHiatt%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DT.%2BL.%26aulast%3DRathore%26aufirst%3DU.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DRosenberg%26aufirst%3DO.%2BS.%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DEmerman%26aufirst%3DM.%26aulast%3DJura%26aufirst%3DN.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3Dd%25E2%2580%2599Enfert%26aufirst%3DC.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DH.%2BS.%26aulast%3DFujimori%26aufirst%3DD.%2BG.%26aulast%3DIdeker%26aufirst%3DT.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFloor%26aufirst%3DS.%2BN.%26aulast%3DFraser%26aufirst%3DJ.%2BS.%26aulast%3DGross%26aufirst%3DJ.%2BD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBeltrao%26aufirst%3DP.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Sastre%26aufirst%3DA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26atitle%3DA%2520SARS-CoV-2%2520protein%2520interaction%2520map%2520reveals%2520targets%2520for%2520drug%2520repurposing%26jtitle%3DNature%26date%3D2020%26volume%3D583%26spage%3D459%26epage%3D468%26doi%3D10.1038%2Fs41586-020-2286-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebrecos, J.</span>; <span class="NLM_string-name">Galvez, R.</span>; <span class="NLM_string-name">Albesa, N.</span>; <span class="NLM_string-name">MunozBlanco, J.</span>; <span class="NLM_string-name">Aguilar, J.</span>; <span class="NLM_string-name">Rojals, V. M.</span>; <span class="NLM_string-name">Casals, S.</span>; <span class="NLM_string-name">Sust, M.</span>; <span class="NLM_string-name">Vaqué, A.</span>; <span class="NLM_string-name">Morte, A.</span>; <span class="NLM_string-name">Gascón, N.</span>; <span class="NLM_string-name">PlataSalamán, C.</span></span> <span> </span><span class="NLM_article-title">In E52862, a First in Class Sigma 1 Receptor Antagonist</span>.  <i>Chronic PostSurgical Neuropathic Pain: An Exploratory Phase II Clinical Trial, 16th World Congress on Pain, Yokohama, Japan</i>: <span class="NLM_publisher-loc">Yokohama, Japan</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cebrecos&author=R.+Galvez&author=N.+Albesa&author=J.+MunozBlanco&author=J.+Aguilar&author=V.+M.+Rojals&author=S.+Casals&author=M.+Sust&author=A.+Vaqu%C3%A9&author=A.+Morte&author=N.+Gasc%C3%B3n&author=C.+PlataSalam%C3%A1n&title=In+E52862%2C+a+First+in+Class+Sigma+1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCebrecos%26aufirst%3DJ.%26atitle%3DIn%2520E52862%252C%2520a%2520First%2520in%2520Class%2520Sigma%25201%2520Receptor%2520Antagonist%26jtitle%3DChronic%2520PostSurgical%2520Neuropathic%2520Pain%253A%2520An%2520Exploratory%2520Phase%2520II%2520Clinical%2520Trial%252C%252016th%2520World%2520Congress%2520on%2520Pain%252C%2520Yokohama%252C%2520Japan%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arroyos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Arconada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segalés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-García, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plata-Salamán, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2289</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Baeyensauthor=J.+Giraldoauthor=J.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+Plata-Salam%C3%A1nauthor=J.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0lj12eLwn-qClw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span> <span> </span><span class="NLM_article-title">Comprehensive 3D-QSAR model predicts binding affinity of structurally diverse sigma 1 receptor ligands</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.8b00521</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.8b00521" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCqs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=486-497&author=Y.+Pengauthor=H.+Dongauthor=W.+J.+Welsh&title=Comprehensive+3D-QSAR+model+predicts+binding+affinity+of+structurally+diverse+sigma+1+receptor+ligands&doi=10.1021%2Facs.jcim.8b00521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands</span></div><div class="casAuthors">Peng, Youyi; Dong, Hiep; Welsh, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-497</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Sigma 1 Receptor (S1R) has attracted intense interest as a pharmaceutical target for various therapeutic indications, including the treatment of neuropathic pain and the potentiation of opioid analgesia.  Efforts by drug developers to rationally design S1R antagonists have been spurred recently by the 2016 publication of the high-resoln. X-ray crystal structure of the ligand-bound human S1R.  Until now, however, the absence in the published literature of a single, large-scale, and comprehensive quant. structure-activity relationship (QSAR) model that encompasses a structurally diverse collection of S1R ligands has impaired rapid progress.  To our best knowledge, the present study represents the first report of a statistically robust and highly predictive 3D-QSAR model (R2 = 0.92, Q2 = 0.62, R2pred = 0.81) based on the X-ray crystal structure of human S1R and constructed from a pooled compilation of 180 S1R antagonists that encompass five structurally diverse chem. families investigated using identical exptl. protocols.  Best practices, as recommended by the Organization for Economic Cooperation and Development (OECD: http://www.oecd.org/), were adopted for pooling data from disparate sources and for QSAR model development and both internal and external model validation.  The practical utility of the final 3D-QSAR model was tested by virtual screening of the DrugBank database of FDA approved drugs supplemented by eight reported S1R antagonists.  Among the top-ranked 40 DrugBank hits, four approved drugs which were previously unknown as S1R antagonists were tested using in vitro radiolabeled human S1R binding assays.  Of these, two drugs (diphenhydramine and phenyltoloxamine) exhibited potent S1R binding affinity with Ki = 58 nM and 160 nM, resp.  As diphenhydramine is approved as an antiallergic, and phenyltoloxamine as an analgesic and sedative, each of these compds. represents a viable starting point for a drug discovery campaign aimed at the development of novel S1R antagonists for a wide range of therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKEL-PzpYGf7Vg90H21EOLACvtfcHk0lhattuwSjnXYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCqs7vP&md5=9ddd5e637344c4e5171e7be08351ab64</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.8b00521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.8b00521%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26atitle%3DComprehensive%25203D-QSAR%2520model%2520predicts%2520binding%2520affinity%2520of%2520structurally%2520diverse%2520sigma%25201%2520receptor%2520ligands%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D486%26epage%3D497%26doi%3D10.1021%2Facs.jcim.8b00521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurpinar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human σ1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">527</span>, <span class="refDoi"> DOI: 10.1038/nature17391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnature17391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=27042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=527&author=H.+R.+Schmidtauthor=S.+Zhengauthor=E.+Gurpinarauthor=A.+Koehlauthor=A.+Manglikauthor=A.+C.+Kruse&title=Crystal+structure+of+the+human+%CF%831+receptor&doi=10.1038%2Fnature17391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human σ1 receptor</span></div><div class="casAuthors">Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Koehl, Antoine; Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7600</span>),
    <span class="NLM_cas:pages">527-530</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human σ1 receptor is an enigmatic endoplasmic reticulum (ER)-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain.  Recently, an addnl. connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models.  Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein-coupled receptors or ligand-gated ion channels, the σ1 receptor is an evolutionary isolate with no discernible similarity to any other human protein.  Despite its increasingly clear importance in human physiol. and disease, the mol. architecture of the σ1 receptor and its regulation by drug-like compds. remain poorly defined.  Here, the authors report crystal structures of the human σ1 receptor in complex with 2 chem. divergent ligands, PD 144418 and 4-(N-benzylpiperidin-4-yl)-4-iodobenzamide (4-IBP).  The structures revealed a trimeric architecture with a single transmembrane domain in each protomer.  The C-terminal domain of the receptor showed an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate assocn. with the cytosolic surface of the ER membrane in cells.  This domain included a cupin-like β-barrel with the ligand-binding site buried at its center.  This large, hydrophobic ligand-binding cavity showed remarkable plasticity in ligand recognition, binding the 2 ligands in similar positions despite dissimilar chem. structures.  Taken together, these results revealed the overall architecture, oligomerization state, and mol. basis for ligand recognition by this important but poorly understood protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQBAf03Pml7Vg90H21EOLACvtfcHk0lhattuwSjnXYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D&md5=fb6df7814060fbd05ba41261ad1061f5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnature17391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17391%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGurpinar%26aufirst%3DE.%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CF%25831%2520receptor%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D527%26doi%3D10.1038%2Fnature17391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhattuwSjnXYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis for sigma1 receptor ligand recognition</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1038/s41594-018-0137-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fs41594-018-0137-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=30291362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=981-987&author=H.+R.+Schmidtauthor=R.+M.+Betzauthor=R.+O.+Drorauthor=A.+C.+Kruse&title=Structural+basis+for+sigma1+receptor+ligand+recognition&doi=10.1038%2Fs41594-018-0137-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for σ1 receptor ligand recognition</span></div><div class="casAuthors">Schmidt, Hayden R.; Betz, Robin M.; Dror, Ron O.; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">981-987</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The s1 receptor is a poorly understood membrane protein expressed throughout the human body.  Ligands targeting the s1 receptor are in clin. trials for treatment of Alzheimer's disease, ischemic stroke, and neuropathic pain.  However, relatively little is known regarding the s1 receptor's mol. function.  Here, we present crystal structures of human s1 receptor bound to the antagonists haloperidol and NE-100, and the agonist (+)-pentazocine, at crystallog. resolns. of 3.1 Å, 2.9 Å, and 3.1 Å, resp.  These structures reveal a unique binding pose for the agonist.  The structures and accompanying mol. dynamics (MD) simulations identify agonist-induced structural rearrangements in the receptor.  Addnl., we show that ligand binding to s1 is a multistep process that is rate limited by receptor conformational change.  We used MD simulations to reconstruct a ligand binding pathway involving two major conformational changes.  These data provide a framework for understanding the mol. basis for s1 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2dgVTV70vbVg90H21EOLACvtfcHk0lisBiH9wQaTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbvM&md5=d12d12aecbd89684824975977ec03e4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0137-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0137-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DStructural%2520basis%2520for%2520sigma1%2520receptor%2520ligand%2520recognition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D981%26epage%3D987%26doi%3D10.1038%2Fs41594-018-0137-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiba, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandler, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Virtual screening for ligand discovery at the sigma1 receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVGns7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1555-1561&author=D.+A.+Greenfieldauthor=H.+R.+Schmidtauthor=M.+A.+Skibaauthor=M.+D.+Mandlerauthor=J.+R.+Andersonauthor=P.+Slizauthor=A.+C.+Kruse&title=Virtual+screening+for+ligand+discovery+at+the+sigma1+receptor&doi=10.1021%2Facsmedchemlett.9b00314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening for Ligand Discovery at the σ1 Receptor</span></div><div class="casAuthors">Greenfield, Daniel A.; Schmidt, Hayden R.; Skiba, Meredith A.; Mandler, Michael D.; Anderson, Jacob R.; Sliz, Piotr; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1555-1561</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The σ1 receptor is a transmembrane protein implicated in several pathophysiol. conditions, including neurodegenerative disease, drug addiction, cancer, and pain.  However, there are no high-throughput functional assays for σ1 receptor drug discovery.  Here, we assessed high-throughput structure-based computational docking for discovery of novel ligands of the σ1 receptor.  We screened a library of over 6 million compds. using the Schr.ovrddot.odinger Glide package, followed by exptl. characterization of top-scoring candidates. 77% of tested candidates bound σ1 with high affinity (KD < 1 μM).  These include compds. with high selectivity for the σ1 receptor compared to the genetically unrelated but pharmacol. similar σ2 receptor, as well as compds. with substantial crossreactivity between the two receptors.  These results establish structure-based virtual screening as a highly effective platform for σ1 receptor ligand discovery and provide compds. to prioritize in studies of σ1 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDfUmoQaAcLVg90H21EOLACvtfcHk0lisBiH9wQaTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVGns7nF&md5=f9bb32db3e629e604044651de2147bb5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00314%26sid%3Dliteratum%253Aachs%26aulast%3DGreenfield%26aufirst%3DD.%2BA.%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DSkiba%26aufirst%3DM.%2BA.%26aulast%3DMandler%26aufirst%3DM.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%2BR.%26aulast%3DSliz%26aufirst%3DP.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DVirtual%2520screening%2520for%2520ligand%2520discovery%2520at%2520the%2520sigma1%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1555%26epage%3D1561%26doi%3D10.1021%2Facsmedchemlett.9b00314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortagere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannemacher, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howells, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span> <span> </span><span class="NLM_article-title">Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6442</span>– <span class="NLM_lpage">6450</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.bmc.2009.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19646882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVenur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6442-6450&author=Y.+Pengauthor=Q.+Zhangauthor=S.+Aroraauthor=S.+M.+Keenanauthor=S.+Kortagereauthor=K.+M.+Wannemacherauthor=R.+D.+Howellsauthor=W.+J.+Welsh&title=Novel+delta+opioid+receptor+agonists+exhibit+differential+stimulation+of+signaling+pathways&doi=10.1016%2Fj.bmc.2009.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways</span></div><div class="casAuthors">Peng, Youyi; Zhang, Qiang; Arora, Sonia; Keenan, Susan M.; Kortagere, Sandhya; Wannemacher, Kenneth M.; Howells, Richard D.; Welsh, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6442-6450</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel family of 1,3,5-trisubstituted 1,2,4-triazoles was discovered as potent and selective ligands for the δ opioid receptor by rational design.  Compd. 5b exhibited low-nanomolar in vitro binding affinity (IC50 = 5.8 nM), excellent selectivity for the δ opioid receptor over the alternative μ and κ opioid receptors, full agonist efficacy in receptor down-regulation and MAP kinase activation assays, and low-efficacy partial agonist activity in stimulation of GTPγS binding.  The apparent discrepancy obsd. in these functional assays may stem from different signaling pathways involved in each case, as found previously for other G-protein coupled receptors.  More biol. studies are underway to better understand the differential stimulation of signaling pathways by these novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnfVZ9vBUgLVg90H21EOLACvtfcHk0lisBiH9wQaTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVenur3K&md5=8380f703ec010029393b2df8b379b3bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DS.%2BM.%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DWannemacher%26aufirst%3DK.%2BM.%26aulast%3DHowells%26aufirst%3DR.%2BD.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26atitle%3DNovel%2520delta%2520opioid%2520receptor%2520agonists%2520exhibit%2520differential%2520stimulation%2520of%2520signaling%2520pathways%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6442%26epage%3D6450%26doi%3D10.1016%2Fj.bmc.2009.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/s0169-409x(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2Fs0169-409x%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0ljKjqT6XXu6QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2Fs0169-409x%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljKjqT6XXu6QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span> <span> </span><span class="NLM_article-title">[3H]-(+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors</span>. <i>Mol. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK2cXht1CktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=117&author=W.+D.+Bowenauthor=B.+R.+De+Costaauthor=S.+B.+Hellewellauthor=J.+M.+Walkerauthor=K.+C.+Rice&title=%5B3H%5D-%28%2B%29-Pentazocine%3A+A+potent+and+highly+selective+benzomorphan-based+probe+for+sigma-1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-( + )-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors</span></div><div class="casAuthors">Bowen, Wayne D.; de Costa, Brian R.; Hellewell, Susan B.; Walker, J. Michael; Rice, Kenner C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neuropharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-26</span>CODEN:
                <span class="NLM_cas:coden">MOLNEO</span>;
        ISSN:<span class="NLM_cas:issn">0959-5244</span>.
    </div><div class="casAbstract">[3H]-(+)-Pentazocine was synthesized and characterized as a benzomorphan-based sigma receptor probe using guinea-pig brain membranes.  [3H]-(+)-Pentazocine exhibited low levels of non-specific binding; 5-10% over the concn. range 3-25 nM.  This compared to 30-35% for [3H]-(+)-N-allylnormetazocine ([3H]-(+)-SKF 10,047), the only other available benzomorphan radioligand, over the same concn. range.  [3H]-(+)-Pentazocine labeled an apparent single class of sites with Kd = 4.8 nM and Bmax = 1,419 fmol/mg protein.  It exhibited a relatively slow assocn. rate and very slow monophasic dissocn. (t1/2 = 7.9 h).  The pharmacol. profile of sites labeled by [3H]-(+)-pentazocine correlated strongly (r = 0.98) with the sigma-1 profile of sites labeled by the prototypic sigma receptor probe [3H]-(+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H]-(+)-3-PPP).  Ligands for several neurotransmitter receptors were inactive at sites labeled by [3H]-(+)-pentazocine, demonstrating the sigma selectivity of this radioligand.  In rat brain membranes, [3H]-(+)-pentazocine selectively labeled sites with the sigma-1 profile, whereas [3H]-1,3-di(o-tolyl)guanidine ([3H]-DTG) (in the presence of a masking concn. of a sigma-1 ligand) labeled sites with the sigma-2 profile.  The high affinity, high selectivity, and low non-specific binding of [3H]-(+)-pentazocine make it a superior benzomorphan-based probe for sigma sites.  Furthermore, due to the low affinity of (+)-pentazocine at sigma-2 sites, [3H]-(+)-pentazocine is a highly selective ligand for the sigma-1 subtype, making it useful in studies of sigma site heterogeneity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfoMHM-tjYF7Vg90H21EOLACvtfcHk0ljKjqT6XXu6QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1CktLg%253D&md5=cff8703ee7410980f0cbb3ad51b800fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DDe%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3D%255B3H%255D-%2528%252B%2529-Pentazocine%253A%2520A%2520potent%2520and%2520highly%2520selective%2520benzomorphan-based%2520probe%2520for%2520sigma-1%2520receptors%26jtitle%3DMol.%2520Neuropharmacol.%26date%3D1993%26volume%3D3%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10087012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1MXit1Khsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=251-260&author=M.+E.+Ganapathyauthor=P.+D.+Prasadauthor=W.+Huangauthor=P.+Sethauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Molecular+and+ligand-binding+characterization+of+the+sigma-receptor+in+the+Jurkat+human+T+lymphocyte+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and ligand-binding characterization of the σ-receptor in the Jurkat human T lymphocyte cell line</span></div><div class="casAuthors">Ganapathy, Malliga E.; Prasad, Puttur D.; Huang, Wei; Seth, Pankaj; Leibach, Frederick H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ-binding site present in the Jurkat human T lymphocyte cell line was investigated.  Jurkat cell membranes were found to have a single saturable binding site for [3H]haloperidol, an σ-ligand (dissocn. const., 3.9 ± 0.3 nM).  The binding of [3H]haloperidol was inhibited by several σ-ligands.  Northern anal. and reverse transcription-polymerase chain reaction provided evidence for the expression of the recently cloned type 1 σ-receptor (σ-R1) in Jurkat cells.  The σ-R1 cDNA cloned from these cells was functional in heterologous expression systems.  When expressed in mammalian cells, the cDNA-induced binding was saturable with dissocn. consts. of 1.9 ± 0.3 nM for [3H]haloperidol and 12 ± 2 nM for (+)-pentazocine.  The binding of [3H]progesterone, a putative endogenous ligand to σ-R1, to the Jurkat cell σ-receptor could be directly demonstrated by using heterologously expressed σ-R1 cDNA.  The binding of [3H]progesterone was saturable, with a dissocn. const. of 88 ± 7 nM.  Progesterone and haloperidol interacted with the receptor competitively.  Reverse transcription-polymerase chain reaction also produced evidence for the existence of an alternatively spliced σ-R1 variant in Jurkat cells.  This splice variant was found to be nonfunctional in ligand-binding assays.  This constitutes the first report on the mol. characterization of the σ-receptor in immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE_luqabecabVg90H21EOLACvtfcHk0lis9aOUXYqlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1Khsbo%253D&md5=40a5b1ac0a0eb679bac0ed580bb42dec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanapathy%26aufirst%3DM.%2BE.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DMolecular%2520and%2520ligand-binding%2520characterization%2520of%2520the%2520sigma-receptor%2520in%2520the%2520Jurkat%2520human%2520T%2520lymphocyte%2520cell%2520line%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma1 receptor ligands for treating neuropathic pain: 6-hydroxypyridazinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2942</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01416</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2942-2961&author=X.+Caoauthor=Y.+Chenauthor=Y.+Zhangauthor=Y.+Lanauthor=J.+Zhangauthor=X.+Xuauthor=Y.+Qiuauthor=S.+Zhaoauthor=X.+Liuauthor=B.-F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma1+receptor+ligands+for+treating+neuropathic+pain%3A+6-hydroxypyridazinones&doi=10.1021%2Facs.jmedchem.5b01416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones</span></div><div class="casAuthors">Cao, Xudong; Chen, Yin; Zhang, Yifang; Lan, Yu; Zhang, Juecheng; Xu, Xiangqing; Qiu, Yinli; Zhao, Song; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2942-2961</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands assocd. with pharmacol. antineuropathic pain activity was synthesized and is described in this article.  In vitro receptor binding studies revealed high σ1 receptor affinity (Ki σ1 = 1.4 nM) and excellent selectivity over not only σ2 receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2H)-one (compd. 54).  Compd. 54 exhibited dose-dependent antiallodynic properties in mouse formalin model and rats chronic constriction injury (CCI) model of neuropathic pain.  In addn., functional activity of compd. 54 was evaluated using phenytoin and indicated that the compd. was a σ1 receptor antagonist.  Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effect was evident in locomotor activity tests.  Last but not least, good safety and favorable pharmacokinetic properties were also noted.  These profiles suggest that compd. 54 may be a member of a novel class of candidate drugs for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouqLloqg6937Vg90H21EOLACvtfcHk0lis9aOUXYqlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrsL8%253D&md5=fd377bf365861bc550f6d4dd5db20af4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01416%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.-F.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma1%2520receptor%2520ligands%2520for%2520treating%2520neuropathic%2520pain%253A%25206-hydroxypyridazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2942%26epage%3D2961%26doi%3D10.1021%2Facs.jmedchem.5b01416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Development of novel alkoxyisoxazoles as sigma-1 receptor antagonists with antinociceptive efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6329</span>– <span class="NLM_lpage">6343</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00571</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6329-6343&author=H.+Sunauthor=M.+Shiauthor=W.+Zhangauthor=Y.-M.+Zhengauthor=Y.-Z.+Xuauthor=J.-J.+Shiauthor=T.+Liuauthor=H.+Gunosewoyoauthor=T.+Pangauthor=Z.-B.+Gaoauthor=F.+Yangauthor=J.+Tangauthor=L.-F.+Yu&title=Development+of+novel+alkoxyisoxazoles+as+sigma-1+receptor+antagonists+with+antinociceptive+efficacy&doi=10.1021%2Facs.jmedchem.6b00571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel alkoxyisoxazoles as sigma-1 receptor antagonists with antinociceptive efficacy</span></div><div class="casAuthors">Sun, Hao; Shi, Min; Zhang, Wei; Zheng, Yue-Ming; Xu, Ya-Zhou; Shi, Jun-Jie; Liu, Ting; Gunosewoyo, Hendra; Pang, Tao; Gao, Zhao-Bing; Yang, Fan; Tang, Jie; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6329-6343</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized.  Preliminary receptor binding assays identified highly potent (Ki < 1 nM) and selective σ1 ligands devoid of binding interactions with the monoamine transporters DAT, NET, and SERT.  In particular, compd. I was shown to possess significant antinociceptive activity in the mouse formalin-induced inflammation pain model when administered i.p. at 40 and 80 mg/kg.  Initial pharmacokinetics evaluation indicated an excellent brain exposure following oral dosing in mice, suggesting that further investigation into the use of alkoxyisoxazoles as σ1 ligands for antinociception is warranted.  This study supports the notion that selective σ1 antagonism could be a useful strategy in the development of novel antipain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMyTThgBAs7Vg90H21EOLACvtfcHk0lis9aOUXYqlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFyntb4%253D&md5=ec9ef2824ddeaef099b4326025130d09</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00571%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DY.-M.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DShi%26aufirst%3DJ.-J.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DZ.-B.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DDevelopment%2520of%2520novel%2520alkoxyisoxazoles%2520as%2520sigma-1%2520receptor%2520antagonists%2520with%2520antinociceptive%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6329%26epage%3D6343%26doi%3D10.1021%2Facs.jmedchem.6b00571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span> <span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0lhvK24ALAk5Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitebread, S.</span></span> <span> </span><span class="NLM_article-title">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+safety-related+drug+attrition%3A+the+use+of+in+vitro+pharmacological+profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0lhvK24ALAk5Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520safety-related%2520drug%2520attrition%253A%2520the%2520use%2520of%2520in%2520vitro%2520pharmacological%2520profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen A; Berge O G; Hunskaar S; Rosland J H; Hole K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eYD3WLpbQP-Kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J. S.</span></span> <span> </span><span class="NLM_article-title">Animal models of pain: progress and challenges</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1038/nrn2606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnrn2606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19259101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=283-294&author=J.+S.+Mogil&title=Animal+models+of+pain%3A+progress+and+challenges&doi=10.1038%2Fnrn2606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pain: progress and challenges</span></div><div class="casAuthors">Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many are frustrated with the lack of translational progress in the pain field, in which huge gains in basic science knowledge obtained using animal models have not led to the development of many new clin. effective compds.  A careful re-examn. of animal models of pain is therefore warranted.  Pain researchers now have at their disposal a much wider range of mutant animals to study, assays that more closely resemble clin. pain states, and dependent measures beyond simple reflexive withdrawal.  However, the complexity of the phenomenon of pain has made it difficult to assess the true value of these advances.  In addn., pain studies are importantly affected by a wide range of modulatory factors, including sex, genotype and social communication, all of which must be taken into account when using an animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMgN3i1-8BbVg90H21EOLACvtfcHk0lhvK24ALAk5Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D&md5=364f8c94a9fa144fe4ea13c6f1f6641f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrn2606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2606%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DAnimal%2520models%2520of%2520pain%253A%2520progress%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D283%26epage%3D294%26doi%3D10.1038%2Fnrn2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polomano, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, G. J.</span></span> <span> </span><span class="NLM_article-title">A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1016/s0304-3959(01)00363-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0304-3959%2801%2900363-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=11731066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=293-304&author=R.+C.+Polomanoauthor=A.+J.+Mannesauthor=U.+S.+Clarkauthor=G.+J.+Bennett&title=A+painful+peripheral+neuropathy+in+the+rat+produced+by+the+chemotherapeutic+drug%2C+paclitaxel&doi=10.1016%2Fs0304-3959%2801%2900363-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel</span></div><div class="casAuthors">Polomano, Rosemary C.; Mannes, Andrew J.; Clark, Uraina S.; Bennett, Gary J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Paclitaxel, an effective anti-neoplastic agent in the treatment of solid tumors, produces a dose-limiting painful peripheral neuropathy in a clin. significant no. of cancer patients.  Prior work has demonstrated paclitaxel-induced neurodegeneration and sensory loss in lab. rodents.  We describe here an exptl. paclitaxel-induced painful peripheral neuropathy.  Adult male rats were given four i.p. injections on alternate days of vehicle or 0.5, 1.0, or 2.0 mg/kg of paclitaxel (Taxol).  Behavioral tests for pain using mech. and thermal stimuli applied to the tail and hind paws, and tests for motor performance, were taken before, during and after dosing for 22-35 days.  All three doses of paclitaxel caused heat-hyperalgesia, mechano-allodynia, mechano-hyperalgesia, and cold-allodynia, but had no effect on motor performance.  Neuropathic pain began within days and lasted for several weeks.  We did not detect any dose-response relation.  Tests at the distal, mid, and proximal tail failed to show evidence of a length-dependent neuropathy.  Vehicle control injections had no effect on any measure.  No significant systemic toxicities were noted in the paclitaxel-treated animals.  Light-microscopic inspection of the sciatic nerve (mid-thigh level), L4-L5 dorsal root ganglia, and dorsal and ventral roots, and the gray and white matter of the L4-L5 spinal cord, showed no structural abnormalities.  Electron microscopic examn. of the sciatic nerve (mid-thigh level) and the L4-L5 dorsal root ganglia and dorsal horns demonstrated no degeneration of myelinated and unmyelinated axons in the sciatic nerve and roots, but revealed endoneurial edema.  This model may be useful in understanding a significant source of pain in cancer patients, and in finding ways to avoid the neurotoxicity that limits paclitaxel therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvg-fNiqHpC7Vg90H21EOLACvtfcHk0lgoFPbBBqtBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Cntrk%253D&md5=3564fa80d47ce00fdb982e47e80eb7b3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2801%2900363-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252801%252900363-3%26sid%3Dliteratum%253Aachs%26aulast%3DPolomano%26aufirst%3DR.%2BC.%26aulast%3DMannes%26aufirst%3DA.%2BJ.%26aulast%3DClark%26aufirst%3DU.%2BS.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26atitle%3DA%2520painful%2520peripheral%2520neuropathy%2520in%2520the%2520rat%2520produced%2520by%2520the%2520chemotherapeutic%2520drug%252C%2520paclitaxel%26jtitle%3DPain%26date%3D2001%26volume%3D94%26spage%3D293%26epage%3D304%26doi%3D10.1016%2Fs0304-3959%2801%2900363-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesenfeld-Hallin, Z.</span></span> <span> </span><span class="NLM_article-title">Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/s0304-3940(00)00787-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0304-3940%2800%2900787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10675798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2000&pages=211-214&author=J.-X.+Haoauthor=X.-J.+Xuauthor=L.+Urbanauthor=Z.+Wiesenfeld-Hallin&title=Repeated+administration+of+systemic+gabapentin+alleviates+allodynia-like+behaviors+in+spinally+injured+rats&doi=10.1016%2Fs0304-3940%2800%2900787-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats</span></div><div class="casAuthors">Hao, J.-X.; Xu, X.-J.; Urban, L.; Wiesenfeld-Hallin, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-214</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The effect of systemic gabapentin, a novel antiepileptic and analgesic, was tested on allodynia-like behaviors in spinal cord injured rats.  On the first day of treatment 30 mg/kg i.p. gabapentin did not alleviate hyper-reactivity to mech. and cold stimulation.  The allodynia was significantly reduced by 100 mg/kg gabapentin, which however, produced sedation and motor impairments.  Repeated administration of 30 mg/kg gabapentin once a day produced a gradually increasing anti-allodynic effect.  Total alleviation of mech. allodynia was obsd. in most rats after the third administration of gabapentin.  Thus, build-up of the antiallodynic effect of gabapentin may develop through a time dependent mechanism or alternatively through a gradual accumulation of the effective central nervous system concn. of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIeJ3MFT_J7Vg90H21EOLACvtfcHk0lgoFPbBBqtBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFamtrc%253D&md5=d1b3c05af4119183a0190313bcb04916</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2900787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252900787-4%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.-X.%26aulast%3DXu%26aufirst%3DX.-J.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DWiesenfeld-Hallin%26aufirst%3DZ.%26atitle%3DRepeated%2520administration%2520of%2520systemic%2520gabapentin%2520alleviates%2520allodynia-like%2520behaviors%2520in%2520spinally%2520injured%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D280%26spage%3D211%26epage%3D214%26doi%3D10.1016%2Fs0304-3940%2800%2900787-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Authier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balayssac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudore, F.</span></span> <span> </span><span class="NLM_article-title">Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.pain.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=17084975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1OqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=225-234&author=B.+Lingauthor=N.+Authierauthor=D.+Balayssacauthor=A.+Eschalierauthor=F.+Coudore&title=Behavioral+and+pharmacological+description+of+oxaliplatin-induced+painful+neuropathy+in+rat&doi=10.1016%2Fj.pain.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat</span></div><div class="casAuthors">Ling, Bing; Authier, Nicolas; Balayssac, David; Eschalier, Alain; Coudore, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-234</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We describe an animal model of nociceptive sensory neuropathy induced by repeat i.v. administration of oxaliplatin in which treated animals partly reproduce the characteristic pain symptoms in oxaliplatin-treated patients.  We tested the ability of 1, 2 and 4 mg/kg oxaliplatin doses injected twice-weekly for four-and-a-half consecutive weeks to induce a nociceptive peripheral neuropathy in male Sprague-Dawley rats.  The behavioral assessment revealed cold allodynia (10 °C) and hyperalgesia (4 °C) symptoms assocd. with a mech. allodynia.  The rats maintained a good general clin. status without motor dysfunction.  The 2 mg/kg oxaliplatin dose and the tail-immersion test in cold water (10 °C) were selected to compare pharmacol. sensitivity between single administered drugs as morphine, lidocaine, carbamazepine, gabapentin and repeated administration of drugs as clomipramine, venlafaxine, calcium and magnesium solns.  Magnesium soln. (90 mg/kg) and venlafaxine (7.5 mg/kg) administration induced an antinociceptive effect whereas gabapentin (300 mg/kg), clomipramine (2.5 mg/kg) and lidocaine (3 and 6 mg/kg) only induced an antiallodynic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfUZ75RfzhSrVg90H21EOLACvtfcHk0lgoFPbBBqtBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1OqsbY%253D&md5=c22e5e5e79542958749726f510a050ee</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DB.%26aulast%3DAuthier%26aufirst%3DN.%26aulast%3DBalayssac%26aufirst%3DD.%26aulast%3DEschalier%26aufirst%3DA.%26aulast%3DCoudore%26aufirst%3DF.%26atitle%3DBehavioral%2520and%2520pharmacological%2520description%2520of%2520oxaliplatin-induced%2520painful%2520neuropathy%2520in%2520rat%26jtitle%3DPain%26date%3D2007%26volume%3D128%26spage%3D225%26epage%3D234%26doi%3D10.1016%2Fj.pain.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altenbach, R. J.</span>; <span class="NLM_string-name">Bogdan, A.</span>; <span class="NLM_string-name">Couty, S.</span>; <span class="NLM_string-name">De
Lemos, E.</span>; <span class="NLM_string-name">Desroy, N.</span>; <span class="NLM_string-name">Duthion, B.</span>; <span class="NLM_string-name">Gfesser, G. A.</span>; <span class="NLM_string-name">Greszler, S. N.</span>; <span class="NLM_string-name">Housseman, C. G.</span>; <span class="NLM_string-name">Koenig, J. R.</span>; <span class="NLM_string-name">Kym, P. R.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Scanio, M. J.</span>; <span class="NLM_string-name">Searle, X.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yeung, M. C.</span>; <span class="NLM_string-name">Zhao, G.</span></span> <span> </span><span class="NLM_article-title">Substituted pyrrolidines and their use in the treatment of cystic fiibrosis</span>. <span class="NLM_patent">WO 2018065962 A1</span>, Apr 12, 2018, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Altenbach&author=A.+Bogdan&author=S.+Couty&author=E.+De%0ALemos&author=N.+Desroy&author=B.+Duthion&author=G.+A.+Gfesser&author=S.+N.+Greszler&author=C.+G.+Housseman&author=J.+R.+Koenig&author=P.+R.+Kym&author=B.+Liu&author=M.+J.+Scanio&author=X.+Searle&author=X.+Wang&author=M.+C.+Yeung&author=G.+Zhao&title=Substituted+pyrrolidines+and+their+use+in+the+treatment+of+cystic+fiibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAltenbach%26aufirst%3DR.%2BJ.%26atitle%3DSubstituted%2520pyrrolidines%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520cystic%2520fiibrosis%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eZaXD3uzGmes7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structure of the S1R antagonist S1RA. (B) Trimeric overall architecture of the human S1R in complex with PD144418 in the X-ray crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>) viewed perpendicular to the ER membrane.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Three protomers are rendered as ribbons, and PD144418 in the A chain is rendered as a green space-filling model. (C) Structures of our novel S1R ligands with substituents R<sub>1</sub>, R<sub class="stack">1</sub><sup class="stack">′</sup>, R<sub>2</sub>, and R<sub>3</sub>: Compound <b>2</b> is (3-(5-(4-(<i>tert</i>-butyl)phenyl)-3-((dimethylamino)methyl)-1<i>H</i>-1,2,4-triazol-1-yl)phenol), with Me = methyl and Bu = butyl. (D) Superposition of our S1R ligand <b>10</b> (magenta ball-and-stick model, docked binding pose) with PD144418 (green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1">5HK1</a>), haloperidol (golden, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ">6DJZ</a>), and NE-100 (dark gray, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0">6DK0</a>) in the ligand-binding site of the human S1R crystal structure. Compound <b>10</b> was docked inside the ligand-binding pocket of the S1R crystal structure 5HK1 using GOLD.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The salt bridge between Glu172 and the ligands is depicted as a blue dashed line. Residues engaged in extensive hydrophobic contacts with ligands are shown as solid gray lines and labeled accordingly. The topology of the ligand-binding pocket is depicted as a light-pink surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>In vivo</i> safety and efficacy studies of compound <b>10</b> in SD rats. (A) Rotarod test (<i>N</i> = 6). (B) Formalin tests (<i>N</i> = 6). (C) Mechanical allodynia in rat models of paclitaxel (Taxol)-induced neuropathic pain (<i>N</i> = 8). (D) Cold hyperalgesia in rat models of paclitaxel (Taxol)-induced neuropathic pain (<i>N</i> = 8). Pre-trt: pretreatment; Post-trt: post-treatment. In contrast, the “gold standard” drug gabapentin was used as the positive control in these studies. *<i>p</i>-value < 0.05 in ANOVA <i>vs</i> the vehicle. Data are expressed as mean ± S.E.M. (error bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>3–11</b> and <b>33–35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sub>3</sub>NHNH<sub>2</sub>, Pfp-OH, EDCI, DIEA, DCM, 25 °C; (b) ethyl-2-amino-thioxoacetate, CH<sub>3</sub>COOH, toluene, 90 °C; (c) R<sub>1</sub>R<sub class="stack">1</sub><sup class="stack">′</sup>NH, AlMe<sub>3</sub>, DCE, 0–50 °C; and (d) DIBAL-H, THF, 0 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/medium/jm0c01964_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>12–32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01964/20210107/images/large/jm0c01964_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01964&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, NBS, THF, 0–25 °C; (b) LiOH, THF, H<sub>2</sub>O, 0–20 °C; (c) pyrrolidine, HATU, DMF, 0–20 °C; (d) (HO)<sub>2</sub>B (CH)<sub>6</sub>R<sub>2</sub> or (Me<sub>2</sub>CHO)<sub>2</sub>B(CH)<sub>6</sub>R<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, Pd(dppf)Cl<sub>2</sub>, 1,4-dioxane, H<sub>2</sub>O, 20–80 °C; and (e) DIBAL-H, THF, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eades, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, P. E.</span></span> <span> </span><span class="NLM_article-title">The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+effects+of+morphine-+and+nalorphine-+like+drugs+in+the+nondependent+and+morphine-dependent+chronic+spinal+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0lgxkh6g3njZ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520effects%2520of%2520morphine-%2520and%2520nalorphine-%2520like%2520drugs%2520in%2520the%2520nondependent%2520and%2520morphine-dependent%2520chronic%2520spinal%2520dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khazan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fakany, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1016/0028-3908(84)90015-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0028-3908%2884%2990015-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=6090969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVert7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=983-987&author=N.+Khazanauthor=G.+A.+Youngauthor=E.+E.+El-Fakanyauthor=O.+Hongauthor=D.+Calligaro&title=Sigma+receptors+mediated+the+psychotomimetic+effects+of+N-allylnormetazocine+%28SKF-10%2C047%29%2C+but+not+its+opioid+agonistic-antagonistic+properties&doi=10.1016%2F0028-3908%2884%2990015-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors mediate the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties</span></div><div class="casAuthors">Khazan, N.; Young, G. A.; El-Fakany, E. E.; Hong, O.; Calligaro, D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">983-7</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    </div><div class="casAbstract">SKF-10047 (I)  [14198-28-8] the prototype σ-agonist, has its opioid entity residing with its (-)-isomer  [14198-28-8], whereas both its (+)-  [58640-82-7] and (-) isomers possess psychotogenic properties similar to those produced by phenyldidine.  (-)-SKF-10047 blocks EEG and behavioral effects of morphine in the naive rat, ppts. withdrawal in morphine-dependent rats, produces phys. dependence as evidenced by naloxone-induced withdrawal, and displaces [3H]dihydromorphine from brain homogenates.  (+)-SKF-10047 did not produce dependence upon chronic treatment, and it did not displace [3H]dihydromorphine from brain homogenates.  Such pharmacodynamic dissocn. with SKF-10047 suggests an assocn. of σ-receptors with psychogenic, but not opioid effects.  The latter are most likely mediated by μ or κ-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZwPMX2KZ-rVg90H21EOLACvtfcHk0ljSOAhU9yoJJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVert7s%253D&md5=5370cf550fed684c93fba77dd5fd2464</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0028-3908%2884%2990015-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0028-3908%252884%252990015-7%26sid%3Dliteratum%253Aachs%26aulast%3DKhazan%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DG.%2BA.%26aulast%3DEl-Fakany%26aufirst%3DE.%2BE.%26aulast%3DHong%26aufirst%3DO.%26aulast%3DCalligaro%26aufirst%3DD.%26atitle%3DSigma%2520receptors%2520mediated%2520the%2520psychotomimetic%2520effects%2520of%2520N-allylnormetazocine%2520%2528SKF-10%252C047%2529%252C%2520but%2520not%2520its%2520opioid%2520agonistic-antagonistic%2520properties%26jtitle%3DNeuropharmacology%26date%3D1984%26volume%3D23%26spage%3D983%26epage%3D987%26doi%3D10.1016%2F0028-3908%2884%2990015-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flandorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striessnig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span> <span> </span><span class="NLM_article-title">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">8072</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.15.8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1073%2Fpnas.93.15.8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=8755605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8072-8077&author=M.+Hannerauthor=F.+F.+Moebiusauthor=A.+Flandorferauthor=H.+G.+Knausauthor=J.+Striessnigauthor=E.+Kempnerauthor=H.+Glossmann&title=Purification%2C+molecular+cloning%2C+and+expression+of+the+mammalian+sigma1-binding+site&doi=10.1073%2Fpnas.93.15.8072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Purification, molecular cloning, and expression of the mammalian sigma1-binding site</span></div><div class="casAuthors">Hanner, Markus; Moebius, Fabian F.; Flandorfer, Astrid; Knaus, Hans-Guenther; Striessnig, Joerg; Kempner, Ellis; Glossman, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8072-8077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sigma-ligands comprise several chem. unrelated drugs such as haloperidol, pentazocine, and ditolylguanidine, which bind to a family of low mol. mass proteins in the endoplasmic reticulum.  These so-called sigma-receptors are believed to mediate various pharmacol. effects of sigma-ligands by as yet unknown mechanisms.  Based on their opposite enantioselectivity for benzomorphans and different mol. masses, two subtypes are differentiated.  We purified the sigma1-binding site as a single 30-kDa protein from guinea pig liver employing the benzomorphan (+)[3H]pentazocine and the aryladize (-)[3H]azidopamil as specific probes.  The purified (+)[3H]pentazocine-binding protein retained its high affinity for haloperidol, pentazocine, and ditolylguanidine.  Partial amino acid sequence obtained after trypsinolysis revealed no homol. to known proteins.  Radiation inactivation of the pentazocine-labeled sigma1-binding site yielded a mol. mass of 24 kDa.  The corresponding cDNA was cloned using degenerate oligonucleotides and cDNA library screening.  Its open reading frame encoded a 25.3-kDa protein with at least one putative transmembrane segment.  The protein expressed in yeast cells transformed with the cDNA showed the pharmacol. characteristics of the brain and liver sigma1-binding site.  The deduced amino acid sequence was structurally unrelated to known mammalian proteins but it shared homol. with fungal proteins involved in sterol synthesis.  Northern blots showed high densities of the sigma1-binding site mRNA in sterol-producing tissues.  This is also in agreement with the known ability of sigma1-binding sites to interact with steroids, such as progesterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3kp2l6ZPKdrVg90H21EOLACvtfcHk0ljSOAhU9yoJJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSqsr8%253D&md5=01c7d3bbab83dd5d18531845213bf267</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.15.8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.15.8072%26sid%3Dliteratum%253Aachs%26aulast%3DHanner%26aufirst%3DM.%26aulast%3DMoebius%26aufirst%3DF.%2BF.%26aulast%3DFlandorfer%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DH.%2BG.%26aulast%3DStriessnig%26aufirst%3DJ.%26aulast%3DKempner%26aufirst%3DE.%26aulast%3DGlossmann%26aufirst%3DH.%26atitle%3DPurification%252C%2520molecular%2520cloning%252C%2520and%2520expression%2520of%2520the%2520mammalian%2520sigma1-binding%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D8072%26epage%3D8077%26doi%3D10.1073%2Fpnas.93.15.8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional characterization of a sigma receptor from rat brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.70030922.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1046%2Fj.1471-4159.1998.70030922.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9489711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1cXht1yrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=922-931&author=P.+Sethauthor=Y.+J.+Feiauthor=H.+W.+Liauthor=W.+Huangauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cloning+and+functional+characterization+of+a+sigma+receptor+from+rat+brain&doi=10.1046%2Fj.1471-4159.1998.70030922.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional characterization of a σ receptor from rat brain</span></div><div class="casAuthors">Seth, Pankaj; Fei, You-Jun; Li, Hui W.; Huang, Wei; Leibach, Frederick H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">922-931</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">The authors have cloned a σ receptor from rat brain and established its functional identity using a heterologous expression system.  The cloned cDNA (1582 bp long) codes for a protein of 223 amino acids that possesses a single putative transmembrane domain.  The amino acid sequence of the rat brain σ receptor is highly homologous to that of the σ receptor recently cloned from guinea pig liver and a human placental cell line but is not related to any other known mammalian receptors.  When expressed in HeLa cells, the rat brain σ receptor cDNA leads to a two- to threefold increase in haloperidol binding, and this cDNA-induced binding is sensitive to inhibition by several σ receptor-specific ligands.  Kinetic anal. using the heterologous expression system has revealed that the rat brain σ receptor interacts with haloperidol with an apparent dissocn. const. (KD) of 3 nM.  Functional expression of the cloned rat brain σ receptor in HeLa cells also leads to an increase in the binding of two other σ ligands, namely, (+)-pentazocine and (+)-3-(3-hydroxyphenyl)-N-(1-propyl) piperidine (PPP).  Pharmacol. characterization of the cloned rat brain σ receptor reveals that it exhibits severalfold higher affinity for clorgyline than for 1,3-di(2-tolyl)guanidine, it interacts with progesterone and testosterone, and its interaction with PPP is markedly enhanced by phenytoin.  In addn., transfection of MCF-7 cells, which do not express type 1 σ receptor mRNA or activity, with the cloned rat brain cDNA leads to the appearance of haloperidol-sensitive binding of (+)-pentazocine, a selective type 1 σ receptor ligand.  These data show that the cloned rat brain cDNA codes for a functional type 1 σ receptor.  Northern blot anal. with poly(A)+ RNA isolated from various rat tissues has indicated that the σ receptor-specific transcript, 1.6 kb in size, is expressed abundantly in liver and moderately in intestine, kidney, brain, and lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0r0iO7VHT7Vg90H21EOLACvtfcHk0ljSOAhU9yoJJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1yrt7c%253D&md5=d61a346c8a8f6d1cebd5747c7b652a07</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70030922.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70030922.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DFei%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DH.%2BW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520of%2520a%2520sigma%2520receptor%2520from%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D70%26spage%3D922%26epage%3D931%26doi%3D10.1046%2Fj.1471-4159.1998.70030922.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a mouse sigma1 receptor</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">2279</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.70062279.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1046%2Fj.1471-4159.1998.70062279.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9603192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1cXjsVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=2279-2285&author=Y.+X.+Panauthor=J.+Meiauthor=J.+Xuauthor=B.+L.+Wanauthor=A.+Zuckermanauthor=G.+W.+Pasternak&title=Cloning+and+characterization+of+a+mouse+sigma1+receptor&doi=10.1046%2Fj.1471-4159.1998.70062279.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a mouse σ1 receptor</span></div><div class="casAuthors">Pan, Ying-Xian; Mei, Jianfeng; Xu, Jin; Wan, Ban-Lin; Zickerman, Amy; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2279-2285</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">A cDNA clone (S2-1a) isolated from a mouse brain cDNA library, using a guinea pig σ1 cDNA as probe, has high homol. to the predicted protein sequence of the guinea pig (88%) and human (90%) σ1 receptors.  Northern anal. revealed a major mRNA of ∼1.8 kb in a wide range of mouse tissues, with highest levels in brain, liver, kidney, and thymus.  Southern anal. and chromosomal mapping in the mouse suggested a single-copy gene in region A5-B2 of chromosome 4.  Expression of the clone in MCF-7 and CHO cells led to a pronounced increase in (+)-[3H] pentazocine binding with a selectivity profile consistent with σ1 receptors.  In vitro translation yielded a protein of ∼28 kDa, as did transfection of a probe contg. the hemagglutinin (HA) epitope (S2-1a.HA) into CHO cells, as detd. by western anal. using an antibody directed against HA.  (+)-[3H]-Pentazocine binding to immunopurified HA-tagged receptor demonstrated conclusively that S2-1a.HA encodes a high-affinity (+)-[3H]pentazocine binding site with characteristics of a murine σ1 receptor.  An antisense oligodeoxynucleotide designed from S2-1a potentiated opioid analgesia in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDPST5L1-NQrVg90H21EOLACvtfcHk0lguasSPv6AWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsVeqsbg%253D&md5=baed21424a67995e16e005956a047371</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70062279.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70062279.x%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DZuckerman%26aufirst%3DA.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520mouse%2520sigma1%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D70%26spage%3D2279%26epage%3D2285%26doi%3D10.1046%2Fj.1471-4159.1998.70062279.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsamba, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlsen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of adhesive binding by desmocollins and desmogleins</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7160</span>– <span class="NLM_lpage">7165</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606272113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1073%2Fpnas.1606272113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=27298358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps12htrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=7160-7165&author=O.+J.+Harrisonauthor=J.+Braschauthor=G.+Lassoauthor=P.+S.+Katsambaauthor=G.+Ahlsenauthor=B.+Honigauthor=L.+Shapiro&title=Structural+basis+of+adhesive+binding+by+desmocollins+and+desmogleins&doi=10.1073%2Fpnas.1606272113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of adhesive binding by desmocollins and desmogleins</span></div><div class="casAuthors">Harrison, Oliver J.; Brasch, Julia; Lasso, Gorka; Katsamba, Phinikoula S.; Ahlsen, Goran; Honig, Barry; Shapiro, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7160-7165</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Desmosomes are intercellular adhesive junctions that impart strength to vertebrate tissues.  Their dense, ordered intercellular attachments are formed by desmogleins (Dsgs) and desmocollins (Dscs), but the nature of trans-cellular interactions between these specialized cadherins is unclear.  Here, using soln. biophysics and coated-bead aggregation expts., we demonstrate family-wise heterophilic specificity: All Dsgs form adhesive dimers with all Dscs, with affinities characteristic of each Dsg:Dsc pair.  Crystal structures of ectodomains from Dsg2 and Dsg3 and from Dsc1 and Dsc2 show binding through a strand-swap mechanism similar to that of homophilic classical cadherins.  However, conserved charged amino acids inhibit Dsg:Dsg and Dsc:Dsc interactions by same-charge repulsion and promote heterophilic Dsg:Dsc interactions through opposite-charge attraction.  These findings show that Dsg:Dsc heterodimers represent the fundamental adhesive unit of desmosomes and provide a structural framework for understanding desmosome assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7Ca1Ou2hFLVg90H21EOLACvtfcHk0lguasSPv6AWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps12htrc%253D&md5=dfd98c8fed7b69cadb8168387ab9b145</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606272113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606272113%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DO.%2BJ.%26aulast%3DBrasch%26aufirst%3DJ.%26aulast%3DLasso%26aufirst%3DG.%26aulast%3DKatsamba%26aufirst%3DP.%2BS.%26aulast%3DAhlsen%26aufirst%3DG.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DL.%26atitle%3DStructural%2520basis%2520of%2520adhesive%2520binding%2520by%2520desmocollins%2520and%2520desmogleins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3D7160%26epage%3D7165%26doi%3D10.1073%2Fpnas.1606272113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.cell.2007.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=17981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=596-610&author=T.+Hayashiauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+at+the+ER-mitochondrion+interface+regulate+Ca%282%2B%29+signaling+and+cell+survival&doi=10.1016%2Fj.cell.2007.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival</span></div><div class="casAuthors">Hayashi, Teruo; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival.  The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5-trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-assocd. ER membrane (MAM).  We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+-sensitive and ligand-operated receptor chaperone at MAM.  Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP.  Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissoc. from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs.  Sig-1Rs can translocate under chronic ER stress.  Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis.  These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concns., regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqHhdVumdO7Vg90H21EOLACvtfcHk0lguasSPv6AWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrzK&md5=7bb4e806d7ad895f9ed1a8c4f7eb7f6c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520at%2520the%2520ER-mitochondrion%2520interface%2520regulate%2520Ca%25282%252B%2529%2520signaling%2520and%2520cell%2520survival%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D596%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anoal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/s0306-4522(00)00014-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0306-4522%2800%2900014-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10771347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=155-170&author=G.+Alonsoauthor=V.-L.+Phanauthor=I.+Guillemainauthor=M.+Saunierauthor=A.+Legrandauthor=M.+Anoalauthor=T.+Maurice&title=Immunocytochemical+localization+of+the+sigma%281%29+receptor+in+the+adult+rat+central+nervous+system&doi=10.1016%2Fs0306-4522%2800%2900014-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system</span></div><div class="casAuthors">Alonso, G.; Phan, V.-L.; Guillemain, I.; Saunier, M.; Legrand, A.; Anoal, M.; Maurice, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-170</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">To characterize the localization of the sigma1 receptor in the adult rat central nervous system, a polyclonal antibody was raised against a 20 amino acid peptide, corresponding to the fragment 143-162 of the cloned sigma1 receptor protein.  Throughout the rostrocaudal regions of the central nervous system extending from the olfactory bulb to the spinal cord, intense to moderate immunostaining was found to be assocd. with: (i) ependymocytes bordering the entire ventricular system, and (ii) neuron-like structures located within the parenchyma.  Double fluorescence studies confirmed that, throughout the parenchyma, sigma1 receptor-immunostaining was essentially assocd. with neuronal structures immunostained for the neuronal marker βIII-tubulin.  In all rats examd., high levels of immunostaining were always assocd. with neurons located within specific regions including the granular layer of the olfactory bulb, various hypothalamic nuclei, the septum, the central gray, motor nuclei of the hindbrain and the dorsal horn of the spinal cord.  In contrast, only faint immunostaining was assocd. with neurons located in the caudate-putamen and the cerebellum.  Electron microscope studies indicated that sigma1 receptor immunostaining was mostly assocd. with neuronal perikarya and dendrites, where it was localized to the limiting plasma membrane, the membrane of mitochondria and of some cisternae of the endoplasmic reticulum.  At the level of synaptic contacts, intense immunostaining was assocd. with postsynaptic structures including the postsynaptic thickening and some polymorphous vesicles, whereas the presynaptic axons were devoid of immunostaining.  These data indicate that the sigma1 receptor antibody prepd. here, represents a promising tool for further investigating the role of σ1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsAacDelSDfbVg90H21EOLACvtfcHk0lg4eo5TT02j1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGhurg%253D&md5=2df1ba6a60488364ad458069e059354d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2800%2900014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252800%252900014-2%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DG.%26aulast%3DPhan%26aufirst%3DV.-L.%26aulast%3DGuillemain%26aufirst%3DI.%26aulast%3DSaunier%26aufirst%3DM.%26aulast%3DLegrand%26aufirst%3DA.%26aulast%3DAnoal%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DImmunocytochemical%2520localization%2520of%2520the%2520sigma%25281%2529%2520receptor%2520in%2520the%2520adult%2520rat%2520central%2520nervous%2520system%26jtitle%3DNeuroscience%26date%3D2000%26volume%3D97%26spage%3D155%26epage%3D170%26doi%3D10.1016%2Fs0306-4522%2800%2900014-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bangaru, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihrauch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. E.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1744-8069-9-47</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-9-47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1186%2F1744-8069-9-47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1744-8069-9-47&author=M.+L.+Bangaruauthor=D.+Weihrauchauthor=Q.+B.+Tangauthor=V.+Zogaauthor=Q.+Hoganauthor=H.+E.+Wu&title=Sigma-1+receptor+expression+in+sensory+neurons+and+the+effect+of+painful+peripheral+nerve+injury&doi=10.1186%2F1744-8069-9-47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-9-47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-9-47%26sid%3Dliteratum%253Aachs%26aulast%3DBangaru%26aufirst%3DM.%2BL.%26aulast%3DWeihrauch%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DQ.%2BB.%26aulast%3DZoga%26aufirst%3DV.%26aulast%3DHogan%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DH.%2BE.%26atitle%3DSigma-1%2520receptor%2520expression%2520in%2520sensory%2520neurons%2520and%2520the%2520effect%2520of%2520painful%2520peripheral%2520nerve%2520injury%26jtitle%3DMol.%2520Pain%26date%3D2013%26volume%3D9%26spage%3D1744-8069-9-47%26doi%3D10.1186%2F1744-8069-9-47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, A.</span></span> <span> </span><span class="NLM_article-title">σ-1 receptors in major depression and anxiety</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1586/ern.09.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1586%2Fern.09.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19589051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1021-1034&author=S.+K.+Kulkarniauthor=A.+Dhir&title=%CF%83-1+receptors+in+major+depression+and+anxiety&doi=10.1586%2Fern.09.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">σ-1 receptors in major depression and anxiety</span></div><div class="casAuthors">Kulkarni, Shrinivas K.; Dhir, Ashish</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Major depression and anxiety are two of the major psychiatric disorders that have some overlapping pathophysiologies, the most significant being the dysfunction in the monoaminergic, GABAergic and glutamatergic systems.  A large no. of drugs that alter these neurotransmitter levels/systems are effective in the treatment of major depression and anxiety.  However, full remission of the clin. symptoms has not been achieved, perhaps owing to the complex pathophysiol. of the diseases.  Thus, the search for newer targets and target-specific drugs continues.  Recently, the role of σ-receptors, particularly the σ-1 receptor subtype, has been identified as a target for the pathophysiol. of neuropsychiatric disorders, and σ-1 receptor modulators are considered to be the drugs of the future for the treatment of major depression and anxiety.  The present review attempts to discuss the role of σ-1 receptors in the pathophysiol. of major depression and anxiety and also tries to position the use of its receptor modulators in the treatment of these two major disorders.  The role of σ-1 receptors in the mechanism of antidepressant action of venlafaxine, bupropion, neurosteroids and one of the herbal antidepressants, berberine, is reviewed.  Although, σ-1 receptor modulators may be future therapeutic options, either as individual agents or adjuvants in the treatment of mental disorders, the topic needs further preclin. and clin. exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBtnV2P59xLVg90H21EOLACvtfcHk0lg4eo5TT02j1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1egtL0%253D&md5=a26dd8928fbbb21fa2f137c4b6b4bc29</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1586%2Fern.09.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.09.40%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3D%25CF%2583-1%2520receptors%2520in%2520major%2520depression%2520and%2520anxiety%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2009%26volume%3D9%26spage%3D1021%26epage%3D1034%26doi%3D10.1586%2Fern.09.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of sigma-1 receptors in Alzheimer’s disease</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">4808</span>– <span class="NLM_lpage">4820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=26131055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=4808-4820&author=J.+L.+Jinauthor=M.+Fangauthor=Y.+X.+Zhaoauthor=X.+Y.+Liu&title=Roles+of+sigma-1+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of sigma-1 receptors in Alzheimer's disease</span></div><div class="casAuthors">Jin Jia-Li; Fang Min; Zhao Yan-Xin; Liu Xue-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4808-20</span>
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of senile dementia all over the world.  Still no existing drugs can effectively reverse the cognitive impairment.  However, Sigma-1 (σ-1) receptors have been long implicated in multiple neurological and psychiatric conditions over these years.  In this review, we discuss the current understanding of σ-1 receptor functions.  Through regulation of lipid rafts, secretases, kinases, neuroceptors and ion channels, σ-1 receptors can influence cellular signal transduction, TCA cycle, oxidative stress, neuron plasticity and neurotransmitter release etc.  Based on this, we suggest the key cellular mechanisms linking σ-1 receptor to Alzheimer's disease.  Besides, we detail the evidences showing that σ-1 receptors agonists, being the promising compounds for treatment of cognitive dysfunction, exhibit robust neuroprotection and anti-amnesia effect against Aβ neurotoxicity in the progress of Alzheimer's disease.  The evidence comes from animal models, preclinical studies in humans and full clinical trials.  In addition, the questions to be solved regarding this receptor are also presented.  When concerned with NMDAR, σ-1 receptor activation may result in two totally different influences on AD.  Utilization of σ-1 agents early in AD remains an overlooked therapeutic opportunity.  This article may pave the way for further studies about sigma-1 receptor on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtgNNdI_x_xG52AMpI4GK2fW6udTcc2eaycy3c1ntIHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbptFynsQ%253D%253D&md5=9a885f6b442e658b1037e96c4fabdfa1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%2BL.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DRoles%2520of%2520sigma-1%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26spage%3D4808%26epage%3D4820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke-Wold, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookerjee, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavendish, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandinaro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, R. R.</span></span> <span> </span><span class="NLM_article-title">Role of sigma-1 receptors in neurodegenerative diseases</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.jphs.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.jphs.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=25704014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2015&pages=17-29&author=L.+Nguyenauthor=B.+P.+Lucke-Woldauthor=S.+A.+Mookerjeeauthor=J.+Z.+Cavendishauthor=M.+J.+Robsonauthor=A.+L.+Scandinaroauthor=R.+R.+Matsumoto&title=Role+of+sigma-1+receptors+in+neurodegenerative+diseases&doi=10.1016%2Fj.jphs.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sigma-1 receptors in neurodegenerative diseases</span></div><div class="casAuthors">Nguyen, Linda; Lucke-Wold, Brandon P.; Mookerjee, Shona A.; Cavendish, John Z.; Robson, Matthew J.; Scandinaro, Anna L.; Matsumoto, Rae R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases with distinct genetic etiologies and pathol. phenotypes appear to share common mechanisms of neuronal cellular dysfunction, including excitotoxicity, calcium dysregulation, oxidative damage, ER stress and mitochondrial dysfunction.  Glial cells, including microglia and astrocytes, play an increasingly recognized role in both the promotion and prevention of neurodegeneration.  Sigma receptors, particularly the sigma-1 receptor subtype, which are expressed in both neurons and glia of multiple regions within the central nervous system, are a unique class of intracellular proteins that can modulate many biol. mechanisms assocd. with neurodegeneration.  These receptors therefore represent compelling putative targets for pharmacol. treating neurodegenerative disorders.  In this review, we provide an overview of the biol. mechanisms frequently assocd. with neurodegeneration, and discuss how sigma-1 receptors may alter these mechanisms to preserve or restore neuronal function.  In addn., we speculate on their therapeutic potential in the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBzbVUAlU9rVg90H21EOLACvtfcHk0lgqu6kflvOfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaksLY%253D&md5=1aa1ab1a9eb49ef2d69eef975a568a2d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jphs.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphs.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DLucke-Wold%26aufirst%3DB.%2BP.%26aulast%3DMookerjee%26aufirst%3DS.%2BA.%26aulast%3DCavendish%26aufirst%3DJ.%2BZ.%26aulast%3DRobson%26aufirst%3DM.%2BJ.%26aulast%3DScandinaro%26aufirst%3DA.%2BL.%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D127%26spage%3D17%26epage%3D29%26doi%3D10.1016%2Fj.jphs.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.-P.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor chaperones and diseases</span>. <i>Cent. Nerv. Syst. Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.2174/1871524910909030184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.2174%2F1871524910909030184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=20021352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=184-189&author=S.-Y.+Tsaiauthor=T.+Hayashiauthor=T.+Moriauthor=T.-P.+Su&title=Sigma-1+receptor+chaperones+and+diseases&doi=10.2174%2F1871524910909030184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor chaperones and diseases</span></div><div class="casAuthors">Tsai, Shang-Yi; Hayashi, Teruo; Mori, Tomohisa; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chaperones are proteins that assist the correct folding of other protein clients either when the clients are being synthesized or at their functional localities.  Chaperones are responsible for certain diseases.  The sigma-1 receptor is recently identified as a receptor chaperone whose activity can be activated/deactivated by specific ligands.  Under physiol. conditions, the sigma-1 receptor chaperones the functional IP3 receptor at the endoplasmic reticulum and mitochondrion interface to ensure proper Ca2+ signaling from endoplasmic reticulum into mitochondrion.  However, under pathol. conditions whereby cells encounter enormous stress that results in the endoplasmic reticulum losing its global Ca2+ homeostasis, the sigma-1 receptor translocates and counteracts the arising apoptosis.  Thus, the sigma-1 receptor is a receptor chaperone essential for the metabotropic receptor signaling and for the survival against cellular stress.  The sigma-1 receptor has been implicated in many diseases including addiction, pain, depression, stroke, and cancer.  Whether the chaperone activity of the sigma-1 receptor attributes to those diseases awaits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBHVqBwWpruLVg90H21EOLACvtfcHk0lgqu6kflvOfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rM&md5=2a24b524318a17026caadb8e64e908c6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030184%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DSigma-1%2520receptor%2520chaperones%2520and%2520diseases%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D184%26epage%3D189%26doi%3D10.2174%2F1871524910909030184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasuriya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. M.</span></span> <span> </span><span class="NLM_article-title">The -1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">18219</span>– <span class="NLM_lpage">18224</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3360-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1523%2FJNEUROSCI.3360-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=24227730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=18219-18224&author=D.+Balasuriyaauthor=A.+P.+Stewartauthor=J.+M.+Edwardson&title=The+-1+Receptor+Interacts+Directly+with+GluN1+But+Not+GluN2A+in+the+GluN1%2FGluN2A+NMDA+Receptor&doi=10.1523%2Fjneurosci.3360-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The σ-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor</span></div><div class="casAuthors">Balasuriya, Dilshan; Stewart, Andrew P.; Edwardson, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18219-18224</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The σ-1 receptor (Sig1R) is widely expressed in the CNS, where it has a neuroprotective role in ischemia and stroke and an involvement in schizophrenia.  The Sig1R interacts functionally with a variety of ion channels, including the NMDA receptor (NMDAR).  Here, we used at. force microscopy (AFM) imaging to investigate the interaction between the Sig1R and the NMDAR.  The Sig1R bound directly to GluN1/GluN2A NMDAR heterotetramers.  Furthermore, the mean angle between pairs of bound Sig1Rs was 72°.  This result suggested that the Sig1R interacts with either GluN1 or GluN2A, but not both, and supports our recent demonstration that the NMDAR subunits adopt an adjacent (i.e., 1/1/2/2) arrangement.  The Sig1R could be coisolated with GluN1 but not with GluN2A, indicating that GluN1 is its specific target within the NMDAR.  Consistent with this conclusion, AFM imaging of coisolated Sig1R and GluN1 revealed GluN1 dimers decorated with Sig1Rs.  In situ proximity ligation assays demonstrated that the Sig1R interacts with GluN1 (but not with GluN2A) within intact cells and also that its C terminus is extracellular.  We conclude that the Sig1R binds to the GluN1/GluN2A NMDAR specifically via the GluN1 subunit.  This interaction likely accounts for at least some of the modulatory effects of Sig1R ligands on the NMDAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBf9xfFdqFgbVg90H21EOLACvtfcHk0lgqu6kflvOfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmu7zI&md5=d4aa9bfc018939547e0d35d7f6da37d9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3360-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3360-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DBalasuriya%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DA.%2BP.%26aulast%3DEdwardson%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520-1%2520Receptor%2520Interacts%2520Directly%2520with%2520GluN1%2520But%2520Not%2520GluN2A%2520in%2520the%2520GluN1%252FGluN2A%2520NMDA%2520Receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D18219%26epage%3D18224%26doi%3D10.1523%2Fjneurosci.3360-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Muñoz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Blázquez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero-Labrador, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Murillo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garzón, J.</span></span> <span> </span><span class="NLM_article-title">The sigma1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.5993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1089%2Fars.2014.5993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=25557043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1OqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=799-818&author=M.+Rodr%C3%ADguez-Mu%C3%B1ozauthor=P.+S%C3%A1nchez-Bl%C3%A1zquezauthor=R.+Herrero-Labradorauthor=R.+Mart%C3%ADnez-Murilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=J.+Garz%C3%B3n&title=The+sigma1+receptor+engages+the+redox-regulated+HINT1+protein+to+bring+opioid+analgesia+under+NMDA+receptor+negative+control&doi=10.1089%2Fars.2014.5993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control</span></div><div class="casAuthors">Rodriguez-Munoz, Maria; Sanchez-Blazquez, Pilar; Herrero-Labrador, Raquel; Martinez-Murillo, Ricardo; Merlos, Manuel; Vela, Jose Miguel; Garzon, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">799-818</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The in vivo pharmacol. of the sigma 1 receptor (σ1R) is certainly complex; however, σ1R antagonists are of therapeutic interest, because they enhance mu-opioid receptor (MOR)-mediated antinociception and reduce neuropathic pain.  Thus, we investigated whether the σ1R is involved in the neg. control that glutamate N-methyl-d-aspartate acid receptors (NMDARs) exert on opioid antinociception.  Results: The MOR C terminus carries the histidine triad nucleotide-binding protein 1 (HINT1) coupled to the regulator of G-protein signaling RGSZ2-neural nitric oxide synthase assembly.  Activated MORs stimulate the prodn. of nitric oxide (NO), and the redox zinc switch RGSZ2 converts this signal into free zinc ions that are required to recruit the redox sensor PKCγ to HINT1 proteins.  Then, PKCγ impairs HINT1-RGSZ2 assocn. and enables σ1R-NR1 interaction with MOR-HINT1 complexes to restrain opioid signaling.  The inhibition of NOS or the absence of σ1Rs prevents HINT1-PKCγ interaction, and MOR-NMDAR cross-regulation fails.  The σ1R antagonists transitorily remove the binding of σ1Rs to NR1 subunits, facilitate the entrance of neg. regulators of NMDARs, likely Ca2+-CaM, and prevent NR1 interaction with HINT1, thereby impairing the neg. feedback of glutamate on opioid analgesia.  Innovation: A redox-regulated process situates MOR signaling under NMDAR control, and in this context, the σ1R binds to the cytosolic C terminal region of the NMDAR NR1 subunit.  Conclusion: The σ1R antagonists enhance opioid analgesia in naive mice by releasing MORs from the neg. influence of NMDARs, and they also reset antinociception in morphine tolerant animals.  Moreover, σ1R antagonists alleviate neuropathic pain, probably by driving the inhibition of up-regulated NMDARs.  Antioxid. Redox Signal. 22, 799-818.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGgPbrrTqQLVg90H21EOLACvtfcHk0lgZiEPJZS3F2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1OqtL4%253D&md5=b0896c51a92e9bd8ecff8029f09c6f97</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.5993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.5993%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Mu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DS%25C3%25A1nchez-Bl%25C3%25A1zquez%26aufirst%3DP.%26aulast%3DHerrero-Labrador%26aufirst%3DR.%26aulast%3DMart%25C3%25ADnez-Murillo%26aufirst%3DR.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DGarz%25C3%25B3n%26aufirst%3DJ.%26atitle%3DThe%2520sigma1%2520receptor%2520engages%2520the%2520redox-regulated%2520HINT1%2520protein%2520to%2520bring%2520opioid%2520analgesia%2520under%2520NMDA%2520receptor%2520negative%2520control%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2015%26volume%3D22%26spage%3D799%26epage%3D818%26doi%3D10.1089%2Fars.2014.5993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalyshyn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1124/mol.109.057083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1124%2Fmol.109.057083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=20089882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=695-703&author=F.+J.+Kimauthor=I.+Kovalyshynauthor=M.+Burgmanauthor=C.+Neilanauthor=C.-C.+Chienauthor=G.+W.+Pasternak&title=Sigma+1+receptor+modulation+of+G-protein-coupled+receptor+signaling%3A+potentiation+of+opioid+transduction+independent+from+receptor+binding&doi=10.1124%2Fmol.109.057083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">σ1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding</span></div><div class="casAuthors">Kim, Felix J.; Kovalyshyn, Ivanka; Burgman, Maxim; Neilan, Claire; Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">695-703</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">σ Ligands modulate opioid actions in vivo, with agonists diminishing morphine analgesia and antagonists enhancing the response.  Using human BE(2)-C neuroblastoma cells that natively express opioid receptors and human embryonic kidney (HEK) cells transfected with a cloned μ opioid receptor, we now demonstrate a similar modulation of opioid function, as assessed by guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding, by σ1 receptors.  σ Ligands do not compete opioid receptor binding.  Administered alone, neither σ agonists nor antagonists significantly stimulated [35S]GTPγS binding.  Yet σ receptor selective antagonists, but not agonists, shifted the EC50 of opioid-induced stimulation of [35S]GTPγS binding by 3- to 10-fold to the left.  This enhanced potency was seen without a change in the efficacy of the opioid, as assessed by the maximal stimulation of [35S]GTPγS binding.  σ1 Receptors phys. assoc. with μ opioid receptors, as shown by coimmunopptn. studies in transfected HEK cells, implying a direct interaction between the proteins.  Thus, σ receptors modulate opioid transduction without influencing opioid receptor binding.  RNA interference knockdown of σ1 in BE(2)-C cells also potentiated μ opioid-induced stimulation of [35S]GTPγS binding.  These modulatory actions are not limited to μ and δ opioid receptors.  In mouse brain membrane prepns., σ1-selective antagonists also potentiated both opioid receptor and muscarinic acetylcholine receptor-mediated stimulation of [35S]GTPγS binding, suggesting a broader role for σ receptors in modulating G-protein-coupled receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBczr3LWvgF7Vg90H21EOLACvtfcHk0lhlw0uTbCw5nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7s%253D&md5=0317009efe9b9e3fc138c5c1371e1953</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.057083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.057083%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DF.%2BJ.%26aulast%3DKovalyshyn%26aufirst%3DI.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DNeilan%26aufirst%3DC.%26aulast%3DChien%26aufirst%3DC.-C.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%25201%2520receptor%2520modulation%2520of%2520G-protein-coupled%2520receptor%2520signaling%253A%2520potentiation%2520of%2520opioid%2520transduction%2520independent%2520from%2520receptor%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D695%26epage%3D703%26doi%3D10.1124%2Fmol.109.057083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span> <span> </span><span class="NLM_article-title">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2879</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.87.6.2867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1152%2Fjn.2002.87.6.2867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=12037190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2002&pages=2867-2879&author=H.+Zhangauthor=J.+Cuevas&title=Sigma+receptors+inhibit+high-voltage-activated+calcium+channels+in+rat+sympathetic+and+parasympathetic+neurons&doi=10.1152%2Fjn.2002.87.6.2867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons</span></div><div class="casAuthors">Zhang, Hongling; Cuevas, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2867-2879</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia.  Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 receptor using single-cell RT-PCR techniques.  The relationship between sigma receptors and calcium channels was studied in isolated neurons of these ganglia under voltage-clamp mode using the perforated-patch configuration of the whole cell patch-clamp recording technique.  Bath application of sigma receptor agonists was shown to rapidly depress peak calcium channel currents in a reversible manner in both SCG and intracardiac ganglion neurons.  The inhibition of barium (IBa) currents was dose-dependent, and half-maximal inhibitory concn. (IC50) values for haloperidol, ibogaine, (+)-pentazocine, and 1,3-Di-O-tolylguanidine (DTG) were 6, 31, 61, and 133 μM, resp.  The rank order potency of haloperidol > ibogaine > (+)-pentazocine > DTG is consistent with the effects on calcium channels being mediated by a sigma-2 receptor.  Preincubation of neurons with the irreversible sigma receptor antagonist, metaphit, blocked DTG-mediated inhibition of Ca2+ channel currents.  Maximum inhibition of calcium channel currents was ≥95%, suggesting that sigma receptors block all calcium channel subtypes found on the cell body of these neurons, which includes N-, L-, P/Q-, and R-type calcium channels.  In addn. to depressing peak Ca2+ channel current, sigma receptors altered the biophys. properties of these channels.  Following sigma receptor activation, Ca2+ channel inactivation rate was accelerated, and the voltage dependence of both steady-state inactivation and activation shifted toward more neg. potentials.  Expts. on the signal transduction cascade coupling sigma receptors and Ca2+ channels demonstrated that neither cell dialysis nor intracellular application of 100 μM guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) abolished the modulation of IBa by sigma receptor agonists.  These data suggest that neither a diffusible cytosolic second messenger nor a G protein is involved in this pathway.  Activation of sigma receptors on sympathetic and parasympathetic neurons is likely to modulate cell-to-cell signaling in autonomic ganglia and thus the regulation of cardiac function by the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TEGVj60pJLVg90H21EOLACvtfcHk0lhlw0uTbCw5nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFSks74%253D&md5=7d0aebce61514d66065e60dda149e038</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.87.6.2867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.87.6.2867%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCuevas%26aufirst%3DJ.%26atitle%3DSigma%2520receptors%2520inhibit%2520high-voltage-activated%2520calcium%2520channels%2520in%2520rat%2520sympathetic%2520and%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D87%26spage%3D2867%26epage%3D2879%26doi%3D10.1152%2Fjn.2002.87.6.2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujalte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lhlw0uTbCw5nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.pain.2009.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19375855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+Del+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+receptors+are+essential+for+capsaicin-induced+mechanical+hypersensitivity%3A+studies+with+selective+sigma-1+ligands+and+sigma-1+knockout+mice&doi=10.1016%2Fj.pain.2009.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice</span></div><div class="casAuthors">Entrena, Jose Manuel; Cobos, Enrique Jose; Nieto, Francisco Rafael; Cendan, Cruz Miguel; Gris, Georgia; Del Pozo, Esperanza; Zamanillo, Daniel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the role of σ1 receptors on capsaicin-induced mech. hypersensitivity and on nociceptive pain induced by punctate mech. stimuli, using wild-type and σ1 receptor knockout (σ1-KO) mice and selective σ1 receptor-acting drugs.  Mutation in σ1-KO mice was confirmed by PCR anal. of genomic DNA and, at the protein level, by [3H](+)-pentazocine binding assays.  Both wild-type and σ1-KO mice not treated with capsaicin showed similar responses to different intensities of mech. stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw.  This indicates that σ1 gene inactivation does not modify the perception of punctate mech. stimuli.  The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mech. allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force).  In contrast, capsaicin was completely unable to induce mech. hypersensitivity in σ1-KO mice.  The high-affinity and selective σ1 antagonists BD-1063, BD-1047 and NE-100, administered s.c. dose-dependently inhibited mech. allodynia induced by capsaicin (1 μg,i.pl.), yielding ED50 (mg/kg) values of 15.80 ± 0.93, 29.31 ± 1.65 and 40.74 ± 7.20, resp.  The effects of the σ1 antagonists were reversed by the σ1 agonist PRE-084 (32 mg/kg, s.c.).  None of the drugs tested modified the responses induced by a painful mech. punctate stimulus (4 g force) in nonsensitized animals.  These results suggest that σ1 receptors are essential for capsaicin-induced mech. hypersensitivity, but are not involved in mech. nociceptive pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwYUgwwMlprVg90H21EOLACvtfcHk0lj9jhwAwFtHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Ortr0%253D&md5=e51c7b76ea146ba992c7d1768e1da9a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptors%2520are%2520essential%2520for%2520capsaicin-induced%2520mechanical%2520hypersensitivity%253A%2520studies%2520with%2520selective%2520sigma-1%2520ligands%2520and%2520sigma-1%2520knockout%2520mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261%26doi%3D10.1016%2Fj.pain.2009.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejada, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2012.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.jpain.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23063344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1107-1121&author=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=M.+A.+Tejadaauthor=D.+Zamanilloauthor=J.+M.+Velaauthor=J.+M.+Baeyens&title=Role+of+sigma-1+receptors+in+paclitaxel-induced+neuropathic+pain+in+mice&doi=10.1016%2Fj.jpain.2012.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span></div><div class="casAuthors">Nieto, Francisco Rafael; Cendan, Cruz Miguel; Sanchez-Fernandez, Cristina; Cobos, Enrique Jose; Entrena, Jose Manuel; Tejada, Miguel Angel; Zamanillo, Daniel; Vela, Jose Miguel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sigma-1 (σ1) receptors play a role in different types of pain and in central sensitization mechanisms; however, it is unknown whether they are involved in chemotherapy-induced neuropathic pain.  We compared the ability of paclitaxel to induce cold (acetone test) and mech. (electronic Von Frey test) allodynia in wild-type (WT) and σ1 receptor knockout (σ1-KO) mice.  We also tested the effect on paclitaxel-induced painful neuropathy of BD-1063 (16-64 mg/kg, s.c.) and S1RA (32-128 mg/kg, s.c.), 2 selective σ1 receptor antagonists that bind to the σ1 receptor with high affinity and competitively.  The responses to cold and mech. stimuli were similar in WT and σ1-KO mice not treated with paclitaxel; however, treatment with paclitaxel (2 mg/kg, i.p., once per day during 5 consecutive days) produced cold and mech. allodynia and an increase in spinal cord diphosphorylated extracellular signal-regulated kinase (pERK) in WT but not in σ1-KO mice.  The administration of BD-1063 or S1RA 30 min before each paclitaxel dose prevented the development of cold and mech. allodynia in WT mice.  Moreover, the acute administration of both σ1 receptor antagonists dose dependently reversed both types of paclitaxel-induced allodynia after they had fully developed.  These results suggest that σ1 receptors play a key role in paclitaxel-induced painful neuropathy.  Perspective: Antagonists of the σ1 receptor may have therapeutic value for the treatment and/or prevention of paclitaxel-induced neuropathic pain.  This possibility is esp. interesting in the context of chemotherapy-induced neuropathy, where the onset of nerve damage is predictable and preventive treatment could be administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHYCYBeIn__bVg90H21EOLACvtfcHk0lj9jhwAwFtHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I&md5=798467267c69e426eae9df6cde797d6d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DTejada%26aufirst%3DM.%2BA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520sigma-1%2520receptors%2520in%2520paclitaxel-induced%2520neuropathic%2520pain%2520in%2520mice%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D1107%26epage%3D1121%26doi%3D10.1016%2Fj.jpain.2012.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canizares, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubero, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Segura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1744-8069-10-11</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-10-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1186%2F1744-8069-10-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1744-8069-10-11&author=F.+R.+Nietoauthor=C.+M.+Cendanauthor=F.+J.+Canizaresauthor=M.+A.+Cuberoauthor=J.+M.+Velaauthor=E.+Fernandez-Seguraauthor=J.+M.+Baeyens&title=Genetic+inactivation+and+pharmacological+blockade+of+sigma-1+receptors+prevent+paclitaxel-induced+sensory-nerve+mitochondrial+abnormalities+and+neuropathic+pain+in+mice&doi=10.1186%2F1744-8069-10-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-10-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-10-11%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCendan%26aufirst%3DC.%2BM.%26aulast%3DCanizares%26aufirst%3DF.%2BJ.%26aulast%3DCubero%26aufirst%3DM.%2BA.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DFernandez-Segura%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DGenetic%2520inactivation%2520and%2520pharmacological%2520blockade%2520of%2520sigma-1%2520receptors%2520prevent%2520paclitaxel-induced%2520sensory-nerve%2520mitochondrial%2520abnormalities%2520and%2520neuropathic%2520pain%2520in%2520mice%26jtitle%3DMol.%2520Pain%26date%3D2014%26volume%3D10%26spage%3D1744-8069-10-11%26doi%3D10.1186%2F1744-8069-10-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of Peripheral μ-Opioid Analgesia by σ1 Receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.208272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1124%2Fjpet.113.208272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=24155346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=32-45&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=R.+Gonz%C3%A1lez-Canoauthor=F.+R.+Nietoauthor=L.+Romeroauthor=A.+Artacho-Cord%C3%B3nauthor=R.+Montesauthor=B.+Fern%C3%A1ndez-Pastorauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Modulation+of+Peripheral+%CE%BC-Opioid+Analgesia+by+%CF%831+Receptors&doi=10.1124%2Fjpet.113.208272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of peripheral μ-opioid analgesia by σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Montilla-Garcia, Angeles; Gonzalez-Cano, Rafael; Nieto, Francisco Rafael; Romero, Lucia; Artacho-Cordon, Antonia; Montes, Rosa; Fernandez-Pastor, Begona; Merlos, Manuel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We evaluated the effects of σ1-receptor inhibition on μ-opioid-induced mech. antinociception and constipation. σ1-Knockout mice exhibited marked mech. antinociception in response to several μ-opioid analgesics (fentanyl, oxycodone, morphine, buprenorphine, and tramadol) at systemic (s.c.) doses that were inactive in wild-type mice and even unmasked the antinociceptive effects of the peripheral μ-opioid agonist loperamide.  Likewise, systemic (s.c.) or local (intraplantar) treatment of wild-type mice with the selective σ1 antagonists BD-1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine dihydrochloride] or S1RA [4-[2-[[5-methyl-1-(2-naphthalenyl)1H-pyrazol-3-yl]oxy]ethyl] morpholine hydrochloride] potentiated μ-opioid antinociception; these effects were fully reversed by the σ1 agonist PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate) hydrochloride], showing the selectivity of the pharmacol. approach.  The μ-opioid antinociception potentiated by σ1 inhibition (by σ1-receptor knockout or σ1-pharmacol. antagonism) was more sensitive to the peripherally restricted opioid antagonist naloxone methiodide than opioid antinociception under normal conditions, indicating a key role for peripheral opioid receptors in the enhanced antinociception.  Direct interaction between the opioid drugs and σ1 receptor cannot account for our results, since the former lacked affinity for σ1 receptors (labeled with [3H](+)-pentazocine).  A peripheral role for σ1 receptors was also supported by their higher d. (Western blot results) in peripheral nervous tissue (dorsal root ganglia) than in several central areas involved in opioid antinociception (dorsal spinal cord, basolateral amygdala, periaqueductal gray, and rostroventral medulla).  In contrast to its effects on nociception, σ1-receptor inhibition did not alter fentanyl- or loperamide-induced constipation, a peripherally mediated nonanalgesic opioid effect.  Therefore, σ1-receptor inhibition may be used as a systemic or local adjuvant to enhance peripheral μ-opioid analgesia without affecting opioid-induced constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXDUF69QHTL7Vg90H21EOLACvtfcHk0lj-87LA7crhGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKju74%253D&md5=3448ecaf8c215210a48a8413b89db2a5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.208272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.208272%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DMontes%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DModulation%2520of%2520Peripheral%2520%25CE%25BC-Opioid%2520Analgesia%2520by%2520%25CF%25831%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D32%26epage%3D45%26doi%3D10.1124%2Fjpet.113.208272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.neuropharm.2013.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23524304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=348-358&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=F.+R.+Nietoauthor=R.+Gonz%C3%A1lez-Canoauthor=A.+Artacho-Cord%C3%B3nauthor=L.+Romeroauthor=%C3%81.+Montilla-Garc%C3%ADaauthor=D.+Zamanilloauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Potentiation+of+morphine-induced+mechanical+antinociception+by+%CF%831+receptor+inhibition%3A+Role+of+peripheral+%CF%831+receptors&doi=10.1016%2Fj.neuropharm.2013.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Nieto, Francisco Rafael; Gonzalez-Cano, Rafael; Artacho-Cordon, Antonia; Romero, Lucia; Montilla-Garcia, Angeles; Zamanillo, Daniel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-358</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the modulation of morphine-induced mech. antinociception and side effects by σ1 receptor inhibition.  Both wild-type (WT) and σ1 receptor knockout (σ1-KO) mice showed similar responses to paw pressure (100-600 g).  The systemic (s.c.) or local (intraplantar) administration of σ1 antagonists (BD-1063, BD-1047, NE-100 and S1RA) was devoid of antinociceptive effects in WT mice.  However, σ1-KO mice exhibited an enhanced mech. antinociception in response to systemic morphine (1-16 mg/kg).  Similarly, systemic treatment of WT mice with σ1 antagonists markedly potentiated morphine-induced antinociception, and its effects were reversed by the selective σ1 agonist PRE-084.  Although the local administration of morphine (50-200 μg) was devoid of antinociceptive effects in WT mice, it induced dose-dependent antinociception in σ1-KO mice.  This effect was limited to the injected paw.  Enhancement of peripheral morphine antinociception was replicated in WT mice locally co-administered with σ1 antagonists and the opioid.  None of the σ1 antagonists tested enhanced morphine-antinociception in σ1-KO mice, confirming a σ1-mediated action.  Morphine-induced side-effects (hyperlocomotion and inhibition of gastrointestinal transit) were unaltered in σ1-KO mice.  These results cannot be explained by a direct interaction of σ1 ligands with μ-opioid receptors or adaptive changes of μ-receptors in σ1-KO mice, given that [3H]DAMGO binding in forebrain, spinal cord, and hind-paw skin membranes was unaltered in mutant mice, and none of the σ1 drugs tested bound to μ-opioid receptors.  These results show that σ1 receptor inhibition potentiates morphine-induced mech. analgesia but not its acute side effects, and that this enhanced analgesia can be induced at peripheral level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2KFSqih3HbVg90H21EOLACvtfcHk0lj-87LA7crhGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D&md5=d21562671453852a7e07c15232726ade</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3D%25C3%2581.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DPotentiation%2520of%2520morphine-induced%2520mechanical%2520antinociception%2520by%2520%25CF%25831%2520receptor%2520inhibition%253A%2520Role%2520of%2520peripheral%2520%25CF%25831%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D348%26epage%3D358%26doi%3D10.1016%2Fj.neuropharm.2013.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocasalbas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touriño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreea Bura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuel Baeyens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>711</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Touri%C3%B1oauthor=S.+Andreea+Buraauthor=B.+Fern%C3%A1ndez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+Manuel+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lg4aA7lfLyLGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTouri%25C3%25B1o%26aufirst%3DC.%26aulast%3DAndreea%2BBura%26aufirst%3DS.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DManuel%2BBaeyens%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrander, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span> <span> </span><span class="NLM_article-title">Sigma1 targeting to suppress aberrant androgen receptor signaling in prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2439</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-16-1055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1158%2F0008-5472.CAN-16-1055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=28235766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2439-2452&author=J.+D.+Thomasauthor=C.+G.+Longenauthor=H.+M.+Oyerauthor=N.+Chenauthor=C.+M.+Maherauthor=J.+M.+Salvinoauthor=B.+Kaniaauthor=K.+N.+Andersonauthor=W.+F.+Ostranderauthor=K.+E.+Knudsenauthor=F.+J.+Kim&title=Sigma1+targeting+to+suppress+aberrant+androgen+receptor+signaling+in+prostate+cancer&doi=10.1158%2F0008-5472.can-16-1055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer</span></div><div class="casAuthors">Thomas, Jeffrey D.; Longen, Charles G.; Oyer, Halley M.; Chen, Nan; Maher, Christina M.; Salvino, Joseph M.; Kania, Blase; Anderson, Kelsey N.; Ostrander, William F.; Knudsen, Karen E.; Kim, Felix J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2439-2452</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suppression of androgen receptor (AR) activity in prostate cancer by androgen depletion or direct AR antagonist treatment, although initially effective, leads to incurable castration-resistant prostate cancer (CRPC) via compensatory mechanisms including resurgence of AR and AR splice variant (ARV) signaling.  Emerging evidence suggests that Sigma1 (also known as sigma-1 receptor) is a unique chaperone or scaffolding protein that contributes to cellular protein homeostasis.  We reported previously that some Sigma1-selective small mols. can be used to pharmacol. modulate protein homeostasis pathways.  We hypothesized that these Sigma1-mediated responses could be exploited to suppress AR protein levels and activity.  Here we demonstrate that treatment with a small-mol. Sigma1 inhibitor prevented 5α- dihydrotestosterone-mediated nuclear translocation of AR and induced proteasomal degrdn. of AR and ARV, suppressing the transcriptional activity and protein levels of both full-length and splice-variant AR.  Consistent with these data, RNAi knockdown of Sigma1 resulted in decreased AR levels and transcriptional activity.  Furthermore, Sigma1 phys. assocd. with ARV7 and ARv567es as well as full-length AR.  Treatment of mice xenografted with ARV-driven CRPC tumors with a drug-like small-mol. Sigma1 inhibitor significantly inhibited tumor growth assocd. with elimination of AR and ARV7 in responsive tumors.  Together, our data show that Sigma1 modulators can be used to suppress AR/ARV-driven prostate cancer cells via regulation of pharmacol. responsive Sigma1-AR/ARV interactions, both in vitro and in vivo.  Cancer Res; 77(9); 2439-52. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRDgJkI_yvYrVg90H21EOLACvtfcHk0lg4aA7lfLyLGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFarsrY%253D&md5=346376aba5fb75a7bf17502e78c02798</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1055%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DLongen%26aufirst%3DC.%2BG.%26aulast%3DOyer%26aufirst%3DH.%2BM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DMaher%26aufirst%3DC.%2BM.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DKania%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DK.%2BN.%26aulast%3DOstrander%26aufirst%3DW.%2BF.%26aulast%3DKnudsen%26aufirst%3DK.%2BE.%26aulast%3DKim%26aufirst%3DF.%2BJ.%26atitle%3DSigma1%2520targeting%2520to%2520suppress%2520aberrant%2520androgen%2520receptor%2520signaling%2520in%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D2439%26epage%3D2452%26doi%3D10.1158%2F0008-5472.can-16-1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, F. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule sigma1 modulator induces autophagic degradation of PD-L1</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-17-0166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1158%2F1541-7786.MCR-17-0166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=29117944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVeiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=243-255&author=C.+M.+Maherauthor=J.+D.+Thomasauthor=D.+A.+Haasauthor=C.+G.+Longenauthor=H.+M.+Oyerauthor=J.+Y.+Tongauthor=F.+J.+Kim&title=Small-molecule+sigma1+modulator+induces+autophagic+degradation+of+PD-L1&doi=10.1158%2F1541-7786.mcr-17-0166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1</span></div><div class="casAuthors">Maher, Christina M.; Thomas, Jeffrey D.; Haas, Derick A.; Longen, Charles G.; Oyer, Halley M.; Tong, Jane Y.; Kim, Felix J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-255</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging evidence suggests that Sigma1 (SIGMAR1, also known as sigma-1 receptor) is a unique ligand-regulated integral membrane scaffolding protein that contributes to cellular protein and lipid homeostasis.  Previously, we demonstrated that some small-mol. modulators of Sigma1 alter endoplasmic reticulum (ER)-assocd. protein homeostasis pathways in cancer cells, including the unfolded protein response and autophagy.  Programmed death-ligand 1 (PD-L1) is a type I integral membrane glycoprotein that is cotranslationally inserted into the ER and is processed and transported through the secretory pathway.  Once at the surface of cancer cells, PD-L1 acts as a T-cell inhibitory checkpoint mol. and suppresses antitumor immunity.  Here, we demonstrate that in Sigma1-expressing triple-neg. breast and androgen-independent prostate cancer cells, PD-L1 protein levels were suppressed by RNAi knockdown of Sigma1 and by small-mol. inhibition of Sigma1.  Sigma1-mediated action was confirmed by pharmacol. competition between Sigma1-selective inhibitor and activator ligands.  When administered alone, the Sigma1 inhibitor decreased cell surface PD-L1 expression and suppressed functional interaction of PD-1 and PD-L1 in a coculture of T cells and cancer cells.  Conversely, the Sigma1 activator increased PD-L1 cell surface expression, demonstrating the ability to pos. and neg. modulate Sigma1 assocd. PD-L1 processing.  We discovered that the Sigma1 inhibitor induced degrdn. of PD-L1 via autophagy, by a mechanism distinct from bulk macroautophagy or general ER stress-assocd. autophagy.  Finally, the Sigma1 inhibitor suppressed IFNγ-induced PD-L1.  Our data demonstrate that small-mol. Sigma1 modulators can be used to regulate PD-L1 in cancer cells and trigger its degrdn. by selective autophagy.  Implications: Sigma1 modulators sequester and eliminate PD-L1 by autophagy, thus preventing functional PD-L1 expression at the cell surface.  This posits Sigma1 modulators as novel therapeutic agents in PD-L1/PD-1 blockade strategies that regulate the tumor immune microenvironment.  Visual Overview: http//mcr.accrjournals.org/content/molcanres/16/02/243/F1.large.jpg.  Mol Cancer Res; 16(2); 243-55. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPoBdyWoswA7Vg90H21EOLACvtfcHk0lg4aA7lfLyLGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVeiurc%253D&md5=84f9aee84ada0bb2b7ce13f2d210b52b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0166%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DC.%2BM.%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DHaas%26aufirst%3DD.%2BA.%26aulast%3DLongen%26aufirst%3DC.%2BG.%26aulast%3DOyer%26aufirst%3DH.%2BM.%26aulast%3DTong%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DF.%2BJ.%26atitle%3DSmall-molecule%2520sigma1%2520modulator%2520induces%2520autophagic%2520degradation%2520of%2520PD-L1%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2018%26volume%3D16%26spage%3D243%26epage%3D255%26doi%3D10.1158%2F1541-7786.mcr-17-0166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhaddou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obernier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezelj, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hüttenhain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaake, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutuncuoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foussard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polacco, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabius, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucheray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Kain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miorin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, Z. Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorba, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrio-Hernandez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Armenta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, C. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzberg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calviello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liboy-Lugo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wankowicz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugur, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savar, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shengjuler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuoglu-Ozturk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Enfert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ideker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floor, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogan, N. J.</span></span> <span> </span><span class="NLM_article-title">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>583</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2286-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fs41586-020-2286-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=32353859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlCqtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=583&publication_year=2020&pages=459-468&author=D.+E.+Gordonauthor=G.+M.+Jangauthor=M.+Bouhaddouauthor=J.+Xuauthor=K.+Obernierauthor=K.+M.+Whiteauthor=M.+J.+O%E2%80%99Mearaauthor=V.+V.+Rezeljauthor=J.+Z.+Guoauthor=D.+L.+Swaneyauthor=T.+A.+Tumminoauthor=R.+H%C3%BCttenhainauthor=R.+M.+Kaakeauthor=A.+L.+Richardsauthor=B.+Tutuncuogluauthor=H.+Foussardauthor=J.+Batraauthor=K.+Haasauthor=M.+Modakauthor=M.+Kimauthor=P.+Haasauthor=B.+J.+Polaccoauthor=H.+Brabergauthor=J.+M.+Fabiusauthor=M.+Eckhardtauthor=M.+Soucherayauthor=M.+J.+Bennettauthor=M.+Cakirauthor=M.+J.+McGregorauthor=Q.+Liauthor=B.+Meyerauthor=F.+Roeschauthor=T.+Valletauthor=A.+Mac+Kainauthor=L.+Miorinauthor=E.+Morenoauthor=Z.+Z.+C.+Naingauthor=Y.+Zhouauthor=S.+Pengauthor=Y.+Shiauthor=Z.+Zhangauthor=W.+Shenauthor=I.+T.+Kirbyauthor=J.+E.+Melnykauthor=J.+S.+Chorbaauthor=K.+Louauthor=S.+A.+Daiauthor=I.+Barrio-Hernandezauthor=D.+Memonauthor=C.+Hernandez-Armentaauthor=J.+Lyuauthor=C.+J.+P.+Mathyauthor=T.+Pericaauthor=K.+B.+Pillaauthor=S.+J.+Ganesanauthor=D.+J.+Saltzbergauthor=R.+Rakeshauthor=X.+Liuauthor=S.+B.+Rosenthalauthor=L.+Calvielloauthor=S.+Venkataramananauthor=J.+Liboy-Lugoauthor=Y.+Linauthor=X.-P.+Huangauthor=Y.+Liuauthor=S.+A.+Wankowiczauthor=M.+Bohnauthor=M.+Safariauthor=F.+S.+Ugurauthor=C.+Kohauthor=N.+S.+Savarauthor=Q.+D.+Tranauthor=D.+Shengjulerauthor=S.+J.+Fletcherauthor=M.+C.+O%E2%80%99Nealauthor=Y.+Caiauthor=J.+C.+J.+Changauthor=D.+J.+Broadhurstauthor=S.+Klippstenauthor=P.+P.+Sharpauthor=N.+A.+Wenzellauthor=D.+Kuzuoglu-Ozturkauthor=H.-Y.+Wangauthor=R.+Trenkerauthor=J.+M.+Youngauthor=D.+A.+Caveroauthor=J.+Hiattauthor=T.+L.+Rothauthor=U.+Rathoreauthor=A.+Subramanianauthor=J.+Noackauthor=M.+Hubertauthor=R.+M.+Stroudauthor=A.+D.+Frankelauthor=O.+S.+Rosenbergauthor=K.+A.+Verbaauthor=D.+A.+Agardauthor=M.+Ottauthor=M.+Emermanauthor=N.+Juraauthor=M.+von+Zastrowauthor=E.+Verdinauthor=A.+Ashworthauthor=O.+Schwartzauthor=C.+d%E2%80%99Enfertauthor=S.+Mukherjeeauthor=M.+Jacobsonauthor=H.+S.+Malikauthor=D.+G.+Fujimoriauthor=T.+Idekerauthor=C.+S.+Craikauthor=S.+N.+Floorauthor=J.+S.+Fraserauthor=J.+D.+Grossauthor=A.+Saliauthor=B.+L.+Rothauthor=D.+Ruggeroauthor=J.+Tauntonauthor=T.+Kortemmeauthor=P.+Beltraoauthor=M.+Vignuzziauthor=A.+Garc%C3%ADa-Sastreauthor=K.+M.+Shokatauthor=B.+K.+Shoichetauthor=N.+J.+Krogan&title=A+SARS-CoV-2+protein+interaction+map+reveals+targets+for+drug+repurposing&doi=10.1038%2Fs41586-020-2286-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span></div><div class="casAuthors">Gordon, David E.; Jang, Gwendolyn M.; Bouhaddou, Mehdi; Xu, Jiewei; Obernier, Kirsten; White, Kris M.; O'Meara, Matthew J.; Rezelj, Veronica V.; Guo, Jeffrey Z.; Swaney, Danielle L.; Tummino, Tia A.; Huttenhain, Ruth; Kaake, Robyn M.; Richards, Alicia L.; Tutuncuoglu, Beril; Foussard, Helene; Batra, Jyoti; Haas, Kelsey; Modak, Maya; Kim, Minkyu; Haas, Paige; Polacco, Benjamin J.; Braberg, Hannes; Fabius, Jacqueline M.; Eckhardt, Manon; Soucheray, Margaret; Bennett, Melanie J.; Cakir, Merve; McGregor, Michael J.; Li, Qiongyu; Meyer, Bjoern; Roesch, Ferdinand; Vallet, Thomas; Mac Kain, Alice; Miorin, Lisa; Moreno, Elena; Naing, Zun Zar Chi; Zhou, Yuan; Peng, Shiming; Shi, Ying; Zhang, Ziyang; Shen, Wenqi; Kirby, Ilsa T.; Melnyk, James E.; Chorba, John S.; Lou, Kevin; Dai, Shizhong A.; Barrio-Hernandez, Inigo; Memon, Danish; Hernandez-Armenta, Claudia; Lyu, Jiankun; Mathy, Christopher J. P.; Perica, Tina; Pilla, Kala Bharath; Ganesan, Sai J.; Saltzberg, Daniel J.; Rakesh, Ramachandran; Liu, Xi; Rosenthal, Sara B.; Calviello, Lorenzo; Venkataramanan, Srivats; Liboy-Lugo, Jose; Lin, Yizhu; Huang, Xi-Ping; Liu, YongFeng; Wankowicz, Stephanie A.; Bohn, Markus; Safari, Maliheh; Ugur, Fatima S.; Koh, Cassandra; Savar, Nastaran Sadat; Tran, Quang Dinh; Shengjuler, Djoshkun; Fletcher, Sabrina J.; O'Neal, Michael C.; Cai, Yiming; Chang, Jason C. J.; Broadhurst, David J.; Klippsten, Saker; Sharp, Phillip P.; Wenzell, Nicole A.; Kuzuoglu-Ozturk, Duygu; Wang, Hao-Yuan; Trenker, Raphael; Young, Janet M.; Cavero, Devin A.; Hiatt, Joseph; Roth, Theodore L.; Rathore, Ujjwal; Subramanian, Advait; Noack, Julia; Hubert, Mathieu; Stroud, Robert M.; Frankel, Alan D.; Rosenberg, Oren S.; Verba, Kliment A.; Agard, David A.; Ott, Melanie; Emerman, Michael; Jura, Natalia; von Zastrow, Mark; Verdin, Eric; Ashworth, Alan; Schwartz, Olivier; d'Enfert, Christophe; Mukherjee, Shaeri; Jacobson, Matt; Malik, Harmit S.; Fujimori, Danica G.; Ideker, Trey; Craik, Charles S.; Floor, Stephen N.; Fraser, James S.; Gross, John D.; Sali, Andrej; Roth, Bryan L.; Ruggero, Davide; Taunton, Jack; Kortemme, Tanja; Beltrao, Pedro; Vignuzzi, Marco; Garcia-Sastre, Adolfo; Shokat, Kevan M.; Shoichet, Brian K.; Krogan, Nevan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">583</span>
        (<span class="NLM_cas:issue">7816</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals and caused worldwide social and economic disruption1,2.  There are no antiviral drugs with proven clin. efficacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and efforts to develop drugs and vaccines are hampered by the limited knowledge of the mol. details of how SARS-CoV-2 infects cells.  Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identified the human proteins that phys. assocd. with each of the SARS-CoV-2 proteins using affinity-purifn. mass spectrometry, identifying 332 high-confidence protein-protein interactions between SARS-CoV-2 and human proteins.  Among these, we identify 66 druggable human proteins or host factors targeted by 69 compds. (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clin. trials and 28 are preclin. compds.).  We screened a subset of these in multiple viral assays and found two sets of pharmacol. agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.  Further studies of these host-factor-targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvJUIvi-Ws7Vg90H21EOLACvtfcHk0lj4Npp_MgbV8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlCqtbrI&md5=ce8b172ae73aacd3b3d8bb64877f4435</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2286-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2286-9%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BE.%26aulast%3DJang%26aufirst%3DG.%2BM.%26aulast%3DBouhaddou%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DObernier%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DRezelj%26aufirst%3DV.%2BV.%26aulast%3DGuo%26aufirst%3DJ.%2BZ.%26aulast%3DSwaney%26aufirst%3DD.%2BL.%26aulast%3DTummino%26aufirst%3DT.%2BA.%26aulast%3DH%25C3%25BCttenhain%26aufirst%3DR.%26aulast%3DKaake%26aufirst%3DR.%2BM.%26aulast%3DRichards%26aufirst%3DA.%2BL.%26aulast%3DTutuncuoglu%26aufirst%3DB.%26aulast%3DFoussard%26aufirst%3DH.%26aulast%3DBatra%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DK.%26aulast%3DModak%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DPolacco%26aufirst%3DB.%2BJ.%26aulast%3DBraberg%26aufirst%3DH.%26aulast%3DFabius%26aufirst%3DJ.%2BM.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DSoucheray%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DCakir%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DVallet%26aufirst%3DT.%26aulast%3DMac%2BKain%26aufirst%3DA.%26aulast%3DMiorin%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DZ.%2BZ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKirby%26aufirst%3DI.%2BT.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DChorba%26aufirst%3DJ.%2BS.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DS.%2BA.%26aulast%3DBarrio-Hernandez%26aufirst%3DI.%26aulast%3DMemon%26aufirst%3DD.%26aulast%3DHernandez-Armenta%26aufirst%3DC.%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DMathy%26aufirst%3DC.%2BJ.%2BP.%26aulast%3DPerica%26aufirst%3DT.%26aulast%3DPilla%26aufirst%3DK.%2BB.%26aulast%3DGanesan%26aufirst%3DS.%2BJ.%26aulast%3DSaltzberg%26aufirst%3DD.%2BJ.%26aulast%3DRakesh%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DS.%2BB.%26aulast%3DCalviello%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DS.%26aulast%3DLiboy-Lugo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWankowicz%26aufirst%3DS.%2BA.%26aulast%3DBohn%26aufirst%3DM.%26aulast%3DSafari%26aufirst%3DM.%26aulast%3DUgur%26aufirst%3DF.%2BS.%26aulast%3DKoh%26aufirst%3DC.%26aulast%3DSavar%26aufirst%3DN.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BD.%26aulast%3DShengjuler%26aufirst%3DD.%26aulast%3DFletcher%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DM.%2BC.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DBroadhurst%26aufirst%3DD.%2BJ.%26aulast%3DKlippsten%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DWenzell%26aufirst%3DN.%2BA.%26aulast%3DKuzuoglu-Ozturk%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.-Y.%26aulast%3DTrenker%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DCavero%26aufirst%3DD.%2BA.%26aulast%3DHiatt%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DT.%2BL.%26aulast%3DRathore%26aufirst%3DU.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DRosenberg%26aufirst%3DO.%2BS.%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DEmerman%26aufirst%3DM.%26aulast%3DJura%26aufirst%3DN.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3Dd%25E2%2580%2599Enfert%26aufirst%3DC.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DH.%2BS.%26aulast%3DFujimori%26aufirst%3DD.%2BG.%26aulast%3DIdeker%26aufirst%3DT.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFloor%26aufirst%3DS.%2BN.%26aulast%3DFraser%26aufirst%3DJ.%2BS.%26aulast%3DGross%26aufirst%3DJ.%2BD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBeltrao%26aufirst%3DP.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Sastre%26aufirst%3DA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26atitle%3DA%2520SARS-CoV-2%2520protein%2520interaction%2520map%2520reveals%2520targets%2520for%2520drug%2520repurposing%26jtitle%3DNature%26date%3D2020%26volume%3D583%26spage%3D459%26epage%3D468%26doi%3D10.1038%2Fs41586-020-2286-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebrecos, J.</span>; <span class="NLM_string-name">Galvez, R.</span>; <span class="NLM_string-name">Albesa, N.</span>; <span class="NLM_string-name">MunozBlanco, J.</span>; <span class="NLM_string-name">Aguilar, J.</span>; <span class="NLM_string-name">Rojals, V. M.</span>; <span class="NLM_string-name">Casals, S.</span>; <span class="NLM_string-name">Sust, M.</span>; <span class="NLM_string-name">Vaqué, A.</span>; <span class="NLM_string-name">Morte, A.</span>; <span class="NLM_string-name">Gascón, N.</span>; <span class="NLM_string-name">PlataSalamán, C.</span></span> <span> </span><span class="NLM_article-title">In E52862, a First in Class Sigma 1 Receptor Antagonist</span>.  <i>Chronic PostSurgical Neuropathic Pain: An Exploratory Phase II Clinical Trial, 16th World Congress on Pain, Yokohama, Japan</i>: <span class="NLM_publisher-loc">Yokohama, Japan</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cebrecos&author=R.+Galvez&author=N.+Albesa&author=J.+MunozBlanco&author=J.+Aguilar&author=V.+M.+Rojals&author=S.+Casals&author=M.+Sust&author=A.+Vaqu%C3%A9&author=A.+Morte&author=N.+Gasc%C3%B3n&author=C.+PlataSalam%C3%A1n&title=In+E52862%2C+a+First+in+Class+Sigma+1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCebrecos%26aufirst%3DJ.%26atitle%3DIn%2520E52862%252C%2520a%2520First%2520in%2520Class%2520Sigma%25201%2520Receptor%2520Antagonist%26jtitle%3DChronic%2520PostSurgical%2520Neuropathic%2520Pain%253A%2520An%2520Exploratory%2520Phase%2520II%2520Clinical%2520Trial%252C%252016th%2520World%2520Congress%2520on%2520Pain%252C%2520Yokohama%252C%2520Japan%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arroyos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Arconada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segalés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-García, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plata-Salamán, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2289</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Baeyensauthor=J.+Giraldoauthor=J.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+Plata-Salam%C3%A1nauthor=J.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0lgFZGm4PqMWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span> <span> </span><span class="NLM_article-title">Comprehensive 3D-QSAR model predicts binding affinity of structurally diverse sigma 1 receptor ligands</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.8b00521</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.8b00521" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCqs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=486-497&author=Y.+Pengauthor=H.+Dongauthor=W.+J.+Welsh&title=Comprehensive+3D-QSAR+model+predicts+binding+affinity+of+structurally+diverse+sigma+1+receptor+ligands&doi=10.1021%2Facs.jcim.8b00521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands</span></div><div class="casAuthors">Peng, Youyi; Dong, Hiep; Welsh, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-497</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Sigma 1 Receptor (S1R) has attracted intense interest as a pharmaceutical target for various therapeutic indications, including the treatment of neuropathic pain and the potentiation of opioid analgesia.  Efforts by drug developers to rationally design S1R antagonists have been spurred recently by the 2016 publication of the high-resoln. X-ray crystal structure of the ligand-bound human S1R.  Until now, however, the absence in the published literature of a single, large-scale, and comprehensive quant. structure-activity relationship (QSAR) model that encompasses a structurally diverse collection of S1R ligands has impaired rapid progress.  To our best knowledge, the present study represents the first report of a statistically robust and highly predictive 3D-QSAR model (R2 = 0.92, Q2 = 0.62, R2pred = 0.81) based on the X-ray crystal structure of human S1R and constructed from a pooled compilation of 180 S1R antagonists that encompass five structurally diverse chem. families investigated using identical exptl. protocols.  Best practices, as recommended by the Organization for Economic Cooperation and Development (OECD: http://www.oecd.org/), were adopted for pooling data from disparate sources and for QSAR model development and both internal and external model validation.  The practical utility of the final 3D-QSAR model was tested by virtual screening of the DrugBank database of FDA approved drugs supplemented by eight reported S1R antagonists.  Among the top-ranked 40 DrugBank hits, four approved drugs which were previously unknown as S1R antagonists were tested using in vitro radiolabeled human S1R binding assays.  Of these, two drugs (diphenhydramine and phenyltoloxamine) exhibited potent S1R binding affinity with Ki = 58 nM and 160 nM, resp.  As diphenhydramine is approved as an antiallergic, and phenyltoloxamine as an analgesic and sedative, each of these compds. represents a viable starting point for a drug discovery campaign aimed at the development of novel S1R antagonists for a wide range of therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKEL-PzpYGf7Vg90H21EOLACvtfcHk0lgbT5mEe8MU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCqs7vP&md5=9ddd5e637344c4e5171e7be08351ab64</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.8b00521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.8b00521%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26atitle%3DComprehensive%25203D-QSAR%2520model%2520predicts%2520binding%2520affinity%2520of%2520structurally%2520diverse%2520sigma%25201%2520receptor%2520ligands%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D486%26epage%3D497%26doi%3D10.1021%2Facs.jcim.8b00521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurpinar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human σ1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">527</span>, <span class="refDoi"> DOI: 10.1038/nature17391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnature17391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=27042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=527&author=H.+R.+Schmidtauthor=S.+Zhengauthor=E.+Gurpinarauthor=A.+Koehlauthor=A.+Manglikauthor=A.+C.+Kruse&title=Crystal+structure+of+the+human+%CF%831+receptor&doi=10.1038%2Fnature17391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human σ1 receptor</span></div><div class="casAuthors">Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Koehl, Antoine; Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7600</span>),
    <span class="NLM_cas:pages">527-530</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human σ1 receptor is an enigmatic endoplasmic reticulum (ER)-resident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain.  Recently, an addnl. connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models.  Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein-coupled receptors or ligand-gated ion channels, the σ1 receptor is an evolutionary isolate with no discernible similarity to any other human protein.  Despite its increasingly clear importance in human physiol. and disease, the mol. architecture of the σ1 receptor and its regulation by drug-like compds. remain poorly defined.  Here, the authors report crystal structures of the human σ1 receptor in complex with 2 chem. divergent ligands, PD 144418 and 4-(N-benzylpiperidin-4-yl)-4-iodobenzamide (4-IBP).  The structures revealed a trimeric architecture with a single transmembrane domain in each protomer.  The C-terminal domain of the receptor showed an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate assocn. with the cytosolic surface of the ER membrane in cells.  This domain included a cupin-like β-barrel with the ligand-binding site buried at its center.  This large, hydrophobic ligand-binding cavity showed remarkable plasticity in ligand recognition, binding the 2 ligands in similar positions despite dissimilar chem. structures.  Taken together, these results revealed the overall architecture, oligomerization state, and mol. basis for ligand recognition by this important but poorly understood protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQBAf03Pml7Vg90H21EOLACvtfcHk0lghjLt18DVGkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gt7o%253D&md5=fb6df7814060fbd05ba41261ad1061f5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnature17391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17391%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGurpinar%26aufirst%3DE.%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CF%25831%2520receptor%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D527%26doi%3D10.1038%2Fnature17391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lghjLt18DVGkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis for sigma1 receptor ligand recognition</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1038/s41594-018-0137-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fs41594-018-0137-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=30291362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=981-987&author=H.+R.+Schmidtauthor=R.+M.+Betzauthor=R.+O.+Drorauthor=A.+C.+Kruse&title=Structural+basis+for+sigma1+receptor+ligand+recognition&doi=10.1038%2Fs41594-018-0137-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for σ1 receptor ligand recognition</span></div><div class="casAuthors">Schmidt, Hayden R.; Betz, Robin M.; Dror, Ron O.; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">981-987</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The s1 receptor is a poorly understood membrane protein expressed throughout the human body.  Ligands targeting the s1 receptor are in clin. trials for treatment of Alzheimer's disease, ischemic stroke, and neuropathic pain.  However, relatively little is known regarding the s1 receptor's mol. function.  Here, we present crystal structures of human s1 receptor bound to the antagonists haloperidol and NE-100, and the agonist (+)-pentazocine, at crystallog. resolns. of 3.1 Å, 2.9 Å, and 3.1 Å, resp.  These structures reveal a unique binding pose for the agonist.  The structures and accompanying mol. dynamics (MD) simulations identify agonist-induced structural rearrangements in the receptor.  Addnl., we show that ligand binding to s1 is a multistep process that is rate limited by receptor conformational change.  We used MD simulations to reconstruct a ligand binding pathway involving two major conformational changes.  These data provide a framework for understanding the mol. basis for s1 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2dgVTV70vbVg90H21EOLACvtfcHk0lgCJ83ZEMSIyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbvM&md5=d12d12aecbd89684824975977ec03e4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0137-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0137-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DStructural%2520basis%2520for%2520sigma1%2520receptor%2520ligand%2520recognition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D981%26epage%3D987%26doi%3D10.1038%2Fs41594-018-0137-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiba, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandler, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Virtual screening for ligand discovery at the sigma1 receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVGns7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1555-1561&author=D.+A.+Greenfieldauthor=H.+R.+Schmidtauthor=M.+A.+Skibaauthor=M.+D.+Mandlerauthor=J.+R.+Andersonauthor=P.+Slizauthor=A.+C.+Kruse&title=Virtual+screening+for+ligand+discovery+at+the+sigma1+receptor&doi=10.1021%2Facsmedchemlett.9b00314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening for Ligand Discovery at the σ1 Receptor</span></div><div class="casAuthors">Greenfield, Daniel A.; Schmidt, Hayden R.; Skiba, Meredith A.; Mandler, Michael D.; Anderson, Jacob R.; Sliz, Piotr; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1555-1561</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The σ1 receptor is a transmembrane protein implicated in several pathophysiol. conditions, including neurodegenerative disease, drug addiction, cancer, and pain.  However, there are no high-throughput functional assays for σ1 receptor drug discovery.  Here, we assessed high-throughput structure-based computational docking for discovery of novel ligands of the σ1 receptor.  We screened a library of over 6 million compds. using the Schr.ovrddot.odinger Glide package, followed by exptl. characterization of top-scoring candidates. 77% of tested candidates bound σ1 with high affinity (KD < 1 μM).  These include compds. with high selectivity for the σ1 receptor compared to the genetically unrelated but pharmacol. similar σ2 receptor, as well as compds. with substantial crossreactivity between the two receptors.  These results establish structure-based virtual screening as a highly effective platform for σ1 receptor ligand discovery and provide compds. to prioritize in studies of σ1 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDfUmoQaAcLVg90H21EOLACvtfcHk0lgCJ83ZEMSIyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVGns7nF&md5=f9bb32db3e629e604044651de2147bb5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00314%26sid%3Dliteratum%253Aachs%26aulast%3DGreenfield%26aufirst%3DD.%2BA.%26aulast%3DSchmidt%26aufirst%3DH.%2BR.%26aulast%3DSkiba%26aufirst%3DM.%2BA.%26aulast%3DMandler%26aufirst%3DM.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%2BR.%26aulast%3DSliz%26aufirst%3DP.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DVirtual%2520screening%2520for%2520ligand%2520discovery%2520at%2520the%2520sigma1%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1555%26epage%3D1561%26doi%3D10.1021%2Facsmedchemlett.9b00314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortagere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannemacher, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howells, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span> <span> </span><span class="NLM_article-title">Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6442</span>– <span class="NLM_lpage">6450</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.bmc.2009.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19646882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVenur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6442-6450&author=Y.+Pengauthor=Q.+Zhangauthor=S.+Aroraauthor=S.+M.+Keenanauthor=S.+Kortagereauthor=K.+M.+Wannemacherauthor=R.+D.+Howellsauthor=W.+J.+Welsh&title=Novel+delta+opioid+receptor+agonists+exhibit+differential+stimulation+of+signaling+pathways&doi=10.1016%2Fj.bmc.2009.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways</span></div><div class="casAuthors">Peng, Youyi; Zhang, Qiang; Arora, Sonia; Keenan, Susan M.; Kortagere, Sandhya; Wannemacher, Kenneth M.; Howells, Richard D.; Welsh, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6442-6450</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel family of 1,3,5-trisubstituted 1,2,4-triazoles was discovered as potent and selective ligands for the δ opioid receptor by rational design.  Compd. 5b exhibited low-nanomolar in vitro binding affinity (IC50 = 5.8 nM), excellent selectivity for the δ opioid receptor over the alternative μ and κ opioid receptors, full agonist efficacy in receptor down-regulation and MAP kinase activation assays, and low-efficacy partial agonist activity in stimulation of GTPγS binding.  The apparent discrepancy obsd. in these functional assays may stem from different signaling pathways involved in each case, as found previously for other G-protein coupled receptors.  More biol. studies are underway to better understand the differential stimulation of signaling pathways by these novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnfVZ9vBUgLVg90H21EOLACvtfcHk0lgCJ83ZEMSIyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVenur3K&md5=8380f703ec010029393b2df8b379b3bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DS.%2BM.%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DWannemacher%26aufirst%3DK.%2BM.%26aulast%3DHowells%26aufirst%3DR.%2BD.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26atitle%3DNovel%2520delta%2520opioid%2520receptor%2520agonists%2520exhibit%2520differential%2520stimulation%2520of%2520signaling%2520pathways%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6442%26epage%3D6450%26doi%3D10.1016%2Fj.bmc.2009.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/s0169-409x(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2Fs0169-409x%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgCJ83ZEMSIyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2Fs0169-409x%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgRaw5Wy7Y1Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span> <span> </span><span class="NLM_article-title">[3H]-(+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors</span>. <i>Mol. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK2cXht1CktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=117&author=W.+D.+Bowenauthor=B.+R.+De+Costaauthor=S.+B.+Hellewellauthor=J.+M.+Walkerauthor=K.+C.+Rice&title=%5B3H%5D-%28%2B%29-Pentazocine%3A+A+potent+and+highly+selective+benzomorphan-based+probe+for+sigma-1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-( + )-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors</span></div><div class="casAuthors">Bowen, Wayne D.; de Costa, Brian R.; Hellewell, Susan B.; Walker, J. Michael; Rice, Kenner C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neuropharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-26</span>CODEN:
                <span class="NLM_cas:coden">MOLNEO</span>;
        ISSN:<span class="NLM_cas:issn">0959-5244</span>.
    </div><div class="casAbstract">[3H]-(+)-Pentazocine was synthesized and characterized as a benzomorphan-based sigma receptor probe using guinea-pig brain membranes.  [3H]-(+)-Pentazocine exhibited low levels of non-specific binding; 5-10% over the concn. range 3-25 nM.  This compared to 30-35% for [3H]-(+)-N-allylnormetazocine ([3H]-(+)-SKF 10,047), the only other available benzomorphan radioligand, over the same concn. range.  [3H]-(+)-Pentazocine labeled an apparent single class of sites with Kd = 4.8 nM and Bmax = 1,419 fmol/mg protein.  It exhibited a relatively slow assocn. rate and very slow monophasic dissocn. (t1/2 = 7.9 h).  The pharmacol. profile of sites labeled by [3H]-(+)-pentazocine correlated strongly (r = 0.98) with the sigma-1 profile of sites labeled by the prototypic sigma receptor probe [3H]-(+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H]-(+)-3-PPP).  Ligands for several neurotransmitter receptors were inactive at sites labeled by [3H]-(+)-pentazocine, demonstrating the sigma selectivity of this radioligand.  In rat brain membranes, [3H]-(+)-pentazocine selectively labeled sites with the sigma-1 profile, whereas [3H]-1,3-di(o-tolyl)guanidine ([3H]-DTG) (in the presence of a masking concn. of a sigma-1 ligand) labeled sites with the sigma-2 profile.  The high affinity, high selectivity, and low non-specific binding of [3H]-(+)-pentazocine make it a superior benzomorphan-based probe for sigma sites.  Furthermore, due to the low affinity of (+)-pentazocine at sigma-2 sites, [3H]-(+)-pentazocine is a highly selective ligand for the sigma-1 subtype, making it useful in studies of sigma site heterogeneity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfoMHM-tjYF7Vg90H21EOLACvtfcHk0lj10Ur45QuBbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1CktLg%253D&md5=cff8703ee7410980f0cbb3ad51b800fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DDe%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3D%255B3H%255D-%2528%252B%2529-Pentazocine%253A%2520A%2520potent%2520and%2520highly%2520selective%2520benzomorphan-based%2520probe%2520for%2520sigma-1%2520receptors%26jtitle%3DMol.%2520Neuropharmacol.%26date%3D1993%26volume%3D3%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span> <span> </span><span class="NLM_article-title">Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10087012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADyaK1MXit1Khsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=251-260&author=M.+E.+Ganapathyauthor=P.+D.+Prasadauthor=W.+Huangauthor=P.+Sethauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Molecular+and+ligand-binding+characterization+of+the+sigma-receptor+in+the+Jurkat+human+T+lymphocyte+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and ligand-binding characterization of the σ-receptor in the Jurkat human T lymphocyte cell line</span></div><div class="casAuthors">Ganapathy, Malliga E.; Prasad, Puttur D.; Huang, Wei; Seth, Pankaj; Leibach, Frederick H.; Ganapathy, Vadivel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ-binding site present in the Jurkat human T lymphocyte cell line was investigated.  Jurkat cell membranes were found to have a single saturable binding site for [3H]haloperidol, an σ-ligand (dissocn. const., 3.9 ± 0.3 nM).  The binding of [3H]haloperidol was inhibited by several σ-ligands.  Northern anal. and reverse transcription-polymerase chain reaction provided evidence for the expression of the recently cloned type 1 σ-receptor (σ-R1) in Jurkat cells.  The σ-R1 cDNA cloned from these cells was functional in heterologous expression systems.  When expressed in mammalian cells, the cDNA-induced binding was saturable with dissocn. consts. of 1.9 ± 0.3 nM for [3H]haloperidol and 12 ± 2 nM for (+)-pentazocine.  The binding of [3H]progesterone, a putative endogenous ligand to σ-R1, to the Jurkat cell σ-receptor could be directly demonstrated by using heterologously expressed σ-R1 cDNA.  The binding of [3H]progesterone was saturable, with a dissocn. const. of 88 ± 7 nM.  Progesterone and haloperidol interacted with the receptor competitively.  Reverse transcription-polymerase chain reaction also produced evidence for the existence of an alternatively spliced σ-R1 variant in Jurkat cells.  This splice variant was found to be nonfunctional in ligand-binding assays.  This constitutes the first report on the mol. characterization of the σ-receptor in immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE_luqabecabVg90H21EOLACvtfcHk0ljLxRV-uW7IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1Khsbo%253D&md5=40a5b1ac0a0eb679bac0ed580bb42dec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanapathy%26aufirst%3DM.%2BE.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DMolecular%2520and%2520ligand-binding%2520characterization%2520of%2520the%2520sigma-receptor%2520in%2520the%2520Jurkat%2520human%2520T%2520lymphocyte%2520cell%2520line%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel sigma1 receptor ligands for treating neuropathic pain: 6-hydroxypyridazinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2942</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01416</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2942-2961&author=X.+Caoauthor=Y.+Chenauthor=Y.+Zhangauthor=Y.+Lanauthor=J.+Zhangauthor=X.+Xuauthor=Y.+Qiuauthor=S.+Zhaoauthor=X.+Liuauthor=B.-F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+sigma1+receptor+ligands+for+treating+neuropathic+pain%3A+6-hydroxypyridazinones&doi=10.1021%2Facs.jmedchem.5b01416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones</span></div><div class="casAuthors">Cao, Xudong; Chen, Yin; Zhang, Yifang; Lan, Yu; Zhang, Juecheng; Xu, Xiangqing; Qiu, Yinli; Zhao, Song; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2942-2961</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By use of the 6-hydroxypyridazinone framework, a new series of potent σ1 receptor ligands assocd. with pharmacol. antineuropathic pain activity was synthesized and is described in this article.  In vitro receptor binding studies revealed high σ1 receptor affinity (Ki σ1 = 1.4 nM) and excellent selectivity over not only σ2 receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-dichlorophenyl)-6-(3-(piperidin-1-yl)propoxy)pyridazin-3(2H)-one (compd. 54).  Compd. 54 exhibited dose-dependent antiallodynic properties in mouse formalin model and rats chronic constriction injury (CCI) model of neuropathic pain.  In addn., functional activity of compd. 54 was evaluated using phenytoin and indicated that the compd. was a σ1 receptor antagonist.  Moreover, no motor impairments were found in rotarod tests at antiallodynic doses and no sedative side effect was evident in locomotor activity tests.  Last but not least, good safety and favorable pharmacokinetic properties were also noted.  These profiles suggest that compd. 54 may be a member of a novel class of candidate drugs for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouqLloqg6937Vg90H21EOLACvtfcHk0ljLxRV-uW7IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrsL8%253D&md5=fd377bf365861bc550f6d4dd5db20af4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01416%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.-F.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520sigma1%2520receptor%2520ligands%2520for%2520treating%2520neuropathic%2520pain%253A%25206-hydroxypyridazinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2942%26epage%3D2961%26doi%3D10.1021%2Facs.jmedchem.5b01416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Development of novel alkoxyisoxazoles as sigma-1 receptor antagonists with antinociceptive efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6329</span>– <span class="NLM_lpage">6343</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00571</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6329-6343&author=H.+Sunauthor=M.+Shiauthor=W.+Zhangauthor=Y.-M.+Zhengauthor=Y.-Z.+Xuauthor=J.-J.+Shiauthor=T.+Liuauthor=H.+Gunosewoyoauthor=T.+Pangauthor=Z.-B.+Gaoauthor=F.+Yangauthor=J.+Tangauthor=L.-F.+Yu&title=Development+of+novel+alkoxyisoxazoles+as+sigma-1+receptor+antagonists+with+antinociceptive+efficacy&doi=10.1021%2Facs.jmedchem.6b00571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel alkoxyisoxazoles as sigma-1 receptor antagonists with antinociceptive efficacy</span></div><div class="casAuthors">Sun, Hao; Shi, Min; Zhang, Wei; Zheng, Yue-Ming; Xu, Ya-Zhou; Shi, Jun-Jie; Liu, Ting; Gunosewoyo, Hendra; Pang, Tao; Gao, Zhao-Bing; Yang, Fan; Tang, Jie; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6329-6343</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of sigma (σ) receptor ligands based on an alkoxyisoxazole scaffold has been designed and synthesized.  Preliminary receptor binding assays identified highly potent (Ki < 1 nM) and selective σ1 ligands devoid of binding interactions with the monoamine transporters DAT, NET, and SERT.  In particular, compd. I was shown to possess significant antinociceptive activity in the mouse formalin-induced inflammation pain model when administered i.p. at 40 and 80 mg/kg.  Initial pharmacokinetics evaluation indicated an excellent brain exposure following oral dosing in mice, suggesting that further investigation into the use of alkoxyisoxazoles as σ1 ligands for antinociception is warranted.  This study supports the notion that selective σ1 antagonism could be a useful strategy in the development of novel antipain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMyTThgBAs7Vg90H21EOLACvtfcHk0ljLxRV-uW7IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFyntb4%253D&md5=ec9ef2824ddeaef099b4326025130d09</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00571%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DY.-M.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DShi%26aufirst%3DJ.-J.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DZ.-B.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DDevelopment%2520of%2520novel%2520alkoxyisoxazoles%2520as%2520sigma-1%2520receptor%2520antagonists%2520with%2520antinociceptive%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6329%26epage%3D6343%26doi%3D10.1021%2Facs.jmedchem.6b00571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span> <span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0ljvMT4HfYkv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitebread, S.</span></span> <span> </span><span class="NLM_article-title">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+safety-related+drug+attrition%3A+the+use+of+in+vitro+pharmacological+profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0ljvMT4HfYkv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520safety-related%2520drug%2520attrition%253A%2520the%2520use%2520of%2520in%2520vitro%2520pharmacological%2520profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen A; Berge O G; Hunskaar S; Rosland J H; Hole K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2ebuRd3XxQamg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J. S.</span></span> <span> </span><span class="NLM_article-title">Animal models of pain: progress and challenges</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1038/nrn2606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1038%2Fnrn2606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=19259101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=283-294&author=J.+S.+Mogil&title=Animal+models+of+pain%3A+progress+and+challenges&doi=10.1038%2Fnrn2606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pain: progress and challenges</span></div><div class="casAuthors">Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-294</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many are frustrated with the lack of translational progress in the pain field, in which huge gains in basic science knowledge obtained using animal models have not led to the development of many new clin. effective compds.  A careful re-examn. of animal models of pain is therefore warranted.  Pain researchers now have at their disposal a much wider range of mutant animals to study, assays that more closely resemble clin. pain states, and dependent measures beyond simple reflexive withdrawal.  However, the complexity of the phenomenon of pain has made it difficult to assess the true value of these advances.  In addn., pain studies are importantly affected by a wide range of modulatory factors, including sex, genotype and social communication, all of which must be taken into account when using an animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMgN3i1-8BbVg90H21EOLACvtfcHk0lh7NsZv0WUssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCntLY%253D&md5=364f8c94a9fa144fe4ea13c6f1f6641f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrn2606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2606%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DAnimal%2520models%2520of%2520pain%253A%2520progress%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D283%26epage%3D294%26doi%3D10.1038%2Fnrn2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polomano, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, G. J.</span></span> <span> </span><span class="NLM_article-title">A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1016/s0304-3959(01)00363-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0304-3959%2801%2900363-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=11731066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=293-304&author=R.+C.+Polomanoauthor=A.+J.+Mannesauthor=U.+S.+Clarkauthor=G.+J.+Bennett&title=A+painful+peripheral+neuropathy+in+the+rat+produced+by+the+chemotherapeutic+drug%2C+paclitaxel&doi=10.1016%2Fs0304-3959%2801%2900363-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel</span></div><div class="casAuthors">Polomano, Rosemary C.; Mannes, Andrew J.; Clark, Uraina S.; Bennett, Gary J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Paclitaxel, an effective anti-neoplastic agent in the treatment of solid tumors, produces a dose-limiting painful peripheral neuropathy in a clin. significant no. of cancer patients.  Prior work has demonstrated paclitaxel-induced neurodegeneration and sensory loss in lab. rodents.  We describe here an exptl. paclitaxel-induced painful peripheral neuropathy.  Adult male rats were given four i.p. injections on alternate days of vehicle or 0.5, 1.0, or 2.0 mg/kg of paclitaxel (Taxol).  Behavioral tests for pain using mech. and thermal stimuli applied to the tail and hind paws, and tests for motor performance, were taken before, during and after dosing for 22-35 days.  All three doses of paclitaxel caused heat-hyperalgesia, mechano-allodynia, mechano-hyperalgesia, and cold-allodynia, but had no effect on motor performance.  Neuropathic pain began within days and lasted for several weeks.  We did not detect any dose-response relation.  Tests at the distal, mid, and proximal tail failed to show evidence of a length-dependent neuropathy.  Vehicle control injections had no effect on any measure.  No significant systemic toxicities were noted in the paclitaxel-treated animals.  Light-microscopic inspection of the sciatic nerve (mid-thigh level), L4-L5 dorsal root ganglia, and dorsal and ventral roots, and the gray and white matter of the L4-L5 spinal cord, showed no structural abnormalities.  Electron microscopic examn. of the sciatic nerve (mid-thigh level) and the L4-L5 dorsal root ganglia and dorsal horns demonstrated no degeneration of myelinated and unmyelinated axons in the sciatic nerve and roots, but revealed endoneurial edema.  This model may be useful in understanding a significant source of pain in cancer patients, and in finding ways to avoid the neurotoxicity that limits paclitaxel therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvg-fNiqHpC7Vg90H21EOLACvtfcHk0lh7NsZv0WUssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Cntrk%253D&md5=3564fa80d47ce00fdb982e47e80eb7b3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2801%2900363-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252801%252900363-3%26sid%3Dliteratum%253Aachs%26aulast%3DPolomano%26aufirst%3DR.%2BC.%26aulast%3DMannes%26aufirst%3DA.%2BJ.%26aulast%3DClark%26aufirst%3DU.%2BS.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26atitle%3DA%2520painful%2520peripheral%2520neuropathy%2520in%2520the%2520rat%2520produced%2520by%2520the%2520chemotherapeutic%2520drug%252C%2520paclitaxel%26jtitle%3DPain%26date%3D2001%26volume%3D94%26spage%3D293%26epage%3D304%26doi%3D10.1016%2Fs0304-3959%2801%2900363-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesenfeld-Hallin, Z.</span></span> <span> </span><span class="NLM_article-title">Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/s0304-3940(00)00787-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2FS0304-3940%2800%2900787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10675798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2000&pages=211-214&author=J.-X.+Haoauthor=X.-J.+Xuauthor=L.+Urbanauthor=Z.+Wiesenfeld-Hallin&title=Repeated+administration+of+systemic+gabapentin+alleviates+allodynia-like+behaviors+in+spinally+injured+rats&doi=10.1016%2Fs0304-3940%2800%2900787-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats</span></div><div class="casAuthors">Hao, J.-X.; Xu, X.-J.; Urban, L.; Wiesenfeld-Hallin, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-214</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The effect of systemic gabapentin, a novel antiepileptic and analgesic, was tested on allodynia-like behaviors in spinal cord injured rats.  On the first day of treatment 30 mg/kg i.p. gabapentin did not alleviate hyper-reactivity to mech. and cold stimulation.  The allodynia was significantly reduced by 100 mg/kg gabapentin, which however, produced sedation and motor impairments.  Repeated administration of 30 mg/kg gabapentin once a day produced a gradually increasing anti-allodynic effect.  Total alleviation of mech. allodynia was obsd. in most rats after the third administration of gabapentin.  Thus, build-up of the antiallodynic effect of gabapentin may develop through a time dependent mechanism or alternatively through a gradual accumulation of the effective central nervous system concn. of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIeJ3MFT_J7Vg90H21EOLACvtfcHk0lh7NsZv0WUssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFamtrc%253D&md5=d1b3c05af4119183a0190313bcb04916</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2900787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252900787-4%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.-X.%26aulast%3DXu%26aufirst%3DX.-J.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DWiesenfeld-Hallin%26aufirst%3DZ.%26atitle%3DRepeated%2520administration%2520of%2520systemic%2520gabapentin%2520alleviates%2520allodynia-like%2520behaviors%2520in%2520spinally%2520injured%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D280%26spage%3D211%26epage%3D214%26doi%3D10.1016%2Fs0304-3940%2800%2900787-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Authier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balayssac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudore, F.</span></span> <span> </span><span class="NLM_article-title">Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2Fj.pain.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=17084975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1OqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=225-234&author=B.+Lingauthor=N.+Authierauthor=D.+Balayssacauthor=A.+Eschalierauthor=F.+Coudore&title=Behavioral+and+pharmacological+description+of+oxaliplatin-induced+painful+neuropathy+in+rat&doi=10.1016%2Fj.pain.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat</span></div><div class="casAuthors">Ling, Bing; Authier, Nicolas; Balayssac, David; Eschalier, Alain; Coudore, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-234</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We describe an animal model of nociceptive sensory neuropathy induced by repeat i.v. administration of oxaliplatin in which treated animals partly reproduce the characteristic pain symptoms in oxaliplatin-treated patients.  We tested the ability of 1, 2 and 4 mg/kg oxaliplatin doses injected twice-weekly for four-and-a-half consecutive weeks to induce a nociceptive peripheral neuropathy in male Sprague-Dawley rats.  The behavioral assessment revealed cold allodynia (10 °C) and hyperalgesia (4 °C) symptoms assocd. with a mech. allodynia.  The rats maintained a good general clin. status without motor dysfunction.  The 2 mg/kg oxaliplatin dose and the tail-immersion test in cold water (10 °C) were selected to compare pharmacol. sensitivity between single administered drugs as morphine, lidocaine, carbamazepine, gabapentin and repeated administration of drugs as clomipramine, venlafaxine, calcium and magnesium solns.  Magnesium soln. (90 mg/kg) and venlafaxine (7.5 mg/kg) administration induced an antinociceptive effect whereas gabapentin (300 mg/kg), clomipramine (2.5 mg/kg) and lidocaine (3 and 6 mg/kg) only induced an antiallodynic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfUZ75RfzhSrVg90H21EOLACvtfcHk0lh7NsZv0WUssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1OqsbY%253D&md5=c22e5e5e79542958749726f510a050ee</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DB.%26aulast%3DAuthier%26aufirst%3DN.%26aulast%3DBalayssac%26aufirst%3DD.%26aulast%3DEschalier%26aufirst%3DA.%26aulast%3DCoudore%26aufirst%3DF.%26atitle%3DBehavioral%2520and%2520pharmacological%2520description%2520of%2520oxaliplatin-induced%2520painful%2520neuropathy%2520in%2520rat%26jtitle%3DPain%26date%3D2007%26volume%3D128%26spage%3D225%26epage%3D234%26doi%3D10.1016%2Fj.pain.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altenbach, R. J.</span>; <span class="NLM_string-name">Bogdan, A.</span>; <span class="NLM_string-name">Couty, S.</span>; <span class="NLM_string-name">De
Lemos, E.</span>; <span class="NLM_string-name">Desroy, N.</span>; <span class="NLM_string-name">Duthion, B.</span>; <span class="NLM_string-name">Gfesser, G. A.</span>; <span class="NLM_string-name">Greszler, S. N.</span>; <span class="NLM_string-name">Housseman, C. G.</span>; <span class="NLM_string-name">Koenig, J. R.</span>; <span class="NLM_string-name">Kym, P. R.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Scanio, M. J.</span>; <span class="NLM_string-name">Searle, X.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yeung, M. C.</span>; <span class="NLM_string-name">Zhao, G.</span></span> <span> </span><span class="NLM_article-title">Substituted pyrrolidines and their use in the treatment of cystic fiibrosis</span>. <span class="NLM_patent">WO 2018065962 A1</span>, Apr 12, 2018, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Altenbach&author=A.+Bogdan&author=S.+Couty&author=E.+De%0ALemos&author=N.+Desroy&author=B.+Duthion&author=G.+A.+Gfesser&author=S.+N.+Greszler&author=C.+G.+Housseman&author=J.+R.+Koenig&author=P.+R.+Kym&author=B.+Liu&author=M.+J.+Scanio&author=X.+Searle&author=X.+Wang&author=M.+C.+Yeung&author=G.+Zhao&title=Substituted+pyrrolidines+and+their+use+in+the+treatment+of+cystic+fiibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAltenbach%26aufirst%3DR.%2BJ.%26atitle%3DSubstituted%2520pyrrolidines%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520cystic%2520fiibrosis%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eabBYaWYH9wzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HK1','PDB','5HK1'); return false;">PDB: 5HK1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DJZ','PDB','6DJZ'); return false;">PDB: 6DJZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DK0','PDB','6DK0'); return false;">PDB: 6DK0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01964">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48175"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01964?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01964</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Selectivity profiling of compound <b>10</b> in SafetyScreen 87; molecular formula strings (SMILES); <sup>1</sup>H NMR of all final compounds; <sup>13</sup>C NMR and HRMS spectra of compounds <b>10</b> and <b>12</b>; and purity report for compound <b>10</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_001.pdf">jm0c01964_si_001.pdf (7.41 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01964/suppl_file/jm0c01964_si_002.csv">jm0c01964_si_002.csv (2.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01964&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01964" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01964" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679924bf09163bf2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
